var title_f34_30_35296="Prednisolone: Pediatric drug information";
var content_f34_30_35296=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Prednisolone: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block inc\" id=\"F12618172\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F12645382\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?36/49/37650?source=see_link\">",
"       Prednisolone (ophthalmic): Pediatric drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?1/54/1896?source=see_link\">",
"       Prednisolone (systemic): Pediatric drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12723 Version 26.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-2ED33AB258-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_30_35296=[""].join("\n");
var outline_f34_30_35296=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?36/49/37650?source=related_link\">",
"      Prednisolone (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?1/54/1896?source=related_link\">",
"      Prednisolone (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_30_35297="Lichen slcerosus papules and plaques on wrist";
var content_f34_30_35297=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F58815&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F58815&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Extragenital lichen sclerosus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple small, white papules, some coaslescing into a larger plaque, are present on the wrist.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_30_35297=[""].join("\n");
var outline_f34_30_35297=null;
var title_f34_30_35298="Posterior shoulder dislocation reduction";
var content_f34_30_35298=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F78488&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F78488&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Posterior shoulder dislocation reduction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 279px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The underlying approach to the traction-countertraction technique demonstrated in this photograph is similar to that employed in the reduction of anterior dislocations. The notable difference is positioning. Note that the patient is upright and the clinician providing traction is standing in front of the patient.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Scott C Sherman, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_30_35298=[""].join("\n");
var outline_f34_30_35298=null;
var title_f34_30_35299="Brain MRI 16 year old vanishing white matter disease";
var content_f34_30_35299=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F81055&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F81055&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 608px\">",
"   <div class=\"ttl\">",
"    Brain MRI of a 16 year old girl with vanishing white matter disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 588px; height: 187px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    MR images of Patient 3. Shown are the transverse T2-weighted (A, B), proton density (C), and coronal fluid-attenuated inversion recovery (FLAIR) (D) images. The abnormal cerebral hemispheric white matter has a homogeneously high signal on T2-weighted images, but partly high and partly low signals on proton density and FLAIR images. The signal intensity is lowest in the white matter closest to the lateral ventricles (C, D). Note the radiating stripelike pattern in the low-signal intensity areas (C, D). Within the posterior limb of the internal capsule, a double line of signal abnormality is seen (B; arrows). Within the brainstem, the central tegmental tracts (A; small arrows) and transverse pontine fibers (A; large arrows) are involved.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Van der Knaap MS, Kamphorst W, Barth PG. Phenotypic variation in leukoencephalopathy with vanishing white matter. Neurology 1998; 51:540. Copyright &copy; 1998 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_30_35299=[""].join("\n");
var outline_f34_30_35299=null;
var title_f34_30_35300="Omphalomesenteric anomalies";
var content_f34_30_35300=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F62526&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F62526&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 558px\">",
"   <div class=\"ttl\">",
"    Anomalies of the omphalomesenteric duct",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 538px; height: 447px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_30_35300=[""].join("\n");
var outline_f34_30_35300=null;
var title_f34_30_35301="Poor R wave progress tutorial";
var content_f34_30_35301=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F58053&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F58053&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 545px\">",
"   <div class=\"ttl\">",
"    Poor R wave progression",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 525px; height: 144px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The R wave height does not become progressively taller from leads V1 to V3 or V4; in this example it remains of low amplitude until V6.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_30_35301=[""].join("\n");
var outline_f34_30_35301=null;
var title_f34_30_35302="View of the carpal tunnel";
var content_f34_30_35302=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F68934&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F68934&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 536px\">",
"   <div class=\"ttl\">",
"    View of the carpal tunnel",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 516px; height: 397px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    View of the carpal tunnel of the left hand. The median nerve and flexor tendons, which are in the tunnel, lie below the transverse carpal ligament that forms the roof of the tunnel.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Harwood-Nuss, A, Wolfson, AB, et al. The Clinical Practice of Emergency Medicine, Third Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2001. Copyright &copy; 2001 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_30_35302=[""].join("\n");
var outline_f34_30_35302=null;
var title_f34_30_35303="Purulent pericarditis";
var content_f34_30_35303=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Purulent pericarditis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/30/35303/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/30/35303/contributors\">",
"     G Ralph Corey, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/30/35303/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/30/35303/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/30/35303/contributors\">",
"     Martin M LeWinter, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/30/35303/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/30/35303/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/30/35303/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/30/35303/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to the widespread use of antibiotics, purulent pericarditis was a frequent complication of pneumococcal pneumonia. In modern times, most cases of purulent pericarditis are associated with nosocomial bloodstream infections (such as in the setting of dialysis), thoracic surgery, or immunosuppression (eg, HIV, chemotherapy).",
"   </p>",
"   <p>",
"    Galen (AD 129 &ndash; 217) was one of the first physicians to recognize and attempt to treat purulent pericarditis. While removing the \"putrefied\" sternum of a patient with posttraumatic pericarditis, he directly observed \"mortification of the pericardium\" in a patient who survived [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    By the beginning of the 19th century, clinicians were aware that purulent fluid collections in the pericardium could occur in patients with pneumonia and pleurisy, and were attempting treatment with percutaneous drainage and pericardiectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Issues related to purulent pericarditis will be reviewed here. Other causes of pericarditis and the management of acute pericarditis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/43/30392?source=see_link\">",
"     \"Etiology of pericardial disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/47/37625?source=see_link\">",
"     \"Clinical presentation and diagnostic evaluation of acute pericarditis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/44/713?source=see_link\">",
"     \"Treatment of acute pericarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Purulent pericarditis is defined as a localized infection of the pericardial space characterized by gross pus in the pericardium or microscopic purulence (&gt;20 leukocytes per oil immersion field). This distinction is important since purulent material in the pericardium is not synonymous with infectious pericarditis, and not all infections produce purulent effusions. As an example, pericarditis due to Mycoplasma hominis or viral infection is rarely macroscopically or microscopically purulent. By contrast, a variety of noninfectious conditions produce an inflammatory exudate that may contain &gt;50,000 white",
"    <span class=\"nowrap\">",
"     cells/microL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence and etiologies of purulent pericarditis have changed significantly in the antibiotic era. In modern practice, purulent pericarditis is relatively uncommon. In a retrospective review performed in Spain between 1972 and 1991, only 33 cases were observed among an inpatient population of 593,600; the diagnosis was not established until postmortem in 14 of these cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Predisposing factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;One study compared 55 patients who died from purulent pericarditis during the post antibiotic era with 145 patients who died from the same condition during the period 1889 to 1943 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/5\">",
"     5",
"    </a>",
"    ]. The following conclusions were reached:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the preantibiotic period, the majority of patients had a primary infectious disease such as pneumonia",
"      <span class=\"nowrap\">",
"       (72/145),",
"      </span>",
"      endocarditis",
"      <span class=\"nowrap\">",
"       (11/145),",
"      </span>",
"      or other",
"      <span class=\"nowrap\">",
"       (41/145).",
"      </span>",
"      Other infectious foci resulting in bacteremia and pericardial infection included the central nervous system, bone, pelvic, skin, and otic structures.",
"     </li>",
"     <li>",
"      In the modern era, only 22 percent of patients with purulent pericarditis had a recognized underlying primary infectious disease, such as pneumonia",
"      <span class=\"nowrap\">",
"       (3/55)",
"      </span>",
"      or meningitis",
"      <span class=\"nowrap\">",
"       (4/55).",
"      </span>",
"     </li>",
"     <li>",
"      In the preantibiotic era, only 14 percent of patients had an underlying non-infectious condition or disease. By contrast, in modern practice, 78 percent had one or more predisposing causes including recent thoracic surgery",
"      <span class=\"nowrap\">",
"       (12/55),",
"      </span>",
"      chronic renal failure",
"      <span class=\"nowrap\">",
"       (9/55),",
"      </span>",
"      or malignancy",
"      <span class=\"nowrap\">",
"       (8/55).",
"      </span>",
"     </li>",
"     <li>",
"      In the antibiotic era, many patients with purulent pericarditis also had preexisting pericardial diseases due to conditions or causes, such as uremia, tumor, or collagen vascular disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other predisposing factors include immunosuppression, alcohol abuse, and chest trauma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several mechanisms by which patients develop purulent pericarditis:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Direct spread from an intrathoracic focus of infection, including extension from a myocardial focus or direct contamination from trauma or thoracic surgery",
"     </li>",
"     <li>",
"      Hematogenous spread",
"     </li>",
"     <li>",
"      Extension from a subdiaphragmatic suppurative focus",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the preantibiotic era, direct pulmonary extension accounted for the probable route of acquisition in almost two-thirds of cases. In two of the larger series of cases of purulent pericarditis in the antibiotic era, direct pulmonary extension accounted for 20 and 25 percent of infections respectively, while hematogenous spread occurred in 29 and 22 percent, perforating injury or surgery in 24 and 29 percent, and myocardial abscess",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    endocarditis in 22 and 14 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/1,5\">",
"     1,5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Direct spread of infection from an intrathoracic focus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Virtually any organism can spread from infected lung into the pericardium; Streptococcus pneumoniae is the most common organism. In a review of 113 cases of pneumococcal pericarditis between 1900 and 1973, 93 percent of cases had a preceding pneumonia and 67 percent had pneumonia with empyema [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Infection can also spread to the pericardium following esophageal perforation. This complication is usually devastating, with a survival rate of only 17 percent in one review of 60 patients with pyopneumopericardium secondary to esophageal perforation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Hematogenous spread",
"    </span>",
"    &nbsp;&mdash;&nbsp;Virtually any organism can spread to the pericardial sac via the hematogenous route. Numerous case reports document an array of common and uncommon bacteria and fungi that have caused purulent pericarditis. Of these pathogens, Staphylococcus aureus and various streptococci are most common [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pneumonia or empyema may be accompanied by bacteremia; in such cases, patients can develop pericardial infection from hematogenous spread or via microscopic septic emboli into the bronchial arterial circulation, with secondary spread to the pericardium, myocardium, or adjacent mediastinum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Extension from a myocardial focus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infective endocarditis can be complicated by perivalvular ring abscess, septic coronary artery emboli, or myocardial abscess &mdash; all of which can result in direct extension of infection to the pericardium. In addition, occasionally a sterile inflammatory pericardial collection can develop in the setting of endocarditis. Therefore a clinical presentation of pericarditis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pericardial fluid in the setting of endocarditis or mural thrombus does not always imply purulent pericarditis, although such findings should be evaluated carefully.",
"   </p>",
"   <p>",
"    Rarely, myocardial infarction can be complicated by infection, resulting in abscess formation and secondary purulent pericarditis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/9\">",
"     9",
"    </a>",
"    ]. A myocardial abscess can also occur as metastatic infection in patients with bacteremia due to organisms such as S. aureus or Salmonella. Such patients may, in turn, develop purulent pericarditis from direct extension of the abscess into the pericardium. In rare cases, coronary artery stents can become infected with S. aureus, resulting in coronary artery aneurysms and purulent pericarditis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Perforating injury or surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Purulent pericarditis may develop as an early or late complication of perforating injury or thoracic surgery. Most of these patients have associated clinical signs or symptoms of mediastinitis or empyema. In some postthoracotomy patients it may be difficult to distinguish between pericardial injury syndrome and purulent pericarditis. S. aureus, enteric gram-negative rods, and Candida species are the most likely pathogens, although virtually any bacteria can cause purulent pericarditis in such situations. Purulent pericarditis due to knife wounds is often polymicrobial; bullet or shell fragment wounds may result in clostridial pericarditis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/31/24055?source=see_link\">",
"     \"Pericardial complications of myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Extension of infection from a subdiaphragmatic suppurative focus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Undrained subphrenic abscesses result in pericardial extension in 2 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/11\">",
"     11",
"    </a>",
"    ]. Rare subdiaphragmatic processes that can result in purulent pericarditis include intrahepatic amoebic abscess, ruptured duodenal or gastric ulcer, infected choledochal cyst, peritonitis, or erosion of intraabdominal tumor into the pericardium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/12,13\">",
"     12,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;S. aureus is the most common cause of purulent pericarditis, accounting for 31 percent of cases in one series and 22 percent in another [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/1,5\">",
"     1,5",
"    </a>",
"    ]. In these reviews, gram-positive organisms caused approximately 40 to 45 percent of all infections; polymicrobial infections were uncommon. S. pneumoniae is the most common cause of purulent pericarditis in the setting of direct spread of infection from an intrathoracic focus. Salmonella bacteremia can also result in purulent pericarditis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/14\">",
"     14",
"    </a>",
"    ]. Many other bacterial organisms have been reported to cause purulent pericarditis, including rare cases of infection with anaerobic bacteria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fungal pathogens have become more common causes of purulent pericarditis. In one series of 26 patients, fungi were the etiology of purulent pericarditis in 19 percent of cases; these patients had predisposing factors for candidemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/1\">",
"     1",
"    </a>",
"    ]. In two reviews summarizing the clinical features of 10 cases of Candida pericarditis, six patients had one or more well known predisposing factors for candidemia including parenteral hyperalimentation, steroid administration, prolonged antibiotic therapy, malignancy, burns, or alcoholism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. The remaining four patients had had recent cardiac surgery.",
"   </p>",
"   <p>",
"    Tuberculosis is the most common cause of subacute or chronic purulent pericarditis in developing countries, particularly where the prevalence of HIV is high [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/18\">",
"     18",
"    </a>",
"    ]. &nbsp;(See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/36/2633?source=see_link\">",
"     \"Tuberculous pericarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Purulent pericarditis is typically an acute illness characterized by high fever, tachycardia, cough, and chest pain (regardless of the pathogen involved or the pathogenesis of infection). In one series, the mean duration of symptoms before hospitalization was three days (range one to six days) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/1\">",
"     1",
"    </a>",
"    ]. In another series, clinical features of pericarditis developed a mean of 10 days after onset of predisposing infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fever is present in virtually all patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/1,4\">",
"     1,4",
"    </a>",
"    ]. Chest pain is less common in purulent pericarditis than in acute pericarditis of other etiologies (25 to 37 percent of patients) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/1,4\">",
"     1,4",
"    </a>",
"    ]. Chest pain may be pleuritic or nonpleuritic. In the postoperative setting, most patients with purulent pericarditis have other signs of mediastinitis or sternal wound infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/48/1800?source=see_link\">",
"     \"Postoperative mediastinitis after cardiac surgery\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/43/30392?source=see_link\">",
"     \"Etiology of pericardial disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A pericardial friction rub is present in 35 to 45 percent of patients with purulent pericarditis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/1,4\">",
"     1,4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/47/37625?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical presentation and diagnostic evaluation of acute pericarditis\", section on 'Pericardial friction rub'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The incidence of cardiac tamponade has varied from 42 to 77 percent in different series; sudden cardiac decompensation can rapidly lead to death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/1,4\">",
"     1,4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/52/19273?source=see_link\">",
"     \"Cardiac tamponade\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The majority of patients with purulent pericarditis are acutely ill; occasional patients have a relatively indolent course of infection. One such case was reported in a hemodialysis patient who was treated twice for lengthy periods for S. aureus bacteremia and then presented with dyspnea, fatigue, and chest discomfort [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/19\">",
"     19",
"    </a>",
"    ]. Chest computed tomography (CT) revealed a large anterior mediastinal mass compressing the heart (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef70734 \" href=\"mobipreview.htm?21/41/22161\">",
"     image 1",
"    </a>",
"    ); the patient underwent pericardiectomy and drainage of pus from the pericardial space. Salmonella may also cause a more indolent course of purulent pericarditis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;General laboratory tests are nonspecific in purulent pericarditis. Anemia and leukocytosis are present in most patients, although those receiving chemotherapy may be leukopenic.",
"   </p>",
"   <p>",
"    In one case series, chest x-rays were abnormal in 25 of 26 patients with purulent pericarditis (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef57640 \" href=\"mobipreview.htm?10/56/11136\">",
"     image 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/1\">",
"     1",
"    </a>",
"    ]. The findings included:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Cardiomegaly",
"      <span class=\"nowrap\">",
"       (19/25)",
"      </span>",
"     </li>",
"     <li>",
"      Pulmonary infiltrates",
"      <span class=\"nowrap\">",
"       (12/25)",
"      </span>",
"     </li>",
"     <li>",
"      Pleural effusions",
"      <span class=\"nowrap\">",
"       (8/25)",
"      </span>",
"     </li>",
"     <li>",
"      Mediastinal widening",
"      <span class=\"nowrap\">",
"       (3/25)",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Electrocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of patients with purulent pericarditis have electrocardiographic findings typical of acute pericarditis. However, the electrocardiogram may be normal in 10 to 35 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/1,4\">",
"     1,4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/47/37625?source=see_link&amp;anchor=H2297355#H2297355\">",
"     \"Clinical presentation and diagnostic evaluation of acute pericarditis\", section on 'Electrocardiogram'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Echocardiography is very useful for detecting fluid in patients with purulent pericarditis, but cannot distinguish between purulent collections and sterile inflammatory effusions. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/28/27077?source=see_link\">",
"     \"Echocardiographic evaluation of the pericardium\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/59/4025?source=see_link&amp;anchor=H5#H5\">",
"     \"Diagnosis and treatment of pericardial effusion\", section on 'Diagnostic approach'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of purulent pericarditis can be overlooked and delayed, particularly since it can be a complication of a variety of primary infectious diseases, trauma, surgery, and diseases in adjacent structures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/5\">",
"     5",
"    </a>",
"    ]. The widespread availability of two-dimensional echocardiography and computerized tomography has improved the antemortem diagnosis. Ultimately, however, the diagnosis of purulent pericarditis is established by obtaining pericardial fluid for culture and microscopy. Since many patients with purulent pericarditis have clinical signs compatible with tamponade, this procedure can be both diagnostic and therapeutic.",
"   </p>",
"   <p>",
"    The diagnosis of purulent pericarditis can be especially difficult when patients with preexisting conditions associated with pericardial effusions develop fever and leukocytosis. In addition, some pathogens (such as Neisseria meningitidis) cause sterile pericardial inflammatory fluid during the convalescent stage of illness, presumably immune-mediated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. Distinguishing sterile inflammation from purulent pericarditis is difficult.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Pericardiocentesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of purulent pericarditis is established by obtaining pericardial fluid for culture and microscopy. Echocardiographically-guided pericardiocentesis using portable echocardiographic equipment is preferable [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/22\">",
"     22",
"    </a>",
"    ]. Alternatively, pericardiocentesis can be performed by a \"blind\" subxiphoid approach or under fluoroscopic guidance and electrocardiographic needle monitoring. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/36/25159?source=see_link\">",
"     \"Technique of pericardiocentesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pericardial fluid should be sent for protein, glucose and cell count, along with Gram stain, acid fast stain, fungal stain, and cultures. Typically the protein concentration is high and glucose levels are less than 35",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (2",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    Pericardial fluid leukocyte counts generally are markedly elevated, ranging from 6000 to",
"    <span class=\"nowrap\">",
"     240,000/microL.",
"    </span>",
"    It is important to obtain an adequate sample of pericardial fluid for culture; swabs taken at the time of surgery are not adequate for obtaining cultures. A minimum of 0.5 mL of fluid should be sent to the microbiology laboratory but a sample of 1 mL or greater is preferred.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28697014\">",
"    <span class=\"h2\">",
"     Additional investigations",
"    </span>",
"    &nbsp;&mdash;&nbsp;For circumstances in which purulent pericarditis is accompanied by bacterial pneumonia, urinary S. pneumoniae antigen testing may be a useful diagnostic tool [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment for purulent pericarditis consists of pericardial drainage and antimicrobial therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/6\">",
"     6",
"    </a>",
"    ]. The best method of drainage remains controversial. Since purulent pericarditis is often a rapidly progressive and fatal infection, the expertise and experience of local clinicians and the availability of technology usually determines which of the following techniques is utilized. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/52/19273?source=see_link&amp;anchor=H27#H27\">",
"     \"Cardiac tamponade\", section on 'Removal of pericardial fluid'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Pericardial drainage",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of options are available for drainage of the infected pericardial fluid.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pericardiocentesis &mdash; Pericardiocentesis is the simplest and often the fastest way to drain the pericardial space. However, thick fluid may either drain poorly or result in loculations in the pericardial space. Furthermore, pericardial constriction may occur following recovery if pericardiocentesis is the primary drainage method [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/4\">",
"       4",
"      </a>",
"      ]. Intrapericardial instillation of fibrinolytics can be used to improve drainage of thick, purulent fluid. Case reports have demonstrated efficacy, although the only two series (12 children and 3 adults) had at least two serious complications [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/24-26\">",
"       24-26",
"      </a>",
"      ]. Until further data are available, surgical subxiphoid drainage is the preferable approach.",
"     </li>",
"     <li>",
"      Subxiphoid pericardiotomy &mdash; Subxiphoid pericardiotomy usually allows more complete and permanent drainage than pericardiocentesis because a pericardial \"window\" is established during the procedure and because manual lysis of adhesions and loculations is easily accomplished with the finger of the operating surgeon. This procedure is usually performed in an operating room, but, when necessary, can be performed at the bedside using local anesthesia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/27\">",
"       27",
"      </a>",
"      ]. This approach was recommended as the preferable course of management by the 2004 ESC guidelines [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Postoperative constrictive pericarditis can occur following this procedure, but is uncommon. A detailed discussion of constrictive pericarditis is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/12/12490?source=see_link\">",
"     \"Constrictive pericarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pericardiectomy &mdash; Pericardiectomy has a higher morbidity and mortality than subxiphoid pericardiotomy. However, pericardiectomy usually achieves complete drainage, and is frequently required in patients with dense adhesions, loculated and thick purulent effusion, recurrent tamponade, persistent infection, and progression to constriction [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/30/35303/abstract/6\">",
"       6",
"      </a>",
"      ]. A full discussion of pericardiectomy is presented separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/12/12490?source=see_link&amp;anchor=H21#H21\">",
"       \"Constrictive pericarditis\", section on 'Chronic constrictive pericarditis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Video-assisted thoracic surgery &mdash; Video-assisted thoracic surgery (VATS) requires intubation and deflation of the left lung. It is usually performed through a small left chest incision. A pericardial window can usually be performed with this procedure, but complete pericardial stripping is not possible. Although this procedure usually achieves good drainage of the pericardial space, it adds little to a subxiphoid pericardiotomy and carries more risk. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/28/41414?source=see_link&amp;anchor=H3#H3\">",
"       \"An overview of medical thoracoscopy\", section on 'Video-assisted versus medical thoracoscopy'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Antimicrobial therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intravenous antimicrobial therapy should be started as soon as the diagnosis of purulent pericarditis is suspected. Initial empiric antibiotic treatment should include coverage for the likely or suspected pathogens. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Microbiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Empiric regimen",
"    </span>",
"    &nbsp;&mdash;&nbsp;The selection of an empiric regimen depends on careful consideration of patient-specific factors that can give clues to an etiologic diagnosis. These factors include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Whether the patient is immunosuppressed",
"     </li>",
"     <li>",
"      Whether the infection began in a health-care setting or in the community",
"     </li>",
"     <li>",
"      The presence of a concurrent infection at another body site",
"     </li>",
"     <li>",
"      The presence of intravascular lines or prosthetic devices",
"     </li>",
"     <li>",
"      Local patterns of antimicrobial resistance",
"     </li>",
"     <li>",
"      Whether the patient has received recent antimicrobial therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In general, empiric therapy for infections that occur in immunosuppressed patients or in a healthcare setting should include coverage for both gram-positive and gram-negative bacterial pathogens. Possible regimens include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"       Vancomycin",
"      </a>",
"      (30",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day divided in two doses with adjustment for decreased renal function); goal is a vancomycin trough serum level of 15",
"      <span class=\"nowrap\">",
"       mcg/mL",
"      </span>",
"      or greater, plus either",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/17/10521?source=see_link\">",
"       Ceftriaxone",
"      </a>",
"      (2 g IV once daily),",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/57/35735?source=see_link\">",
"       cefotaxime",
"      </a>",
"      (2 g every eight hours) or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/10/36000?source=see_link\">",
"       gentamicin",
"      </a>",
"      (3",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per 24 hours divided equally in two or three doses)",
"      <strong>",
"       OR",
"      </strong>",
"     </li>",
"     <li>",
"      A carbapenem, such as imipenem (500 mg IV every six hours) or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/38/32359?source=see_link\">",
"       meropenem",
"      </a>",
"      (1 g IV every eight hours)",
"      <strong>",
"       OR",
"      </strong>",
"     </li>",
"     <li>",
"      A beta-lactam plus beta-lactamase inhibitor, such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/45/42710?source=see_link\">",
"       ticarcillin-clavulanate",
"      </a>",
"      (3.1 g IV every four hours),",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/41/24216?source=see_link\">",
"       piperacillin-tazobactam",
"      </a>",
"      (4.5 g every six hours)",
"      <strong>",
"       or",
"      </strong>",
"      &nbsp;",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?1/8/1160?source=see_link\">",
"       ampicillin-sulbactam",
"      </a>",
"      (3 g IV every six hours)",
"      <strong>",
"       OR",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/33/16919?source=see_link\">",
"       Cefepime",
"      </a>",
"      (2 g IV every 12 hours)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, empiric therapy with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/12/16586?source=see_link\">",
"     fluconazole",
"    </a>",
"    (200 to 400 mg intravenously once daily) is recommended for patients who are severely immunosuppressed, for those who have had recent care in an intensive care unit, or for recipients of recent broad-spectrum antimicrobial therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Pathogen-directed therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;After a microbiologic diagnosis has been established by blood",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pericardial fluid cultures, therapy should be directed at the specific pathogen isolated. If a methicillin-susceptible S. aureus is recovered from cultures of the blood",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pericardial fluid,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/36/1608?source=see_link\">",
"     nafcillin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/15/8437?source=see_link\">",
"     oxacillin",
"    </a>",
"    (2 g IV every four hours) should be substituted for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    in patients who are not allergic to beta-lactam antibiotics. There is no role for pericardial instillation of antibiotic, since therapeutic levels in the pericardial fluid are achieved by intravenous administration of antibiotics.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Duration of therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The duration of therapy must be individualized. Intravenous therapy should be continued until fever and clinical signs of infection have resolved and until the white blood cell count is normal. In general this usually consists of a total of approximately two to four weeks of therapy, depending on the adequacy of drainage and the antimicrobial susceptibility of the infecting bacteria.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4270450\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Purulent pericarditis is a localized infection of the pericardial space producing fluid that is macroscopically or microscopically purulent. This distinction is important since purulent material in the pericardium is not synonymous with infectious pericarditis, and not all infections produce purulent effusions. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The mechanisms by which patients develop purulent pericarditis include: direct spread from an intrathoracic focus of infection, hematogenous spread, extension from a myocardial focus, direct contamination from trauma or thoracic surgery, and extension from a subdiaphragmatic suppurative focus. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Staphylococcus aureus is the most common cause of purulent pericarditis. Other important pathogens include Streptococcus pneumoniae, Salmonella, Candida, and tuberculosis. Polymicrobial infections are uncommon. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Purulent pericarditis is typically an acute illness characterized by high fever, tachycardia, cough, and chest pain. Chest pain, however, is less common in purulent pericarditis than in acute pericarditis of other etiologies; when present it may be pleuritic or nonpleuritic. In the postoperative setting, most patients with purulent pericarditis have signs of mediastinitis or sternal wound infection. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of purulent pericarditis is established by obtaining pericardial fluid for culture and microscopy. Echocardiographically-guided pericardiocentesis is preferable. Pericardial fluid should be sent for protein, glucose and cell count, along with Gram stain, acid fast stain, fungal stain, and cultures. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment for purulent pericarditis consists of pericardial drainage and antimicrobial therapy. Pericardiocentesis is frequently the fastest way to drain the pericardial space, although thick fluid may either drain poorly or result in loculations in the pericardial space. Subxiphoid pericardiotomy usually allows more complete and permanent drainage than pericardiocentesis because a pericardial \"window\" is established during the procedure and because manual lysis of adhesions and loculations is easily accomplished. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Intravenous antimicrobial therapy should be started as soon as the diagnosis of purulent pericarditis is suspected. Initial empiric antibiotic treatment should include coverage for the likely or suspected pathogens. The selection of an empiric regimen depends on careful consideration of patient-specific factors that can give clues to an etiologic diagnosis. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Empiric regimen'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      After a microbiologic diagnosis has been established by blood",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      pericardial fluid cultures, therapy should be directed at the specific pathogen isolated. The duration of therapy must be individualized. Intravenous therapy should be continued until fever and clinical signs of infection have resolved and until the white blood cell count is normal. In general this usually requires a total of two to four weeks of therapy. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Pathogen-directed therapy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H23\">",
"       'Duration of therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/1\">",
"      Rubin RH, Moellering RC Jr. Clinical, microbiologic and therapeutic aspects of purulent pericarditis. Am J Med 1975; 59:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/2\">",
"      Boyle JO, Pearce ML, Guze LB. Purulent pericarditis. Review of the literature and report of eleven cases. Medicine (Baltimore) 1961; 40:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/3\">",
"      Kenney RT, Li JS, Clyde WA Jr, et al. Mycoplasmal pericarditis: evidence of invasive disease. Clin Infect Dis 1993; 17 Suppl 1:S58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/4\">",
"      Sagrist&agrave;-Sauleda J, Barrab&eacute;s JA, Permanyer-Miralda G, Soler-Soler J. Purulent pericarditis: review of a 20-year experience in a general hospital. J Am Coll Cardiol 1993; 22:1661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/5\">",
"      Klacsmann PG, Bulkley BH, Hutchins GM. The changed spectrum of purulent pericarditis: an 86 year autopsy experience in 200 patients. Am J Med 1977; 63:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/6\">",
"      Maisch B, Seferovi�� PM, Risti�� AD, et al. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 2004; 25:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/7\">",
"      Kauffman CA, Watanakunakorn C, Phair JP. Purulent pneumococcal pericarditis. A continuing problem in the antibiotic era. Am J Med 1973; 54:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/8\">",
"      Miller WL, Osborn MJ, Sinak LJ, Westbrook BM. Pyopneumopericardium attributed to an esophagopericardial fistula: report of a survivor and review of the literature. Mayo Clin Proc 1991; 66:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/9\">",
"      KATZ A. ABSCESS OF THE MYOCARDIUM COMPLICATING INFARCTION: REPORT OF TWO CASES. Can Med Assoc J 1964; 91:1225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/10\">",
"      Schoenkerman AB, Lundstrom RJ. Coronary stent infections: a case series. Catheter Cardiovasc Interv 2009; 73:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/11\">",
"      Ochsner A, DeBakey ME. Subphrenic abscess: Collective review and analysis of 3608 collected and personal cases. Int Abstr Surg 1938; 66:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/12\">",
"      Ochsner A, DeBakey ME. Amebic hepatitis and hepatic abscess: analysis of 181 cases with review of the literature. Surgery 1943; 13:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/13\">",
"      Myer, HW. Pneumopyopericardium. J Thorac Cardiovasc Surg 1948; 17:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/14\">",
"      Parikh SV, Memon N, Echols M, et al. Purulent pericarditis: report of 2 cases and review of the literature. Medicine (Baltimore) 2009; 88:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/15\">",
"      Brook I. Pericarditis caused by anaerobic bacteria. Int J Antimicrob Agents 2009; 33:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/16\">",
"      Schrank JH Jr, Dooley DP. Purulent pericarditis caused by Candida species: case report and review. Clin Infect Dis 1995; 21:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/17\">",
"      Kraus WE, Valenstein PN, Corey GR. Purulent pericarditis caused by Candida: report of three cases and identification of high-risk populations as an aid to early diagnosis. Rev Infect Dis 1988; 10:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/18\">",
"      Cegielski P, Dukes CS. Pericardial effusion in AIDS. Circulation 1997; 96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/19\">",
"      Nwiloh JO, Egbe PA, Tagoe AT, Weaver LW. Staphylococcus aureus pericarditis masquerading as anterior mediastinal mass: mediastinal mass from pericarditis. Chest 2000; 118:1832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/20\">",
"      Pierce HI, Cooper EB. Meningococcal pericarditis. Clinical features andd therapy in five patients. Arch Intern Med 1972; 129:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/21\">",
"      Morse JR, Oretsky MI, Hudson JA. Pericarditis as a complication of meningococcal meningitis. Ann Intern Med 1971; 74:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/22\">",
"      Salem K, Mulji A, Lonn E. Echocardiographically guided pericardiocentesis - the gold standard for the management of pericardial effusion and cardiac tamponade. Can J Cardiol 1999; 15:1251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/23\">",
"      Nakagawa C, Kasahara K, Yonekawa S, et al. Purulent pericarditis due to Streptococcus pneumoniae diagnosed by pneumococcal urinary antigen assay and 16S rDNA sequence of the pericardial fluid. Intern Med 2010; 49:1653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/24\">",
"      Defouilloy C, Meyer G, Slama M, et al. Intrapericardial fibrinolysis: a useful treatment in the management of purulent pericarditis. Intensive Care Med 1997; 23:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/25\">",
"      Juneja R, Kothari SS, Saxena A, et al. Intrapericardial streptokinase in purulent pericarditis. Arch Dis Child 1999; 80:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/26\">",
"      Ust&uuml;nsoy H, Celkan MA, Sivrikoz MC, et al. Intrapericardial fibrinolytic therapy in purulent pericarditis. Eur J Cardiothorac Surg 2002; 22:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35303/abstract/27\">",
"      Van Trigt P, Douglas J, Smith PK, et al. A prospective trial of subxiphoid pericardiotomy in the diagnosis and treatment of large pericardial effusion. A follow-up report. Ann Surg 1993; 218:777.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2128 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-1745D172DA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_30_35303=[""].join("\n");
var outline_f34_30_35303=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H4270450\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Predisposing factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Direct spread of infection from an intrathoracic focus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Hematogenous spread",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Extension from a myocardial focus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Perforating injury or surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Extension of infection from a subdiaphragmatic suppurative focus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Electrocardiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Echocardiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Pericardiocentesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28697014\">",
"      Additional investigations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Pericardial drainage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Antimicrobial therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Empiric regimen",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Pathogen-directed therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Duration of therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4270450\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/2128\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/2128|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?21/41/22161\" title=\"diagnostic image 1\">",
"      Pericarditis mediastinal mass",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?10/56/11136\" title=\"diagnostic image 2\">",
"      Chest x-ray of a pericardial effusion",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/28/41414?source=related_link\">",
"      An overview of medical thoracoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/52/19273?source=related_link\">",
"      Cardiac tamponade",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/47/37625?source=related_link\">",
"      Clinical presentation and diagnostic evaluation of acute pericarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/12/12490?source=related_link\">",
"      Constrictive pericarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/59/4025?source=related_link\">",
"      Diagnosis and treatment of pericardial effusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/28/27077?source=related_link\">",
"      Echocardiographic evaluation of the pericardium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/43/30392?source=related_link\">",
"      Etiology of pericardial disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/31/24055?source=related_link\">",
"      Pericardial complications of myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/48/1800?source=related_link\">",
"      Postoperative mediastinitis after cardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/36/25159?source=related_link\">",
"      Technique of pericardiocentesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/44/713?source=related_link\">",
"      Treatment of acute pericarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/36/2633?source=related_link\">",
"      Tuberculous pericarditis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_30_35304="Poststreptococcal glomerulonephritis in children";
var content_f34_30_35304=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Poststreptococcal glomerulonephritis in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/30/35304/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/30/35304/contributors\">",
"     Patrick Niaudet, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/30/35304/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/30/35304/contributors\">",
"     F Bruder Stapleton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/30/35304/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/30/35304/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/30/35304/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Poststreptococcal glomerulonephritis (PSGN) is caused by prior infection with specific nephritogenic strains of group A beta-hemolytic streptococcus. The clinical presentation of PSGN varies from asymptomatic, microscopic hematuria to the full-blown acute nephritic syndrome, characterized by red to brown urine, proteinuria (which can reach the nephrotic range), edema, hypertension, and acute kidney injury. The prognosis is generally favorable, especially in children, but in some cases, the long-term prognosis is not benign.",
"   </p>",
"   <p>",
"    The clinical manifestations, diagnosis, management, course of disease, and prognosis of PSGN will be reviewed here.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although PSGN continues to be the most common cause of acute nephritis in children globally, it primarily occurs in developing countries. Of the estimated 470,000 new annual cases of PSGN worldwide, 97 percent occur in developing countries, with an annual incidence that ranges from 9.5 to 28.5 per 100,000 individuals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In more developed and industrialized countries, the incidence has decreased over the past three decades [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. Based upon data from the Italian Biopsy registry, the estimated annual incidence was 0.3 per 100,000 individuals between 1992 and 1994 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/5\">",
"     5",
"    </a>",
"    ]. The risk of PSGN is increased in older patients (greater than 60 years of age) and in children between 5 and 12 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. PSGN is uncommon in children less than three years of age.",
"   </p>",
"   <p>",
"    PSGN can present as a sporadic case or during an epidemic of group A streptococcal (GAS) infection (ie, skin and throat infections) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/2\">",
"     2",
"    </a>",
"    ]. The incidence of clinically detectable PSGN in children infected during a GAS epidemic is about 5 to 10 percent with pharyngitis and 25 percent with skin infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;PSGN appears to be caused by glomerular immune complex disease induced by specific nephritogenic strains of group A beta-hemolytic streptococcus (GAS). The resulting glomerular immune complex disease triggers complement activation and inflammation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/20/40261?source=see_link\">",
"     \"Pathogenesis of tissue injury in glomerulonephritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/30/18921?source=see_link\">",
"     \"Mechanisms of immune injury of the glomerulus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/1/12311?source=see_link&amp;anchor=H2#H2\">",
"     \"Overview of the pathogenesis and causes of glomerulonephritis in children\", section on 'Pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following are proposed mechanisms for the immunologic glomerular injury induced by GAS infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/9\">",
"     9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Deposition of circulating immune complexes with streptococcal antigenic components",
"     </li>",
"     <li>",
"      In situ immune complex formation resulting from deposition of streptococcal antigens within the glomerular basement membrane (GBM) and subsequent antibody binding",
"     </li>",
"     <li>",
"      In situ glomerular immune complex formation promoted by antibodies to streptococcal antigens that cross-react with glomerular components (molecular mimicry)",
"     </li>",
"     <li>",
"      Alteration of a normal renal antigen that elicits autoimmune reactivity",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The available evidence suggests that the major pathogenetic mechanism is in situ immune complex formation due to deposition of streptococcal nephritogenic antigens within the glomerulus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Nephritogenic antigens",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two leading candidates for the putative streptococcal antigen(s) responsible for PSGN [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/9\">",
"     9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nephritis-associated plasmin receptor (NAPlr), a glycolytic enzyme, which has glyceraldehyde-3-phosphate dehydrogenase (GAPDH) activity",
"     </li>",
"     <li>",
"      Streptococcal pyrogenic exotoxin B (SPE B), a cationic cysteine proteinase",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Results from the following studies provide support for the role of these proteins in the pathogenesis of PSGN:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of Japanese patients with PSGN, NAPlr was present in renal biopsy samples obtained within the first 14 days of their disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/10\">",
"       10",
"      </a>",
"      ]. Antibodies to NAPlr were present in the sera of 92 percent of patients with PSGN, and 60 percent of patients with uncomplicated group A streptococcal infections.",
"     </li>",
"     <li>",
"      In another report that included patients from Latin America and Switzerland, SPE B was found in 12 of 17 biopsies. SPE B deposition colocalized with complement deposition and within the subepithelial electron dense deposits (humps) that are characteristic of PSGN (",
"      <a class=\"graphic graphic_picture graphicRef76739 \" href=\"mobipreview.htm?38/23/39288\">",
"       picture 1",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/11\">",
"       11",
"      </a>",
"      ]. Antibodies to SPE B were detected in the convalescent sera in all 53 patients who were tested. In contrast, circulating antibodies to NAPlr were found in only 5 of 47 tested sera, and in only one biopsy sample.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although the findings from the last study support the role of SPE B as the more likely nephritogenic antigen, an alternate explanation is that separate antigens are responsible for PSGN in different parts of the world",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    patients with varying genetic backgrounds [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/2,9\">",
"     2,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Independent of the immune response, both SPE B and NAPlr can activate the alternate complement pathway (a characteristic finding in PSGN) and enhance the expression of adhesion molecules. SPE B also can stimulate the production of chemotactic cytokines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Complement'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Light microscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Light microscopy shows a diffuse proliferative glomerulonephritis with prominent endocapillary proliferation and numerous neutrophils (",
"    <a class=\"graphic graphic_picture graphicRef80304 \" href=\"mobipreview.htm?19/17/19734\">",
"     picture 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef51022 \" href=\"mobipreview.htm?32/44/33478\">",
"     picture 3",
"    </a>",
"    ). Trichrome stain may show small subepithelial hump-shaped deposits. The severity of involvement varies and usually correlates with the clinical findings. Patients who are asymptomatic or have mild disease may have biopsies that show little glomerular involvement, whereas, patients with diffuse endocapillary proliferative glomerulonephritis are more likely to have full-blown acute nephritic syndrome (ie, red to brown urine, proteinuria, edema, hypertension, and acute renal failure). Crescent formation is uncommon and is associated with a poor prognosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Immunofluorescence microscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunofluorescence (IF) microscopy reveals a characteristic pattern of deposits of immunoglobulin (IgG) and C3 distributed in a diffuse granular pattern within the mesangium, and glomerular capillary walls (",
"    <a class=\"graphic graphic_picture graphicRef56846 \" href=\"mobipreview.htm?7/1/7184\">",
"     picture 4",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/12\">",
"     12",
"    </a>",
"    ]. Other immune reactants (eg, IgM, IgA, fibrin, and other complement components) may also be detected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Electron microscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most characteristic feature detected by electron microscopy (EM) are the dome-shaped subepithelial electron-dense deposits that are referred to as humps (",
"    <a class=\"graphic graphic_picture graphicRef76739 \" href=\"mobipreview.htm?38/23/39288\">",
"     picture 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/13\">",
"     13",
"    </a>",
"    ]. These deposits along with subendothelial deposits are immune complexes and correspond to the deposits of IgG and C3 found on IF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Subendothelial immune deposits and subsequent complement activation are responsible for the local influx of inflammatory cells, leading to a proliferative glomerulonephritis, an active urine sediment, and a variable decline in glomerular filtration rate [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Subepithelial \"humps\" are responsible for epithelial cell damage and proteinuria, similar to that seen in membranous nephropathy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/15\">",
"       15",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?18/54/19306?source=see_link\">",
"       \"Causes and diagnosis of membranous nephropathy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It has been proposed that the clinical course of PSGN is related to the different rates of clearance of immune complexes at these two sites. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Correlation with histologic recovery'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical presentation varies from asymptomatic, microscopic hematuria to the full-blown acute nephritic syndrome, characterized by red to brown urine, proteinuria (which can reach the nephrotic range), edema, hypertension, and an elevation in serum creatinine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/16-18\">",
"     16-18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is usually an antecedent history of a group A beta-hemolytic streptococcal (GAS) skin or throat infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/6,16,17\">",
"     6,16,17",
"    </a>",
"    ]. The latent period between GAS infection and PSGN is dependent upon the site of infection: between one and three weeks following GAS pharyngitis and between three and six weeks following GAS skin infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following symptoms are the most common presenting signs in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/16-18,20\">",
"     16-18,20",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Edema &mdash; Generalized edema is present in about two-thirds of patients due to sodium and water retention. In severe cases, fluid overload leads to respiratory distress due to pulmonary edema.",
"     </li>",
"     <li>",
"      Gross hematuria &mdash; Gross hematuria is present in about 30 to 50 percent of patients. The urine looks smoky, and tea or coca cola-colored.",
"     </li>",
"     <li>",
"      Hypertension &mdash; Hypertension is present in 50 to 90 percent of patients and varies from mild to severe. It is primarily caused by fluid retention. Hypertensive encephalopathy was an uncommon but serious complication. These patients require emergent intervention. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/53/17241?source=see_link&amp;anchor=H7#H7\">",
"       \"Approach to hypertensive emergencies and urgencies in children\", section on 'Hypertensive encephalopathy'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/33/23065?source=see_link\">",
"       \"Management of hypertensive emergencies and urgencies in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Subclinical cases of PSGN are primarily characterized by microscopic hematuria [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/17,21,22\">",
"       17,21,22",
"      </a>",
"      ]. Such patients were often detected during epidemics.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    PSGN is associated with a variable decline in glomerular filtration rate that is detected by a rise in serum creatinine. Acute renal failure requiring dialysis is uncommon. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/53/19290?source=see_link\">",
"     \"Acute kidney injury in children: Clinical features, etiology, evaluation, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Laboratory findings",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Urinalysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The urinalysis in patients with PSGN reveal hematuria (some of the red cells are typically dysmorphic) with or without red blood cell casts, varying degrees of proteinuria (",
"    <a class=\"graphic graphic_picture graphicRef79440 graphicRef62064 graphicRef55778 \" href=\"mobipreview.htm?8/16/8455\">",
"     picture 5A-C",
"    </a>",
"    ), and often pyuria. Nephrotic range proteinuria is uncommon and occurs in about 5 percent of cases at presentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/23\">",
"     23",
"    </a>",
"    ]. The urinalysis should be performed on a freshly voided specimen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Complement",
"    </span>",
"    &nbsp;&mdash;&nbsp;In about 90 percent of patients, C3 and CH50 (total complement activity) are significantly depressed in the first two weeks of the disease course [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. In comparison, C4 and C2 levels are usually normal or only mildly decreased. The C3 and CH 50 return to normal within four to eight weeks after presentation.",
"   </p>",
"   <p>",
"    The combination of a low C3 level and a normal or only slightly decreased C4 level indicates activation of the alternative pathway of complement. In contrast, lupus nephritis is associated with activation of the classical pathway with reductions in both C3 and C4. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/25/10647?source=see_link&amp;anchor=H20#H20\">",
"     \"Overview and clinical assessment of the complement system\", section on 'Patterns associated with activation of specific pathways'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because PSGN presents weeks after an antecedent GAS infection, only about 25 percent of patients will have either a positive throat or skin culture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/6\">",
"     6",
"    </a>",
"    ]. In patients with impetigo, there is an increased likelihood of obtaining a positive skin culture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Serology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elevated titers of antibodies to extracellular streptococcal products is evidence of a recent GAS infection. The streptozyme test, which measures five different streptococcal antibodies, is positive in more than 95 percent of patients due to pharyngitis and about 80 percent of those with skin infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/26-28\">",
"     26-28",
"    </a>",
"    ]. It includes the following antibodies:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Anti-streptolysin (ASO)",
"     </li>",
"     <li>",
"      Anti-hyaluronidase (AHase)",
"     </li>",
"     <li>",
"      Anti-streptokinase (ASKase)",
"     </li>",
"     <li>",
"      Anti-nicotinamide-adenine dinucleotidase (anti-NAD)",
"     </li>",
"     <li>",
"      Anti-DNAse B antibodies",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These antibodies can also be measured individually. After a pharyngeal infection, the ASO, anti-DNAse B, anti-NAD, and AHase titers are commonly elevated. In comparison, only the anti-DNAse B and AHase titers are typically increased after a skin infection.",
"   </p>",
"   <p>",
"    If only the ASO titer is used to screen for GAS infection, it may be falsely low or negative in patients with skin infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/26\">",
"     26",
"    </a>",
"    ] . In addition, the rise in ASO titer may be blunted in patients with pharyngitis who have received antimicrobial therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;PSGN is usually diagnosed based upon clinical findings of acute nephritis and demonstration of a recent group A beta-hemolytic streptococcal (GAS) infection.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The clinical findings of acute nephritis include hematuria with or without red blood cell casts, variable degrees of proteinuria, edema, and hypertension. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Documentation of a recent GAS infection includes either a positive throat or skin culture or serologic tests (eg, ASO or streptozyme test). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Serology'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although a low C3",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    CH 50 (total complement) level are consistent with a diagnosis of PSGN, these complement components may also be decreased in other forms of glomerulonephritis, including membranoproliferative glomerulonephritis. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A delay in the diagnosis of PSGN is more common in children who do not have a history of an antecedent GAS infection and have microscopic hematuria. This was illustrated in a case series of 57 children with PSGN who had a delay in diagnosis of greater than 24 hours [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/29\">",
"     29",
"    </a>",
"    ]. In most of the patients, presenting findings were due to volume overload and included hypertension, edema, and pulmonary edema. The authors concluded that acute nephritis needs to be considered in any child who presents with symptoms secondary to volume overload and that a urinalysis should be obtained as an initial diagnostic test.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Renal biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renal biopsy is not performed in most patients to confirm the diagnosis of PSGN, since the clinical history is usually highly suggestive and resolution of PSGN typically begins within one week of presentation.",
"   </p>",
"   <p>",
"    A biopsy is usually performed in patients in whom other glomerular disorders are being considered because they deviate from the natural course of the PSGN or they present late without a clear history of prior streptococcal infection. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Differential diagnosis'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H19\">",
"     'Course'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Persistently low C3 levels beyond six weeks are suggestive of a diagnosis of membranoproliferative glomerulonephritis.",
"     </li>",
"     <li>",
"      Recurrent episodes of hematuria are suggestive of IgA nephropathy and are rare in PSGN.",
"     </li>",
"     <li>",
"      A progressive increase in serum creatinine is uncharacteristic of PSGN, but there are occasional patients who do not recover from the acute episode. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Course'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of PSGN is generally straightforward in patients once the diagnosis of acute nephritis is made, there is documentation of a recent group A beta-hemolytic streptococcal (GAS) infection, and the nephritis begins to resolve within one or two weeks of presentation. However, if there is progressive disease beyond two weeks, persistent hematuria or hypertension beyond four or six weeks, or there is not adequate documentation of an antecedent GAS infection, the following causes of GN need to be considered. A renal biopsy may be needed to differentiate PSGN from these other disorders.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Membranoproliferative glomerulonephritis (MPGN) &mdash; The presentation of MPGN may be indistinguishable initially from PSGN. It typically presents with hematuria, hypertension, proteinuria, and hypocomplementemia following an upper respiratory infection. However, patients with MPGN continue to have persistent nephritis and hypocomplementemia beyond four to six weeks and possibly a further elevation in serum creatinine. In contrast, patients with PSGN typically have resolution of their disease and a return of normal C3 and CH50 levels. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/51/43833?source=see_link\">",
"       \"Clinical presentation, classification, and causes of membranoproliferative glomerulonephritis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      IgA nephropathy &mdash; Patients with IgA nephropathy often present after an upper respiratory infection, similar to the presentation of patients with PSGN. Potential distinguishing features from PSGN include a shorter time between the antecedent illness and hematuria is (less than 5 versus more than 10 days in PSGN) and a history of prior episodes of gross hematuria since recurrence is rare in PSGN. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/31/27130?source=see_link&amp;anchor=H14578038#H14578038\">",
"       \"Differential diagnosis and evaluation of glomerular disease\", section on 'Hematuria following upper respiratory infection'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/19/1337?source=see_link\">",
"       \"Clinical presentation and diagnosis of IgA nephropathy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Secondary causes of glomerulonephritis &mdash; Lupus nephritis and Henoch-Sch&ouml;nlein purpura (IgA vasculitis) nephritis share similar features to PSGN. However, extrarenal manifestations of the underlying systemic diseases and laboratory testing should differentiate them from PSGN. Measurement of serum complement may also be helpful. Hypocomplementemia is not characteristic of Henoch-Sch&ouml;nlein purpura (IgA vasculitis) and the hypocomplementemia that occurs in lupus nephritis is, as mentioned above, associated with reductions in both C3 and C4, whereas C4 levels are normal in PSGN. (See",
"      <a class=\"medical medical_review\" href=\"./renal-manifestations-of-henoch-schonlein-purpura-iga-vasculitis?source=see_link\">",
"       \"Renal manifestations of Henoch-Sch&ouml;nlein purpura (IgA vasculitis)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/3/27706?source=see_link\">",
"       \"Diagnosis and classification of renal disease in systemic lupus erythematosus\"",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H12\">",
"       'Complement'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      Both hepatitis B and endocarditis-associated glomerulonephritis share common features with PSGN and also will present with reductions in C3 and C4. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/28/44488?source=see_link\">",
"       \"Renal disease associated with hepatitis B virus infection\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/27/5556?source=see_link\">",
"       \"Renal disease in the setting of infective endocarditis or an infected ventriculoatrial shunt\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Postinfectious GN due to other microbial agents &mdash; Acute nephritis due to viral and other bacterial agents has been reported (",
"      <a class=\"graphic graphic_table graphicRef76710 \" href=\"mobipreview.htm?2/4/2124\">",
"       table 1",
"      </a>",
"      ). Their clinical presentation is similar to PSGN except that there is no documentation of an antecedent GAS infection.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no specific therapy for PSGN. There is no evidence that aggressive immunosuppressive therapy has a beneficial effect in patients with rapidly progressive crescentic disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/30\">",
"     30",
"    </a>",
"    ]. However, patients with more than 30 percent crescents on renal biopsy are often treated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    pulses. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/51/18231?source=see_link&amp;anchor=H11#H11\">",
"     \"Overview of the classification and treatment of rapidly progressive (crescentic) glomerulonephritis\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Management is supportive and is focused on treating the clinical manifestations of the disease, particularly complications due to volume overload. These include hypertension and, less commonly, pulmonary edema. General measures include sodium and water restriction and loop diuretics. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/7/7288?source=see_link&amp;anchor=H17#H17\">",
"     \"Evaluation and management of edema in children\", section on 'General treatment approach'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Loop diuretics generally provide a prompt diuresis with reduction of blood pressure and edema. In our practice, intravenous",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/52/28488?source=see_link\">",
"     furosemide",
"    </a>",
"    is given at an initial dose of 1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    (maximum 40 mg).",
"   </p>",
"   <p>",
"    Infrequently, patients have hypertensive encephalopathy due to severe hypertension. These patients should be treated emergently to reduce their blood pressure. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/33/23065?source=see_link&amp;anchor=H7#H7\">",
"     \"Management of hypertensive emergencies and urgencies in children\", section on 'Approach'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with PSGN have variable reductions in renal function, and some patients require dialysis during the acute episode. The management of acute kidney injury in children, including indications for dialysis, is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/16/42249?source=see_link&amp;anchor=H265511452#H265511452\">",
"     \"Prevention and management of acute kidney injury (acute renal failure) in children\", section on 'Management of acute kidney injury (AKI)'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with evidence of persistent group A streptococcal infection should be given a course of antibiotic therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/38/2666?source=see_link\">",
"     \"Treatment and prevention of streptococcal tonsillopharyngitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/21/21846?source=see_link&amp;anchor=H11#H11\">",
"     \"Impetigo\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     COURSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Resolution of the clinical manifestations of PSGN is generally quite rapid, assuming concurrent resolution of the infection. A diuresis typically begins within one week, and the serum creatinine returns to the previous baseline by three to four weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/18,31\">",
"     18,31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The urinary abnormalities disappear at differing rates. Hematuria usually resolves within three to six months. Proteinuria also falls during recovery, but at a much slower rate. A mild increase in protein excretion is still present in 15 percent at 3 years, and 2 percent at 7 to 10 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In severe cases with nephrotic range proteinuria, this degree of proteinuria may persist for six months or more, long after the hematuria has disappeared [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. Patients first seen at this late stage are often thought to have one of the causes of the idiopathic nephrotic syndrome (eg, membranous nephropathy, focal segmental glomerulosclerosis, or minimal change disease).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Correlation with histologic recovery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The histologic course parallels the improvements seen clinically. There is a marked reduction in the number of inflammatory cells in the glomeruli and the number of immune deposits seen on electron microscopy as the clinical manifestations resolve [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/15,35\">",
"     15,35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prolonged resolution of proteinuria compared to the more rapid return of renal function and remission of hematuria probably reflects the slower rate of clearance of subepithelial compared to subendothelial immune complexes.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Subendothelial immune complexes are rapidly cleared by the inflammatory cells from the systemic circulation, thereby accounting for the resolution of hematuria and renal insufficiency [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/15\">",
"       15",
"      </a>",
"      ]. They may not be seen on renal biopsy unless performed early in the course.",
"     </li>",
"     <li>",
"      Subepithelial deposits are separated from circulating inflammatory cells by the glomerular basement membrane, thereby limiting their rate of removal [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/15,35\">",
"       15,35",
"      </a>",
"      ]. In general, the degree of proteinuria correlates with the number of subepithelial deposits [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Recurrence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrent episodes of PSGN are rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/16\">",
"     16",
"    </a>",
"    ]. This may be due to the long-term persistence of antibodies to nephritis-associated streptococcal antigen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Nephritogenic antigens'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients, particularly children, have an excellent outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/2,14,18,32\">",
"     2,14,18,32",
"    </a>",
"    ]. This is true even in patients who present with acute renal failure and may have crescents on the initial renal biopsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/30,31,37\">",
"     30,31,37",
"    </a>",
"    ]. A review of three case series of 229 children with PSGN found that approximately 20 percent had an abnormal urinalysis (proteinuria",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hematuria), but almost all (92 to 99 percent) had normal or only modestly reduced renal function 5 to 18 years after presentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, the long-term prognosis of PSGN is not always benign [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/38\">",
"     38",
"    </a>",
"    ]. Some patients, particularly adults, develop hypertension, recurrent proteinuria (with a relatively normal urine sediment), and renal insufficiency as long as 10 to 40 years after the initial illness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/39-42\">",
"     39-42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These late renal complications are associated with glomerulosclerosis on renal biopsy, which is thought to be hemodynamically-mediated. According to this hypothesis, some glomeruli are irreversibly damaged during the acute episode and compensatory hyperfiltration in the remaining glomeruli maintains a relatively normal glomerular filtration rate. However, this adaptive response results in increases in glomerular pressure and size, both of which may then contribute to nonimmunologic glomerular injury and progressive renal dysfunction. It is possible that, in those patients who develop glomerulosclerosis, renal damage can be prevented or ameliorated by antihypertensive therapy (preferentially with an angiotensin converting enzyme inhibitor). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/19/26938?source=see_link\">",
"     \"Secondary factors and progression of chronic kidney disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An alternate explanation for the late development of renal failure in patients diagnosed initially with PSGN is that some patients may actually have membranoproliferative glomerulonephritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35304/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Differential diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Poststreptococcal glomerular nephritis (PSGN) is the most common cause of acute nephritis worldwide. It primarily occurs in the developing world. The risk of PSGN is greatest in children between 5 and 12 years of age, and older adults greater than 60 years of age. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      PSGN is caused by glomerular immune complex disease induced by specific nephritogenic strains of group A beta-hemolytic streptococcus (GAS). The two leading candidate nephritogenic antigens are nephritis-associated plasmin receptor and streptococcal pyrogenic exotoxin B. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The characteristic pathologic features of PSGN are demonstrated by electron microscopy (dome-shaped subepithelial deposits), (",
"      <a class=\"graphic graphic_picture graphicRef56846 \" href=\"mobipreview.htm?7/1/7184\">",
"       picture 4",
"      </a>",
"      ) and immunofluorescence (deposition of IgG and C3 in a diffuse granular pattern in the mesangium and glomerular capillary walls), (",
"      <a class=\"graphic graphic_picture graphicRef51022 \" href=\"mobipreview.htm?32/44/33478\">",
"       picture 3",
"      </a>",
"      ). The light microscopic findings of cellular infiltration and glomerular proliferation are nonspecific. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Pathology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although, the most common clinical findings include edema, gross hematuria, and hypertension, the presentation of PSGN varies from asymptomatic, microscopic hematuria to the full-blown acute nephritic syndrome (gross hematuria, proteinuria, edema, hypertension, and acute kidney injury). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laboratory findings include an abnormal urinalysis (dysmorphic red blood cells, varying degrees of proteinuria, red blood cell casts, and pyuria), positive serology for antibodies to streptococcal antigens, and hypocomplementemia. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Laboratory findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      PSGN is typically diagnosed based upon the findings of acute nephritis and demonstration of a recent GAS infection. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although several glomerulonephritis (eg, membranoproliferative glomerulonephritis and IgA nephropathy) have similar presentations to PSGN, specific clinical differences usually can differentiate among them. In cases, where the diagnosis is uncertain, a renal biopsy may be needed to identify the specific renal disease. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Differential diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16\">",
"       'Renal biopsy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is no specific therapy to treat PSGN. Management is supportive and is focused upon treating the volume overload that causes the clinical complications of PSGN. These general measures include sodium and water restriction, and diuretic therapy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In patients with acute renal failure, dialysis may be required. The indications for dialysis are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/16/42249?source=see_link&amp;anchor=H265511452#H265511452\">",
"       \"Prevention and management of acute kidney injury (acute renal failure) in children\", section on 'Management of acute kidney injury (AKI)'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In patients with hypertension, we suggest administration of lasix to provide a prompt diuresis and a reduction of blood pressure (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Infrequently, patients may have hypertensive encephalopathy due to severe hypertension and require emergent therapy to reduce their blood pressure. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Management'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/33/23065?source=see_link&amp;anchor=H7#H7\">",
"       \"Management of hypertensive emergencies and urgencies in children\", section on 'Approach'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most patients, particularly children, have complete clinical recovery, and resolution of their disease process begins within the first two weeks. However, there is a small subset of patients who have late renal complications (ie, hypertension, increasing proteinuria, and renal insufficiency). (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Course'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H22\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/1\">",
"      Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005; 5:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/2\">",
"      Rodriguez-Iturbe B, Musser JM. The current state of poststreptococcal glomerulonephritis. J Am Soc Nephrol 2008; 19:1855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/3\">",
"      Zhang Y, Shen Y, Feld LG, Stapleton FB. Changing pattern of glomerular disease at Beijing Children's Hospital. Clin Pediatr (Phila) 1994; 33:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/4\">",
"      Roy S 3rd, Stapleton FB. Changing perspectives in children hospitalized with poststreptococcal acute glomerulonephritis. Pediatr Nephrol 1990; 4:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/5\">",
"      Coppo R, Gianoglio B, Porcellini MG, Maringhini S. Frequency of renal diseases and clinical indications for renal biopsy in children (report of the Italian National Registry of Renal Biopsies in Children). Group of Renal Immunopathology of the Italian Society of Pediatric Nephrology and Group of Renal Immunopathology of the Italian Society of Nephrology. Nephrol Dial Transplant 1998; 13:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/6\">",
"      Blyth CC, Robertson PW, Rosenberg AR. Post-streptococcal glomerulonephritis in Sydney: a 16-year retrospective review. J Paediatr Child Health 2007; 43:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/7\">",
"      STETSON CA, RAMMELKAMP CH Jr, KRAUSE RM, et al. Epidemic acute nephritis: studies on etiology, natural history and prevention. Medicine (Baltimore) 1955; 34:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/8\">",
"      Anthony BF, Kaplan EL, Wannamaker LW, et al. Attack rates of acute nephritis after type 49 streptococcal infection of the skin and of the respiratory tract. J Clin Invest 1969; 48:1697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/9\">",
"      Rodr&iacute;guez-Iturbe B, Batsford S. Pathogenesis of poststreptococcal glomerulonephritis a century after Clemens von Pirquet. Kidney Int 2007; 71:1094.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/10\">",
"      Yoshizawa N, Yamakami K, Fujino M, et al. Nephritis-associated plasmin receptor and acute poststreptococcal glomerulonephritis: characterization of the antigen and associated immune response. J Am Soc Nephrol 2004; 15:1785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/11\">",
"      Batsford SR, Mezzano S, Mihatsch M, et al. Is the nephritogenic antigen in post-streptococcal glomerulonephritis pyrogenic exotoxin B (SPE B) or GAPDH? Kidney Int 2005; 68:1120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/12\">",
"      Sorger K, Balun J, H&uuml;bner FK, et al. The garland type of acute postinfectious glomerulonephritis: morphological characteristics and follow-up studies. Clin Nephrol 1983; 20:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/13\">",
"      Kimmelstiel, P. THe hump-a lesion of glomerulonephritis. Bull Pathol 1965; 6:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/14\">",
"      Tejani A, Ingulli E. Poststreptococcal glomerulonephritis. Current clinical and pathologic concepts. Nephron 1990; 55:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/15\">",
"      Fries JW, Mendrick DL, Rennke HG. Determinants of immune complex-mediated glomerulonephritis. Kidney Int 1988; 34:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/16\">",
"      Sanjad S, Tolaymat A, Whitworth J, Levin S. Acute glomerulonephritis in children: a review of 153 cases. South Med J 1977; 70:1202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/17\">",
"      Sagel I, Treser G, Ty A, et al. Occurrence and nature of glomerular lesions after group A streptococci infections in children. Ann Intern Med 1973; 79:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/18\">",
"      Lewy JE, Salinas-Madrigal L, Herdson PB, et al. Clinico-pathologic correlations in acute poststreptococcal glomerulonephritis. A correlation between renal functions, morphologic damage and clinical course of 46 children with acute poststreptococcal glomerulonephritis. Medicine (Baltimore) 1971; 50:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/19\">",
"      Nissenson AR, Baraff LJ, Fine RN, Knutson DW. Poststreptococcal acute glomerulonephritis: fact and controversy. Ann Intern Med 1979; 91:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/20\">",
"      Becquet O, Pasche J, Gatti H, et al. Acute post-streptococcal glomerulonephritis in children of French Polynesia: a 3-year retrospective study. Pediatr Nephrol 2010; 25:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/21\">",
"      Dodge WF, Spargo BH, Travis LB. Occurrence of acute glomerulonephritis in sibling contacts of children with sporadic acute glomerulonephritis. Pediatrics 1967; 40:1028.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/22\">",
"      Rodr&iacute;guez-Iturbe B, Rubio L, Garc&iacute;a R. Attack rate of poststreptococcal nephritis in families. A prospective study. Lancet 1981; 1:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/23\">",
"      Baldwin DS, Gluck MC, Schacht RG, Gallo G. The long-term course of poststreptococcal glomerulonephritis. Ann Intern Med 1974; 80:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/24\">",
"      Lewis EJ, Carpenter CB, Schur PH. Serum complement component levels in human glomerulonephritis. Ann Intern Med 1971; 75:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/25\">",
"      Cameron JS, Vick RM, Ogg CS, et al. Plasma C3 and C4 concentrations in management of glomerulonephritis. Br Med J 1973; 3:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/26\">",
"      Kaplan EL, Anthony BF, Chapman SS, et al. The influence of the site of infection on the immune response to group A streptococci. J Clin Invest 1970; 49:1405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/27\">",
"      Ayoub EM, Wannamaker LW. Streptococcal antibody titers in Sydenham's chorea. Pediatrics 1966; 38:946.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/28\">",
"      Eison TM, Ault BH, Jones DP, et al. Post-streptococcal acute glomerulonephritis in children: clinical features and pathogenesis. Pediatr Nephrol 2011; 26:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/29\">",
"      Pais PJ, Kump T, Greenbaum LA. Delay in diagnosis in poststreptococcal glomerulonephritis. J Pediatr 2008; 153:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/30\">",
"      Roy S 3rd, Murphy WM, Arant BS Jr. Poststreptococcal crescenteric glomerulonephritis in children: comparison of quintuple therapy versus supportive care. J Pediatr 1981; 98:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/31\">",
"      Ferrario F, Kourilsky O, Morel-Maroger L. Acute endocapillary glomerulonephritis in adults: a histologic and clinical comparison between patients with and without initial acute renal failure. Clin Nephrol 1983; 19:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/32\">",
"      Potter EV, Lipschultz SA, Abidh S, et al. Twelve to seventeen-year follow-up of patients with poststreptococcal acute glomerulonephritis in Trinidad. N Engl J Med 1982; 307:725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/33\">",
"      Sorger K, Gessler M, H&uuml;bner FK, et al. Follow-up studies of three subtypes of acute postinfectious glomerulonephritis ascertained by renal biopsy. Clin Nephrol 1987; 27:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/34\">",
"      Raff A, Hebert T, Pullman J, Coco M. Crescentic post-streptococcal glomerulonephritis with nephrotic syndrome in the adult: is aggressive therapy warranted? Clin Nephrol 2005; 63:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/35\">",
"      T&ouml;rnroth T. The fate of subepithelial deposits in acute poststreptococcal glomerulonephritis. Lab Invest 1976; 35:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/36\">",
"      Watanabe T, Yoshizawa N. Recurrence of acute poststreptococcal glomerulonephritis. Pediatr Nephrol 2001; 16:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/37\">",
"      Leonard CD, Nagle RB, Striker GE, et al. Acute glomerulonephritis with prolonged oliguria. An analysis of 29 cases. Ann Intern Med 1970; 73:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/38\">",
"      Kanjanabuch T, Kittikowit W, Eiam-Ong S. An update on acute postinfectious glomerulonephritis worldwide. Nat Rev Nephrol 2009; 5:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/39\">",
"      Baldwin DS. Poststreptococcal glomerulonephritis. A progressive disease? Am J Med 1977; 62:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/40\">",
"      Pinto SW, Sesso R, Vasconcelos E, et al. Follow-up of patients with epidemic poststreptococcal glomerulonephritis. Am J Kidney Dis 2001; 38:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/41\">",
"      Baldwin DS. Chronic glomerulonephritis: nonimmunologic mechanisms of progressive glomerular damage. Kidney Int 1982; 21:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35304/abstract/42\">",
"      Lien JW, Mathew TH, Meadows R. Acute post-streptococcal glomerulonephritis in adults: a long-term study. Q J Med 1979; 48:99.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6118 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-189.41.172.26-C9598D4138-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_30_35304=[""].join("\n");
var outline_f34_30_35304=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Nephritogenic antigens",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Light microscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Immunofluorescence microscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Electron microscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Urinalysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Complement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Culture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Serology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Renal biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      COURSE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Correlation with histologic recovery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Recurrence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6118\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6118|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?38/23/39288\" title=\"picture 1\">",
"      Postinfectious GN EM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?19/17/19734\" title=\"picture 2\">",
"      Postinfectious GN Light Low",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?32/44/33478\" title=\"picture 3\">",
"      Poststrep GN high power",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?7/1/7184\" title=\"picture 4\">",
"      Postinfectious GN IF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?24/0/24591\" title=\"picture 5A\">",
"      Phase contrast micrograph showing dysmorphic red cells in urine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?13/47/14079\" title=\"picture 5B\">",
"      Scanning electron micrograph showing dysmorphic red cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?34/38/35424\" title=\"picture 5C\">",
"      Photomicrograph of urine sediment with a red cell cast",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6118|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?2/4/2124\" title=\"table 1\">",
"      Causes postinf GN",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/53/19290?source=related_link\">",
"      Acute kidney injury in children: Clinical features, etiology, evaluation, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/53/17241?source=related_link\">",
"      Approach to hypertensive emergencies and urgencies in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/54/19306?source=related_link\">",
"      Causes and diagnosis of membranous nephropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/19/1337?source=related_link\">",
"      Clinical presentation and diagnosis of IgA nephropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/51/43833?source=related_link\">",
"      Clinical presentation, classification, and causes of membranoproliferative glomerulonephritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/3/27706?source=related_link\">",
"      Diagnosis and classification of renal disease in systemic lupus erythematosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/31/27130?source=related_link\">",
"      Differential diagnosis and evaluation of glomerular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/7/7288?source=related_link\">",
"      Evaluation and management of edema in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/21/21846?source=related_link\">",
"      Impetigo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/33/23065?source=related_link\">",
"      Management of hypertensive emergencies and urgencies in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/30/18921?source=related_link\">",
"      Mechanisms of immune injury of the glomerulus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/25/10647?source=related_link\">",
"      Overview and clinical assessment of the complement system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/51/18231?source=related_link\">",
"      Overview of the classification and treatment of rapidly progressive (crescentic) glomerulonephritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/1/12311?source=related_link\">",
"      Overview of the pathogenesis and causes of glomerulonephritis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/20/40261?source=related_link\">",
"      Pathogenesis of tissue injury in glomerulonephritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/16/42249?source=related_link\">",
"      Prevention and management of acute kidney injury (acute renal failure) in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/28/44488?source=related_link\">",
"      Renal disease associated with hepatitis B virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/27/5556?source=related_link\">",
"      Renal disease in the setting of infective endocarditis or an infected ventriculoatrial shunt",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"./renal-manifestations-of-henoch-schonlein-purpura-iga-vasculitis?source=related_link\">",
"      Renal manifestations of Henoch-Sch&ouml;nlein purpura (IgA vasculitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/19/26938?source=related_link\">",
"      Secondary factors and progression of chronic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/38/2666?source=related_link\">",
"      Treatment and prevention of streptococcal tonsillopharyngitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_30_35305="Approach to the diagnosis and therapy of lower extremity deep vein thrombosis";
var content_f34_30_35305=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to the diagnosis and therapy of lower extremity deep vein thrombosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/30/35305/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/30/35305/contributors\">",
"     Stephen A Landaw, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/30/35305/contributors\">",
"     Kenneth A Bauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/30/35305/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/30/35305/contributors\">",
"     Lawrence LK Leung, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/30/35305/contributors\">",
"     Jess Mandel, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/30/35305/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/30/35305/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/30/35305/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 11, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deep vein thrombosis (DVT) and acute pulmonary embolism (PE) are two manifestations of the same disorder, venous thromboembolism (VTE). DVT of the lower extremity is subdivided into two categories:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Distal (calf) vein thrombosis, in which thrombi remain confined to the deep calf veins",
"     </li>",
"     <li>",
"      Proximal vein thrombosis, in which thrombosis involves the popliteal, femoral, or iliac veins",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Proximal vein thrombosis is of greater importance clinically, since it is more commonly associated with the development of pulmonary emboli. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/4/43082?source=see_link&amp;anchor=H412636#H412636\">",
"     \"Treatment of lower extremity deep vein thrombosis\", section on 'Introduction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are a number of questions that arise when a patient is suspected of having deep vein thrombosis (DVT) of the lower extremity. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      What is the differential diagnosis and what are the possible risk factors for DVT?",
"     </li>",
"     <li>",
"      What is the best way to diagnose or exclude DVT?",
"     </li>",
"     <li>",
"      What is the appropriate initial therapy for DVT; when is hospitalization not required?",
"     </li>",
"     <li>",
"      What is the recommended long-term treatment for DVT (eg, agents to use, monitoring the degree of anticoagulation, length of time treatment is needed)?",
"     </li>",
"     <li>",
"      When should one screen for the presence of a hypercoagulable state, not only in the patient, but also in family members?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic review will serve as a guide for answering the above questions in a patient suspected of having DVT of the lower extremity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35305/abstract/1\">",
"     1",
"    </a>",
"    ]. Each section will provide links to UpToDate reviews in which extended discussions of that subject can be found. Patient information documents covering these issues are also available. (See",
"    <a class=\"medical medical_patient\" href=\"mobipreview.htm?12/44/12998?source=see_link\">",
"     \"Patient information: Deep vein thrombosis (DVT) (Beyond the Basics)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_patient\" href=\"mobipreview.htm?21/15/21747?source=see_link\">",
"     \"Patient information: Warfarin (Coumadin) (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The pathogenesis, clinical manifestations, diagnosis, and treatment of DVT in infants and children are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/28/25033?source=see_link\">",
"     \"Pathogenesis and clinical manifestations of venous thrombosis and thromboembolism in infants and children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/57/14234?source=see_link\">",
"     \"Diagnosis and treatment of venous thrombosis and thromboembolism in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Upper extremity DVT, the pathogenesis and natural course of which differs considerably from that of lower extremity DVT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35305/abstract/2\">",
"     2",
"    </a>",
"    ], is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/6/27754?source=see_link\">",
"     \"Primary (spontaneous) upper extremity deep vein thrombosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/26/27050?source=see_link\">",
"     \"Catheter-induced upper extremity venous thrombosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Longitudinal Investigation of Thromboembolism Etiology (LITE), which combined information from two prospective cohort studies, the Atherosclerosis Risk in Communities (ARIC) and the Cardiovascular Health Study (CHS), determined the incidence of symptomatic DVT and pulmonary embolism in 21,680 participants aged &ge;45 years who were followed for 7.6 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35305/abstract/3\">",
"     3",
"    </a>",
"    ]. The following observations were made:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The age-standardized incidence of first-time venous thromboembolism (VTE) was 1.92 per 1000 person-years. Rates were higher in men than women, and increased with age in both sexes. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/48/43786?source=see_link&amp;anchor=H50#H50\">",
"       \"Overview of the causes of venous thrombosis\", section on 'Cardiovascular risk factors'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Of the 366 VTE events, most of the 191 cases of secondary VTE were associated with more than one underlying condition. These included cancer (48 percent), hospitalization (52 percent), surgery (42 percent), and major trauma (6 percent). There was no antecedent trauma, surgery, immobilization, or diagnosis of cancer in 48 percent of cases. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/48/43786?source=see_link&amp;anchor=H21#H21\">",
"       \"Overview of the causes of venous thrombosis\", section on 'Acquired thrombophilia'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Among 1102 acutely ill, immobilized general medical patients enrolled in the MEDENOX study, multiple logistic regression analysis found the following factors to be significantly and independently associated with an increased risk for VTE, most of which were asymptomatic and diagnosed by venography of both lower extremities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35305/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Presence of an acute infectious disease",
"     </li>",
"     <li>",
"      Age &gt;75 years",
"     </li>",
"     <li>",
"      Cancer",
"     </li>",
"     <li>",
"      History of prior VTE",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     INITIAL APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;When approaching the patient with suspected DVT of the lower extremity, it is important to appreciate that only a minority of patients actually have the disease and will require anticoagulation. This illustrates the importance of using validated algorithms to evaluate patients with suspected DVT, along with objective testing to establish the diagnosis. Given the potential risks associated with proximal lower extremity DVT that is not treated (eg, fatal pulmonary emboli) and the potential risk of anticoagulating a patient who does not have a DVT (eg, life-threatening bleeding), accurate diagnosis is essential.",
"   </p>",
"   <p>",
"    Risk factors for DVT should be sought in all patients. These include the following (",
"    <a class=\"graphic graphic_table graphicRef59759 \" href=\"mobipreview.htm?1/6/1132\">",
"     table 1",
"    </a>",
"    ) (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/48/43786?source=see_link\">",
"     \"Overview of the causes of venous thrombosis\"",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      History of immobilization or prolonged",
"      <span class=\"nowrap\">",
"       hospitalization/bed",
"      </span>",
"      rest",
"     </li>",
"     <li>",
"      Recent surgery",
"     </li>",
"     <li>",
"      Obesity",
"     </li>",
"     <li>",
"      Prior episode(s) of venous thromboembolism",
"     </li>",
"     <li>",
"      Lower extremity trauma",
"     </li>",
"     <li>",
"      Malignancy",
"     </li>",
"     <li>",
"      Use of oral contraceptives or hormone replacement therapy",
"     </li>",
"     <li>",
"      Pregnancy or postpartum status",
"     </li>",
"     <li>",
"      Stroke",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;Classic symptoms of DVT include swelling, pain, and erythema of the involved extremity. There is not necessarily a correlation between the location of symptoms and the site of thrombosis. Symptoms in the calf alone are often the presenting manifestation of significant proximal vein involvement, while some patients with whole leg symptoms are found to have isolated calf vein DVT.",
"   </p>",
"   <p>",
"    A complete thrombosis history includes the age of onset, location of prior thromboses, and results of objective diagnostic studies documenting thrombotic episodes in the patient. The patient should be carefully questioned concerning recent potential precipitating conditions prior to the time of thrombosis, such as surgical procedures, hospitalization, trauma, pregnancy, heart failure, and immobility. Women should be carefully questioned regarding use of oral contraceptives or hormone replacement therapy as well as their obstetric history. The presence of recurrent fetal loss in the second or third trimester suggests the possible presence of an inherited thrombophilia or antiphospholipid antibodies. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/2/41000?source=see_link&amp;anchor=H6#H6\">",
"     \"Obstetrical manifestations of the antiphospholipid syndrome\", section on 'Adverse outcomes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to events proximate to the time of thrombosis, patients should also be questioned about previous exposure and outcome in situations that predispose to thrombosis, such as pregnancy, cesarean section, and surgery.",
"   </p>",
"   <p>",
"    Questions should include the presence of significant disorders, such as collagen-vascular disease, myeloproliferative disease, atherosclerotic disease, or nephrotic syndrome and about the use of drugs which can induce antiphospholipid antibodies such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/57/15254?source=see_link\">",
"     hydralazine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/34/36391?source=see_link\">",
"     procainamide",
"    </a>",
"    , and phenothiazines.",
"   </p>",
"   <p>",
"    The patient should also be questioned about a past history of cancer, and the results, if any, of regular screening examinations for cancer (eg, mammography, colonoscopy, pelvic examinations) since recurrent thrombosis in spite of therapeutic anticoagulation with oral anticoagulants is more frequent in patients with VTE in association with active cancer or an occult neoplasm. Other findings that may suggest an underlying malignancy are constitutional symptoms such as loss of appetite, weight loss, fatigue, pain, hematochezia, hemoptysis, and hematuria. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/43/35514?source=see_link&amp;anchor=H4#H4\">",
"     \"Hypercoagulable disorders associated with malignancy\", section on 'Venous thromboembolism'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4884402\">",
"    <span class=\"h3\">",
"     Family history",
"    </span>",
"    &nbsp;&mdash;&nbsp;A positive family history of VTE is particularly important, since a well documented history of VTE in one or more first-degree relatives under age 50 suggests the presence of a hereditary defect",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    an increased susceptibility for venous thromboembolic disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35305/abstract/5\">",
"     5",
"    </a>",
"    ]. This was most conclusively shown in a population-based study of the incidence of VTE according to the presence or absence of VTE in a sibling [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35305/abstract/6\">",
"     6",
"    </a>",
"    ]. Standard incidence ratios for VTE were 2.27, 51.9, and 53.7 for patients with one, two, or three or more affected siblings, respectively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Special clinical settings",
"    </span>",
"    &nbsp;&mdash;&nbsp;There a number of clinical settings which may suggest the presence of a specific risk factor for DVT. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Recurrent unprovoked DVT in a young patient (age &lt;50) may suggest either the presence of an inherited hypercoagulable state or a congenital anomaly of the inferior vena cava. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/48/43786?source=see_link&amp;anchor=H15#H15\">",
"       \"Overview of the causes of venous thrombosis\", section on 'Inferior vena cava abnormalities'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Recurrent left lower extremity DVT of the left lower extremity may indicate the presence of the May-Thurner syndrome with thrombosis of the left iliac vein due to compression of this vein between the overlying right iliac artery and the vertebral column. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/48/43786?source=see_link&amp;anchor=H14#H14\">",
"       \"Overview of the causes of venous thrombosis\", section on 'May-Thurner syndrome'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physical examination may reveal a palpable cord (reflecting a thrombosed vein), calf or thigh pain, unilateral edema or swelling with a difference in calf diameters, warmth, tenderness, erythema,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    superficial venous dilation.",
"   </p>",
"   <p>",
"    In the general physical examination, special attention should be directed to the vascular system, extremities (eg, looking for signs of superficial or deep vein thrombosis), chest, heart, abdominal organs, and skin (eg, skin necrosis, livedo reticularis). There may be pain and tenderness in the thigh along the course of the major veins (\"painful deep vein syndrome\"). Tenderness on deep palpation of the calf muscles is suggestive, but not diagnostic. Homans&rsquo; sign is also unreliable. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/41/11930?source=see_link&amp;anchor=H6#H6\">",
"     \"Evaluation of the patient with established venous thrombosis\", section on 'Physical exam'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, each of the above signs and symptoms is nonspecific and has low accuracy for making the diagnosis of DVT. A 2005 meta-analysis of diagnostic cohort studies of patients with suspected DVT concluded the following concerning these physical findings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35305/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Only a difference in calf diameters (likelihood ratio, LR 1.8; 95% CI 1.5-2.2) was of potential value for ruling in DVT.",
"     </li>",
"     <li>",
"      Only absence of calf swelling (LR 0.67; 95% CI 0.58-0.78) and absence of a difference in calf diameters (LR 0.57; 95% CI 0.44-0.72) were of potential value for ruling out DVT.",
"     </li>",
"     <li>",
"      Individual clinical features are poorly predictive of DVT when not combined in a formal prediction rule (eg, Wells score, see below) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/30/35305/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Accordingly, further diagnostic testing is required to confirm or exclude the diagnosis of DVT (see",
"    <a class=\"local\" href=\"#H19\">",
"     'Diagnosis of DVT'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Venous thromboembolism may also be associated with other clinical disorders such as heart failure and the myeloproliferative neoplasms. The presence or absence of relevant physical exam findings (eg, splenomegaly in polycythemia vera) should be ascertained.",
"   </p>",
"   <p>",
"    The physical examination may also reveal signs of hepatic vein thrombosis (Budd-Chiari syndrome), such as ascites and hepatomegaly, or edema due to the nephrotic syndrome. The hypercoagulable state associated with the nephrotic syndrome may manifest as renal vein thrombosis, which is usually asymptomatic unless associated with pulmonary embolism. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/12/3273?source=see_link\">",
"     \"Renal vein thrombosis and hypercoagulable state in nephrotic syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Phlegmasia cerulea dolens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phlegmasia cerulea dolens is an uncommon form of massive proximal (eg, iliofemoral) venous thrombosis of the lower extremities associated with a high degree of morbidity and mortality. Signs and symptoms include sudden severe leg pain with swelling, cyanosis, edema, venous gangrene, compartment syndrome, and arterial compromise, often followed by followed by circulatory collapse and shock. Delay in treatment may result in death or loss of the patient's limb. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/4/43082?source=see_link&amp;anchor=H19#H19\">",
"     \"Treatment of lower extremity deep vein thrombosis\", section on 'Phlegmasia cerulea dolens'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Screening for malignancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since venous thromboembolism may be the first manifestation of an underlying malignancy, rectal examination and stool testing for occult blood should be performed and women should undergo a pelvic examination to rule out the presence of a previously unsuspected pelvic mass or malignancy. However, a routine exhaustive search for an occult malignancy is neither warranted nor cost effective.",
"   </p>",
"   <p>",
"    Even in patients with recurrent idiopathic DVT, who represent a high risk group, a cancer, if present, will usually have made its presence known during the interval period between thrombotic events. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/43/35514?source=see_link&amp;anchor=H8#H8\">",
"     \"Hypercoagulable disorders associated with malignancy\", section on 'Use of cancer screening'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Laboratory testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial laboratory evaluation in patients with venous thrombosis should include a complete blood count and platelet count, coagulation studies (eg, prothrombin time, activated partial thromboplastin time), renal function tests, and urinalysis.",
"   </p>",
"   <p>",
"    Consideration should be given to obtaining a prostate-specific antigen measurement in men over the age of 50. Any abnormality observed on initial testing should be investigated aggressively. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/41/11930?source=see_link&amp;anchor=H7#H7\">",
"     \"Evaluation of the patient with established venous thrombosis\", section on 'Laboratory tests'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;When approaching the patient with suspected DVT of the lower extremity, it is important to appreciate that only a minority of patients (17 and 32 percent in two large series) actually have the disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35305/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The differential diagnosis in patients with suspected DVT includes a variety of disorders, including musculoskeletal injury and venous insufficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35305/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. The range of disorders that can mimic DVT was illustrated in a study of 160 consecutive patients with suspected DVT who had negative venograms; the following causes of the leg pain were identified [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35305/abstract/11\">",
"     11",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Muscle strain, tear, or twisting injury to the leg &mdash; 40 percent",
"     </li>",
"     <li>",
"      Leg swelling in a paralyzed limb &mdash; 9 percent",
"     </li>",
"     <li>",
"      Lymphangitis or lymph obstruction &mdash; 7 percent",
"     </li>",
"     <li>",
"      Venous insufficiency &mdash; 7 percent",
"     </li>",
"     <li>",
"      Popliteal (Baker's) cyst &mdash; 5 percent",
"     </li>",
"     <li>",
"      Cellulitis &mdash; 3 percent",
"     </li>",
"     <li>",
"      Knee abnormality &mdash; 2 percent",
"     </li>",
"     <li>",
"      Unknown &mdash; 26 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Cellulitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bacterial cellulitis is a frequent complication in the leg with chronic swelling due to venous insufficiency or lymphedema. The warmth and redness often skip areas, leading to the erroneous clinical diagnosis of superficial phlebitis. Some patients with venous insufficiency develop a low-grade \"chemical\" cellulitis, which resembles bacterial cellulitis but without constitutional symptoms. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/33/12825?source=see_link\">",
"     \"Cellulitis and erysipelas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Superficial thrombophlebitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Superficial vein phlebitis is most likely in the presence of palpable, tender superficial veins. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/25/43417?source=see_link\">",
"     \"Superficial thrombophlebitis of the lower extremity\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Venous valvular insufficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic venous insufficiency is the most common cause of chronic unilateral leg edema (",
"    <a class=\"graphic graphic_picture graphicRef56758 \" href=\"mobipreview.htm?3/63/4080\">",
"     picture 1",
"    </a>",
"    ) and is usually associated with a past history of DVT. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/43/33462?source=see_link\">",
"     \"Diagnostic evaluation of chronic venous insufficiency\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/17/13592?source=see_link\">",
"     \"Clinical evaluation of lower extremity chronic venous disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Lymphedema",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lymphedema is an important cause of chronic, rather than acute, edema of the extremities. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/52/1866?source=see_link\">",
"     \"Clinical manifestations and diagnosis of lymphedema\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Popliteal (Baker's) cyst",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of popliteal cysts in adults are due to either distention of a bursa by fluid originating from a knee joint lesion or posterior herniation of the joint capsule due to increased intraarticular pressure. A popliteal cyst that causes calf symptoms is usually leaking or has ruptured. It can cause leg swelling via compression of the popliteal vein and may result in DVT if the vein is compressed sufficiently. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/29/6618?source=see_link&amp;anchor=H16#H16\">",
"     \"Evaluation of the active adult patient with knee pain\", section on 'Popliteal cyst'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Internal derangement of the knee",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pain, inflammation, and swelling can accompany knee joint pathology. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/29/6618?source=see_link\">",
"     \"Evaluation of the active adult patient with knee pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Drug-induced edema",
"    </span>",
"    &nbsp;&mdash;&nbsp;Leg swelling is a side effect of some drugs, such as calcium channel blockers. The edema is usually bilateral but can be asymmetric if there is underlying venous pathology; signs of inflammation are not present. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/36/34375?source=see_link&amp;anchor=H16#H16\">",
"     \"Clinical manifestations and diagnosis of edema in adults\", section on 'Venous insufficiency or thrombosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Calf muscle pull or tear",
"    </span>",
"    &nbsp;&mdash;&nbsp;A calf muscle pull or tear is frequently induced by unaccustomed physical activity. There may be signs of bleeding within muscle compartments of the affected leg. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/0/1030?source=see_link\">",
"     \"Posterior and medial ankle tendinopathies not involving the Achilles tendon\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     DIAGNOSIS OF DVT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of invasive and non-invasive approaches are possible (eg, contrast venography, impedance plethysmography, compression ultrasonography, D-dimer testing). In most circumstances, compression ultrasonography is the noninvasive approach of choice for the diagnosis of symptomatic patients with a first episode of suspected DVT (",
"    <a class=\"graphic graphic_algorithm graphicRef52720 \" href=\"mobipreview.htm?41/20/42318\">",
"     algorithm 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/12/33994?source=see_link\">",
"     \"Diagnosis of suspected deep vein thrombosis of the lower extremity\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A negative D-dimer assay may be insufficient to rule out DVT as a stand-alone test in patient populations with a high prevalence of venous thromboembolism, and not all D-dimer assays are validated for this application. However, a D-dimer level &lt;500",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    by ELISA or a negative SimpliRED assay in conjunction with a low clinical probability (ie, Wells score) (",
"    <a class=\"graphic graphic_table graphicRef75871 \" href=\"mobipreview.htm?23/1/23580\">",
"     table 2",
"    </a>",
"    ) (",
"    <a class=\"calc calc_professional\" href=\"mobipreview.htm?1/30/1505?source=see_link\">",
"     calculator 1",
"    </a>",
"    ) or other negative noninvasive tests may be useful in excluding DVT, without the need for ultrasound testing. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/12/33994?source=see_link&amp;anchor=H21#H21\">",
"     \"Diagnosis of suspected deep vein thrombosis of the lower extremity\", section on 'D-dimer'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A positive noninvasive study in patients with a first episode of DVT usually establishes the diagnosis, with a positive predictive value for compression ultrasonography of 94 percent (95% CI: 87-98 percent). If the initial study is negative and the clinical suspicion of DVT is high, a repeat study should be obtained on day 5 to 7. Use of a single study via extended (complete) lower extremity ultrasonography may obviate the need for repeat testing. However, this technique requires specialized instrumentation and is highly dependent on user expertise. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/12/33994?source=see_link&amp;anchor=H18#H18\">",
"     \"Diagnosis of suspected deep vein thrombosis of the lower extremity\", section on 'Extended (complete) lower extremity ultrasound'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Venography is currently used only when noninvasive testing is not clinically feasible or the results are equivocal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Pretest probability",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasonography and D-dimer tests for DVT are most useful when the results are combined with an assessment of pretest probability of DVT. One report of 593 patients with suspected DVT validated a measure of pretest probability (Wells score) (",
"    <a class=\"graphic graphic_table graphicRef75871 \" href=\"mobipreview.htm?23/1/23580\">",
"     table 2",
"    </a>",
"    ) (",
"    <a class=\"calc calc_professional\" href=\"mobipreview.htm?1/30/1505?source=see_link\">",
"     calculator 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35305/abstract/13\">",
"     13",
"    </a>",
"    ]. DVT was documented in 3, 17, and 75 percent of patients with low, moderate, or high pretest probabilities, respectively. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/12/33994?source=see_link&amp;anchor=H19#H19\">",
"     \"Diagnosis of suspected deep vein thrombosis of the lower extremity\", section on 'Addition of pretest probability (Wells score)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Wells score",
"    </span>",
"    &nbsp;&mdash;&nbsp;While other pretest probability scoring systems are available, such as the Hamilton score [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35305/abstract/14\">",
"     14",
"    </a>",
"    ] and the Primary Care Rule (AMUSE score) proposed for use in primary care patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35305/abstract/15\">",
"     15",
"    </a>",
"    ], the Wells score for DVT (ie, Wells criteria for DVT) appears to be most commonly used (",
"    <a class=\"graphic graphic_table graphicRef75871 \" href=\"mobipreview.htm?23/1/23580\">",
"     table 2",
"    </a>",
"    ) (",
"    <a class=\"calc calc_professional\" href=\"mobipreview.htm?1/30/1505?source=see_link\">",
"     calculator 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/12/33994?source=see_link&amp;anchor=H29#H29\">",
"     \"Diagnosis of suspected deep vein thrombosis of the lower extremity\", section on 'Clinical decision rule for primary care providers'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A review of 15 studies in which the Wells score was tested concluded the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35305/abstract/16\">",
"     16",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients in the low pretest probability category had a median negative predictive value for DVT of 96 percent (range: 87 to 100 percent), indicating the usefulness of the Wells score for ruling out DVT.",
"     </li>",
"     <li>",
"      The median negative predictive value for DVT in patients with a low pretest probability was improved further by the presence of a negative test for D-dimer (median value 99 percent, range: 96 to 100 percent).",
"     </li>",
"     <li>",
"      Positive predictive values for DVT rarely exceeded 75 percent for patients in the high pretest probability category, indicating that these rules alone were not as useful for identifying patients who did have thrombosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The value and limitations of the Wells score, with or without D-dimer testing, in identifying patients who may not require further investigation in order to rule out deep vein thrombosis, are discussed in depth separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/12/33994?source=see_link&amp;anchor=H27#H27\">",
"     \"Diagnosis of suspected deep vein thrombosis of the lower extremity\", section on 'Limitations of the Wells score'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SCREENING FOR A HYPERCOAGULABLE STATE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Inherited and acquired hypercoagulable states",
"    </span>",
"    &nbsp;&mdash;&nbsp;A biologic risk factor for venous thrombosis can be identified in over 60 percent of Caucasian patients under age 50 with a first idiopathic DVT. In addition, there is often more than one factor at play in a given patient. As an example, 50 percent of thrombotic events in patients with inherited thrombophilia are associated with an accompanying acquired risk factor (eg, surgery, pregnancy, use of oral contraceptives).",
"   </p>",
"   <p>",
"    Some patients have more than one form of inherited thrombophilia or may have combinations of inherited as well as acquired thrombophilic states and are at even greater risk for thrombosis (",
"    <a class=\"graphic graphic_table graphicRef72836 \" href=\"mobipreview.htm?43/18/44331\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/48/43786?source=see_link&amp;anchor=H4#H4\">",
"     \"Overview of the causes of venous thrombosis\", section on 'Inherited thrombophilia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A thrombophilic state leading to venous thrombosis can be inherited or acquired:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <span class=\"nowrap\">",
"       Congenital/inherited",
"      </span>",
"      (eg, factor V Leiden, protein C deficiency)",
"     </li>",
"     <li>",
"      Acquired (eg, following orthopedic surgery, antiphospholipid antibody)",
"     </li>",
"     <li>",
"      Associated with systemic disease (eg, malignancy)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Who to test",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is currently no consensus regarding who to test for inherited thrombophilia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/41/11930?source=see_link&amp;anchor=H8#H8\">",
"     \"Evaluation of the patient with established venous thrombosis\", section on 'Screening for inherited thrombophilia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, the likelihood of identifying an inherited thrombophilia is increased several-fold by screening only patients with one or more of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Initial thrombosis occurring prior to age 50 without an immediately identified risk factor (ie, idiopathic or unprovoked venous thrombosis)",
"     </li>",
"     <li>",
"      A family history of venous thromboembolism (ie, first-degree relatives with VTE prior to age 50)",
"     </li>",
"     <li>",
"      Recurrent venous thrombosis",
"     </li>",
"     <li>",
"      Thrombosis occurring in unusual vascular beds such as portal, hepatic, mesenteric, or cerebral veins",
"     </li>",
"     <li>",
"      A history of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      -induced skin necrosis, which suggests protein C deficiency (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/52/841?source=see_link\">",
"       \"Protein C deficiency\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Value of screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although we can identify patients at increased risk for inherited thrombophilia, there is no clear clinical value to screening for the following reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Even if a hypercoagulable workup uncovers abnormalities predisposing to VTE, the strongest risk factor for VTE recurrence is the prior VTE event itself, particularly if idiopathic.",
"     </li>",
"     <li>",
"      Patients with idiopathic VTE, whether or not they have an identifiable inherited thrombophilia, are at high risk for recurrence (as high as 7 to 8 percent per year in some studies) after",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      is discontinued, at least for the first few years after the event. Thus, the presence or absence of an inherited thrombophilia will usually not change the decision regarding length of warfarin therapy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/4/43082?source=see_link&amp;anchor=H26#H26\">",
"       \"Treatment of lower extremity deep vein thrombosis\", section on 'Idiopathic VTE'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Screening information can be used to identify family members with an inherited thrombophilia, but anticoagulant prophylaxis is rarely recommended in asymptomatic affected family members outside of high risk situations. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/26/20903?source=see_link&amp;anchor=H15692258#H15692258\">",
"       \"Screening for inherited thrombophilia in asymptomatic populations\", section on 'Summary'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Screening test interference",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of factors can interfere with screening tests for thrombophilia (",
"    <a class=\"graphic graphic_table graphicRef76966 \" href=\"mobipreview.htm?43/22/44396\">",
"     table 4",
"    </a>",
"    ). Therefore, it is generally best not to undertake testing at the time of presentation with VTE. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/41/11930?source=see_link&amp;anchor=H23#H23\">",
"     \"Evaluation of the patient with established venous thrombosis\", section on 'Technical screening issues'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     TREATMENT OF DVT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Rationale",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary objectives of treatment of DVT are to prevent",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    treat the following complications:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Prevent further clot extension",
"     </li>",
"     <li>",
"      Prevention of acute pulmonary embolism",
"     </li>",
"     <li>",
"      Reducing the risk of recurrent thrombosis",
"     </li>",
"     <li>",
"      Treatment of massive iliofemoral thrombosis with acute lower limb ischemia",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      venous gangrene (ie, phlegmasia cerulea dolens)",
"     </li>",
"     <li>",
"      Limiting the development of late complications, such as the post-thrombotic syndrome, chronic venous insufficiency, and chronic thromboembolic pulmonary hypertension.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Anticoagulant therapy is indicated for patients with symptomatic proximal DVT, since pulmonary embolism will occur in approximately 50 percent of untreated individuals, most often within days or weeks of the event.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Initial therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following recommendations for the treatment of acute venous thromboembolic disease are in accord with the 2012 ACCP evidence-based clinical practice guidelines for antithrombotic and thrombolytic therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/30/35305/abstract/17,18\">",
"     17,18",
"    </a>",
"    ], as well as recommendations of the British Committee for Standards in Haematology, the joint guidelines of the American College of Physicians and the American Academy of Family Physicians, and the American Heart",
"    <span class=\"nowrap\">",
"     Association/American",
"    </span>",
"    College of Cardiology. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/4/43082?source=see_link&amp;anchor=H42#H42\">",
"     \"Treatment of lower extremity deep vein thrombosis\", section on 'Summary and recommendations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with DVT or pulmonary embolism should be treated acutely with LMW",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"       fondaparinux",
"      </a>",
"      , unfractionated intravenous heparin, or adjusted-dose subcutaneous heparin.",
"     </li>",
"     <li>",
"      Dosing requirements for LMW",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      are different for each LMW product. Minimal elements for early discharge",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      outpatient therapy with LMW heparin or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"       fondaparinux",
"      </a>",
"      are shown in the table (",
"      <a class=\"graphic graphic_table graphicRef70140 \" href=\"mobipreview.htm?16/35/16955\">",
"       table 5",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/4/43082?source=see_link&amp;anchor=H13#H13\">",
"       \"Treatment of lower extremity deep vein thrombosis\", section on 'Outpatient use'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      When unfractionated",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      is used, the dose should be sufficient to prolong the activated partial thromboplastin time (aPTT) to 1.5 to 2.5 times the mean of the control value, or the upper limit of the normal aPTT range. A survey of available weight-based nomograms supports the view that they represent a safe and cost-effective strategy for unfractionated heparin dosing in a number of different health care settings (",
"      <a class=\"graphic graphic_table graphicRef58483 \" href=\"mobipreview.htm?41/28/42444\">",
"       table 6",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/8/33930?source=see_link&amp;anchor=H7#H7\">",
"       \"Therapeutic use of heparin and low molecular weight heparin\", section on 'Heparin monitoring'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/8/33930?source=see_link&amp;anchor=H15#H15\">",
"       \"Therapeutic use of heparin and low molecular weight heparin\", section on 'Administration and efficacy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Treatment with LMW",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"       fondaparinux",
"      </a>",
"      , or unfractionated heparin should be continued for at least five days and oral anticoagulation with a vitamin K antagonist should be overlapped with LMW heparin, fondaparinux, or unfractionated heparin for at least four to five days. No such overlap is required if",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/16/5384?source=see_link\">",
"       rivaroxaban",
"      </a>",
"      is chosen.",
"     </li>",
"     <li>",
"      For most patients,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      should be initiated simultaneously with the",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      , at an initial oral dose of approximately 5",
"      <span class=\"nowrap\">",
"       mg/day.",
"      </span>",
"      In elderly patients and in those at high risk of bleeding or who are undernourished, debilitated, or have heart failure or liver disease, the starting dose should be reduced. The heparin product can be discontinued on day five or six if the INR has been therapeutic for two consecutive days. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/17/42266?source=see_link&amp;anchor=H23#H23\">",
"       \"Therapeutic use of warfarin\", section on 'Initial dose'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/17/42266?source=see_link&amp;anchor=H24#H24\">",
"       \"Therapeutic use of warfarin\", section on 'Maintenance therapy'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/14/1258?source=see_link&amp;anchor=H11#H11\">",
"       \"Anticoagulation in older adults\", section on 'Increased sensitivity to warfarin'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients receiving unfractionated",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      (UFH), ACCP Guidelines suggest that platelet counts be obtained regularly to monitor for the development of thrombocytopenia. The frequency and timing of such counts depends upon the clinical situation. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/8/33930?source=see_link&amp;anchor=H11#H11\">",
"       \"Therapeutic use of heparin and low molecular weight heparin\", section on 'Platelet count monitoring'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      The heparin product should be stopped if any one of the following occurs: a precipitous or sustained fall in the platelet count, or a platelet count",
"      <span class=\"nowrap\">",
"       &lt;100,000/microL.",
"      </span>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/59/40890?source=see_link\">",
"       \"Heparin-induced thrombocytopenia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The use of thrombolytic agents, surgical thrombectomy, or percutaneous mechanical thrombectomy in the treatment of venous thromboembolism must be individualized. Patients with hemodynamically unstable PE or massive iliofemoral thrombosis (ie, phlegmasia cerulea dolens), and who are also at low risk to bleed, are the most appropriate candidates for such treatment. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/1/28697?source=see_link\">",
"       \"Fibrinolytic (thrombolytic) therapy in acute pulmonary embolism and lower extremity deep vein thrombosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Inferior vena caval filter placement is recommended when there is a contraindication to, or a failure of, anticoagulant therapy in an individual with, or at high risk for, proximal vein thrombosis or PE. It is also recommended in patients with recurrent thromboembolism despite adequate anticoagulation, for chronic recurrent embolism with pulmonary hypertension, and with the concurrent performance of surgical pulmonary embolectomy or pulmonary thromboendarterectomy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/28/16840?source=see_link\">",
"       \"Placement of inferior vena cava filters and their complications\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Oral anticoagulation with a vitamin K antagonist should prolong the INR to a target of 2.5 (range: 2.0 to 3.0). If the use of a vitamin K antagonist is contraindicated or inconvenient, long-term therapy can be undertaken with either adjusted-dose unfractionated",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      , low molecular weight heparin,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"       fondaparinux",
"      </a>",
"      , or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/16/5384?source=see_link\">",
"       rivaroxaban",
"      </a>",
"      . (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/8/33930?source=see_link&amp;anchor=H29#H29\">",
"       \"Therapeutic use of heparin and low molecular weight heparin\", section on 'Use of LMW heparin'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Use of the newer oral anticoagulants (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/39/8825?source=see_link\">",
"       dabigatran",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/16/5384?source=see_link\">",
"       rivaroxaban",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/62/39911?source=see_link\">",
"       apixaban",
"      </a>",
"      ) for the initial",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      continued treatment of DVT is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/4/43082?source=see_link&amp;anchor=H7479951#H7479951\">",
"       \"Treatment of lower extremity deep vein thrombosis\", section on 'Other orally-active anticoagulants'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Duration of treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The duration of anticoagulation therapy varies with the clinical setting as well as with patient values and preferences.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with a first thromboembolic event in the context of a reversible or time-limited risk factor (eg, trauma, surgery) should be treated for three months.",
"     </li>",
"     <li>",
"      Patients with a first idiopathic thromboembolic event should be treated for a minimum of three months. Following this, all patients should be evaluated for the",
"      <span class=\"nowrap\">",
"       risk/benefit",
"      </span>",
"      ratio of long-term therapy.",
"     </li>",
"     <li>",
"      Indefinite therapy is preferred in patients with a first unprovoked episode of",
"      <strong>",
"       proximal",
"      </strong>",
"      DVT who have a greater concern about recurrent VTE and a relatively lower concern about the burdens of long-term anticoagulant therapy.",
"     </li>",
"     <li>",
"      In patients with a first isolated unprovoked or provoked episode of",
"      <strong>",
"       distal",
"      </strong>",
"      DVT, three months of anticoagulant therapy, rather than indefinite therapy, appears to be sufficient.",
"     </li>",
"     <li>",
"      Most patients with advanced malignancy should be treated indefinitely or until the cancer resolves. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?18/58/19367?source=see_link\">",
"       \"Treatment of venous thromboembolism in patients with malignancy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This issue is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/4/43082?source=see_link&amp;anchor=H25#H25\">",
"     \"Treatment of lower extremity deep vein thrombosis\", section on 'Length of treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     General medical management",
"    </span>",
"    &nbsp;&mdash;&nbsp;The general medical management of the acute episode of DVT is individualized. Once anticoagulation has been started and the patient's symptoms (ie, pain, swelling) are under control, early ambulation is advised. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/4/43082?source=see_link&amp;anchor=H44#H44\">",
"     \"Treatment of lower extremity deep vein thrombosis\", section on 'Medical management'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    During initial ambulation, and for the first two years following an episode of VTE, use of an elastic compression stocking has been recommended to prevent the post-thrombotic syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/37/23127?source=see_link&amp;anchor=H436298802#H436298802\">",
"     \"Post-thrombotic (postphlebitic) syndrome\", section on 'Compression therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?1/3/1075?source=see_link\">",
"       \"Patient information: Deep vein thrombosis (blood clots in the legs) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?12/44/12998?source=see_link\">",
"       \"Patient information: Deep vein thrombosis (DVT) (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?21/15/21747?source=see_link\">",
"       \"Patient information: Warfarin (Coumadin) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Only a minority of patients suspected to have deep vein thrombosis (DVT) actually have the disease and will require anticoagulation. This illustrates the importance of using validated algorithms to evaluate patients with suspected DVT, along with objective testing to establish the diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Suspecting the diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of DVT is suspected in a patient with a palpable cord (reflecting a thrombosed vein), calf pain, ipsilateral edema or swelling with a difference in calf diameters, warmth, tenderness, erythema,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    superficial venous dilation in one or both lower extremities. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Initial approach'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H19\">",
"     'Diagnosis of DVT'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h3\">",
"     Pretest probability",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pretest probability of DVT can be determined by using the Wells score (",
"    <a class=\"calc calc_professional\" href=\"mobipreview.htm?1/30/1505?source=see_link\">",
"     calculator 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Pretest probability'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with a low probability Wells score and a negative D-dimer are unlikely to have DVT and do not need further testing.",
"     </li>",
"     <li>",
"      Patients with a moderate or high probability Wells score should have noninvasive testing for DVT. Compression ultrasonography is the noninvasive approach of choice for the diagnosis of patients with a first episode of suspected DVT.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h2\">",
"     Confirming the diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A positive noninvasive study in patients with a first episode of DVT usually establishes the diagnosis. If the initial study is negative and the clinical suspicion of DVT is high, a repeat study should be obtained on day 5 to 7. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/12/33994?source=see_link\">",
"     \"Diagnosis of suspected deep vein thrombosis of the lower extremity\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h2\">",
"     Screening for hypercoagulable conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Screening for a hypercoagulable state is not generally recommended unless the results are likely to change subsequent therapy for the patient or family members. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/41/11930?source=see_link&amp;anchor=H8#H8\">",
"     \"Evaluation of the patient with established venous thrombosis\", section on 'Screening for inherited thrombophilia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anticoagulant therapy is indicated for patients with symptomatic proximal DVT, since pulmonary embolism will occur in approximately 50 percent of untreated individuals, most often within days or weeks of the event. (See",
"    <a class=\"local\" href=\"#H30\">",
"     'Initial therapy'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/4/43082?source=see_link\">",
"     \"Treatment of lower extremity deep vein thrombosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Initial treatment should be started",
"      <strong>",
"       acutely.",
"      </strong>",
"      Available approved choices include unfractionated",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      , low molecular weight heparin,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/35/40503?source=see_link\">",
"       fondaparinux",
"      </a>",
"      , or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/16/5384?source=see_link\">",
"       rivaroxaban",
"      </a>",
"      . If a heparin preparation or fondaparinux is chosen, treatment should be continued for at least five days and oral anticoagulation with a vitamin K antagonist overlapped with one of these agents for at least four to five days. No such overlap is required if rivaroxaban is chosen. The preferred choice of anticoagulation is discussed in depth separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/4/43082?source=see_link&amp;anchor=H43#H43\">",
"       \"Treatment of lower extremity deep vein thrombosis\", section on 'Initial anticoagulation regimen'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Use of thrombolytic agents or thrombectomy is individualized. Patients with hemodynamically unstable pulmonary embolus (PE) or massive iliofemoral thrombosis and a low bleeding risk are the most appropriate candidates. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/1/28697?source=see_link&amp;anchor=H17#H17\">",
"       \"Fibrinolytic (thrombolytic) therapy in acute pulmonary embolism and lower extremity deep vein thrombosis\", section on 'Lower extremity deep vein thrombosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Inferior vena caval filter placement is recommended when there is a contraindication to, or a complication of, anticoagulant therapy in an individual with, or at high risk for, proximal vein thrombosis or PE. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/28/16840?source=see_link&amp;anchor=H2#H2\">",
"       \"Placement of inferior vena cava filters and their complications\", section on 'Indications'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h2\">",
"     Treatment duration",
"    </span>",
"    &nbsp;&mdash;&nbsp;The duration of anticoagulation therapy varies with the clinical setting as well as with patient values and preferences. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/4/43082?source=see_link&amp;anchor=H25#H25\">",
"     \"Treatment of lower extremity deep vein thrombosis\", section on 'Length of treatment'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/4/43082?source=see_link&amp;anchor=H48#H48\">",
"     \"Treatment of lower extremity deep vein thrombosis\", section on 'Distal (calf vein) thrombosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with a first",
"      <strong>",
"       proximal",
"      </strong>",
"      DVT due to a reversible or time-limited risk factor (eg, trauma, surgery) and those with a first unprovoked or provoked episode of",
"      <strong>",
"       distal",
"      </strong>",
"      DVT should be treated for three months.",
"     </li>",
"     <li>",
"      Indefinite therapy might be preferred in patients with a first unprovoked episode of",
"      <strong>",
"       proximal",
"      </strong>",
"      DVT or",
"      <strong>",
"       pulmonary embolism",
"      </strong>",
"      who have a greater concern about recurrent VTE and a relatively lower concern about the risks and burdens of long-term anticoagulant therapy.",
"     </li>",
"     <li>",
"      Most patients with advanced malignancy should be treated indefinitely or until the cancer resolves. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?18/58/19367?source=see_link\">",
"       \"Treatment of venous thromboembolism in patients with malignancy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35305/abstract/1\">",
"      Goodacre S. In the clinic. Deep venous thrombosis. Ann Intern Med 2008; 149:ITC3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35305/abstract/2\">",
"      Lechner D, Wiener C, Weltermann A, et al. Comparison between idiopathic deep vein thrombosis of the upper and lower extremity regarding risk factors and recurrence. J Thromb Haemost 2008; 6:1269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35305/abstract/3\">",
"      Cushman M, Tsai AW, White RH, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 2004; 117:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35305/abstract/4\">",
"      Alikhan R, Cohen AT, Combe S, et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med 2004; 164:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35305/abstract/5\">",
"      Bezemer ID, van der Meer FJ, Eikenboom JC, et al. The value of family history as a risk indicator for venous thrombosis. Arch Intern Med 2009; 169:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35305/abstract/6\">",
"      Z&ouml;ller B, Li X, Sundquist J, Sundquist K. Age- and gender-specific familial risks for venous thromboembolism: a nationwide epidemiological study based on hospitalizations in Sweden. Circulation 2011; 124:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35305/abstract/7\">",
"      Goodacre S, Sutton AJ, Sampson FC. Meta-analysis: The value of clinical assessment in the diagnosis of deep venous thrombosis. Ann Intern Med 2005; 143:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35305/abstract/8\">",
"      Qaseem A, Snow V, Barry P, et al. Current diagnosis of venous thromboembolism in primary care: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med 2007; 146:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35305/abstract/9\">",
"      Birdwell BG, Raskob GE, Whitsett TL, et al. The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis. Ann Intern Med 1998; 128:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35305/abstract/10\">",
"      Huisman MV, B&uuml;ller HR, ten Cate JW, Vreeken J. Serial impedance plethysmography for suspected deep venous thrombosis in outpatients. The Amsterdam General Practitioner Study. N Engl J Med 1986; 314:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35305/abstract/11\">",
"      Hull R, Hirsh J, Sackett DL, et al. Clinical validity of a negative venogram in patients with clinically suspected venous thrombosis. Circulation 1981; 64:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35305/abstract/12\">",
"      Gorman WP, Davis KR, Donnelly R. ABC of arterial and venous disease. Swollen lower limb-1: general assessment and deep vein thrombosis. BMJ 2000; 320:1453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35305/abstract/13\">",
"      Wells PS, Anderson DR, Bormanis J, et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet 1997; 350:1795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35305/abstract/14\">",
"      Subramaniam RM, Chou T, Heath R, Allen R. Importance of pretest probability score and D-dimer assay before sonography for lower limb deep venous thrombosis. AJR Am J Roentgenol 2006; 186:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35305/abstract/15\">",
"      van der Velde EF, Toll DB, Ten Cate-Hoek AJ, et al. Comparing the diagnostic performance of 2 clinical decision rules to rule out deep vein thrombosis in primary care patients. Ann Fam Med 2011; 9:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35305/abstract/16\">",
"      Tamariz LJ, Eng J, Segal JB, et al. Usefulness of clinical prediction rules for the diagnosis of venous thromboembolism: a systematic review. Am J Med 2004; 117:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35305/abstract/17\">",
"      Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133:454S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/30/35305/abstract/18\">",
"      Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e419S.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1322 Version 26.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-197.136.42.3-293D88DB16-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_30_35305=[""].join("\n");
var outline_f34_30_35305=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H34\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      INITIAL APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4884402\">",
"      - Family history",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Special clinical settings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Phlegmasia cerulea dolens",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Screening for malignancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Laboratory testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Cellulitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Superficial thrombophlebitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Venous valvular insufficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Lymphedema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Popliteal (Baker's) cyst",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Internal derangement of the knee",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Drug-induced edema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Calf muscle pull or tear",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      DIAGNOSIS OF DVT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Pretest probability",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Wells score",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SCREENING FOR A HYPERCOAGULABLE STATE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Inherited and acquired hypercoagulable states",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Who to test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Value of screening",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Screening test interference",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      TREATMENT OF DVT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Rationale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Initial therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Duration of treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      General medical management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Suspecting the diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      - Pretest probability",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      Confirming the diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      Screening for hypercoagulable conditions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      Treatment duration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/1322\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/1322|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?41/20/42318\" title=\"algorithm 1\">",
"      Diagnostic algorithm for DVT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/1322|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?3/63/4080\" title=\"picture 1\">",
"      Skin changes of chronic venous insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/1322|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?1/6/1132\" title=\"table 1\">",
"      Causes of venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/1/23580\" title=\"table 2\">",
"      Pretest probability of DVT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?43/18/44331\" title=\"table 3\">",
"      Risk VTE multiple defects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?43/22/44396\" title=\"table 4\">",
"      Thrombophilia test interference",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/35/16955\" title=\"table 5\">",
"      Outpatient care for VTE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?41/28/42444\" title=\"table 6\">",
"      Weight based heparin nomogram",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?1/30/1505?source=related_link\" title=\"calculator 1\">",
"      Calculator: DVT probability: Wells score system",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/14/1258?source=related_link\">",
"      Anticoagulation in older adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/26/27050?source=related_link\">",
"      Catheter-induced upper extremity venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/33/12825?source=related_link\">",
"      Cellulitis and erysipelas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/17/13592?source=related_link\">",
"      Clinical evaluation of lower extremity chronic venous disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/36/34375?source=related_link\">",
"      Clinical manifestations and diagnosis of edema in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/52/1866?source=related_link\">",
"      Clinical manifestations and diagnosis of lymphedema",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/57/14234?source=related_link\">",
"      Diagnosis and treatment of venous thrombosis and thromboembolism in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/12/33994?source=related_link\">",
"      Diagnosis of suspected deep vein thrombosis of the lower extremity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/43/33462?source=related_link\">",
"      Diagnostic evaluation of chronic venous insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/29/6618?source=related_link\">",
"      Evaluation of the active adult patient with knee pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/41/11930?source=related_link\">",
"      Evaluation of the patient with established venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/1/28697?source=related_link\">",
"      Fibrinolytic (thrombolytic) therapy in acute pulmonary embolism and lower extremity deep vein thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/59/40890?source=related_link\">",
"      Heparin-induced thrombocytopenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/43/35514?source=related_link\">",
"      Hypercoagulable disorders associated with malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/2/41000?source=related_link\">",
"      Obstetrical manifestations of the antiphospholipid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/48/43786?source=related_link\">",
"      Overview of the causes of venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/28/25033?source=related_link\">",
"      Pathogenesis and clinical manifestations of venous thrombosis and thromboembolism in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?12/44/12998?source=related_link\">",
"      Patient information: Deep vein thrombosis (DVT) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?1/3/1075?source=related_link\">",
"      Patient information: Deep vein thrombosis (blood clots in the legs) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?21/15/21747?source=related_link\">",
"      Patient information: Warfarin (Coumadin) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/28/16840?source=related_link\">",
"      Placement of inferior vena cava filters and their complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/37/23127?source=related_link\">",
"      Post-thrombotic (postphlebitic) syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/0/1030?source=related_link\">",
"      Posterior and medial ankle tendinopathies not involving the Achilles tendon",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/6/27754?source=related_link\">",
"      Primary (spontaneous) upper extremity deep vein thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/52/841?source=related_link\">",
"      Protein C deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/12/3273?source=related_link\">",
"      Renal vein thrombosis and hypercoagulable state in nephrotic syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/26/20903?source=related_link\">",
"      Screening for inherited thrombophilia in asymptomatic populations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/25/43417?source=related_link\">",
"      Superficial thrombophlebitis of the lower extremity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/8/33930?source=related_link\">",
"      Therapeutic use of heparin and low molecular weight heparin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/17/42266?source=related_link\">",
"      Therapeutic use of warfarin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/4/43082?source=related_link\">",
"      Treatment of lower extremity deep vein thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/58/19367?source=related_link\">",
"      Treatment of venous thromboembolism in patients with malignancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_30_35306="Mycosis fungoides patch";
var content_f34_30_35306=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F80073%7EDERM%2F60650%7EHEME%2F52131%7EHEME%2F73078&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F80073%7EDERM%2F60650%7EHEME%2F52131%7EHEME%2F73078&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mycosis fungoides - patch stage",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 323px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Subtle erythematous patches with slight scale are present on the buttocks of this patient with mycosis fungoides.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mycosis fungoides - patch stage",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFEAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDn4GwoJHXuauA5wBy3XpVNUYAYyalAbGVY5HWuI9hbDppCzYPGOKglf5cBRj1FPlTJLckVDLlVOB0qiZbGPqx3LtA5HGa5i4BSUt6CuqvMFTkc965rUEwM+9b02c1RGfqKiWzUgcgc1S0y7KfuX/A1oTYaDnuMViiJhImAck8Vq1cxvZ3OttjmM4wGH61etJzkgiq1nESoBHNadtbr6d+tc8zaJoWsnQEDJrRhILZBrMi/d8tz2GKtxnIzg4zWEjogi8GABbnmouh3Zzk9u9NRztACgCpG4Jx0FQUyeIjbuOPpUsIYgfKefeoIgGX5Dke3SrcTZGeN47UiolnrCQ7ZIHT2rnr8+ZMc84Nb0rHyiep7msCdi8+0jGf1q4Gcx1tHlferUUZRyOmeSDTIflZfyq4yjJ56DOabYooaE9+KFjy3TjsRUny7AcZzShSANoGKi5oo3GogBORmrkR7Akiq8cZ8zK/jVnY2c5+oqWWokzbOCOCalLH5T+eajjQkYyAPSrUURKFcKy+pqWzVIEbKDK8+maZKu1BLsAAPFPUbWwoBPpmpkKyrkqwHvxU8xbhcZFcL1OOevFWxMn3gvSqs0AkBZlJqBrYr86Pgemad0yoQaLjyqzLlgwz09DSpH02sdw9eapNhArOOc8EVOJkRQ3IB7HikbJWLsMnzD5gwXgjGKshlWQFWPA4DHisYXLu4AQAnjPrStcyLjexQDoSMigpxubck8SqQrPu6nHIFVpL1cbVBU9OnFZTykfdcHcM8DoaEcIfmY7vckc0iXGxcFwd/zEsc/exxTbi/KgrgFjwCD2qrK4KgkYBPBBqrM5IOPp700SkWBNJuzIcDt6GpRdqDzkMPas9XYAc8Z79qjmlZhgZPrnjNA+VPcvm4BcbgCDTJ3B4yMelZpdvMHfaORTTcMz4cAH1qkRKny7EjNuJxyR+lV3zkk/SpmkAzgbceneq88o2EjI/CqIdxrHABzWfqRzC68/dPf2qaaQggj0qpetvgkBPOM5prclrQn0Q+ZZxADJwMity2jIYnA5/T61znhtiltHg8DqK662C4zjAbnn1pslbFf7Oyk7G2gHIxRGA2FPJznOeKmuck/KpBJ6U9FywAUhR2/nSC+hl3MBkDhiQdygH8ah1iNYVQo+cHO31rRuQoLxjhQN2G9fWsjUH3opxk479qtO5zTVjD1edJYtygFgQRn+X86q2jb5JsnHGQT0OKhcmOVllYgb8fTmprmHyooWRsMD19Qa02Rmb6NuUAMS2KeqsNwPNRQFSu5T+JqwD6Nwak0QBMLndk1WuEIUsD+dXym1MjriqU+WUqevrTTEzIucYHJ96wNRXAYj1zXSTx8cjpXP6jkAjHB4xWsDCZjucJsIyBzVnTreNoEd1ywYlfaq00ZLHvWrpkPkRKrcnqc1s5WRzuPMzQtIyMenYVrW6gE5AOR3qhHk7R09a0IAdveuWTOmKJio4x1PWpY1+Xk4PpSIu4An8auog+U4GzHXFZNm60KscZDf8A16cTtPQEE96shRkH+HsDTJIQ4IJPtSAfAqxLtjG0dQMcVdhC8FhhqrQ4UAMMAHippH2g7c80DTsSyNGMhSM4/OsiVQZGbHHarDg7uvJ60yNCckd+1WtCHqQ2yOJ5C7lo2wVX+7WhG3GSckcc01Ytv+FPCgcjpUPVlIUuCMgHHSnRk78HOKQIckEDHUc0oOJME8YpFxJ1Tk9iKtQnBG7tUNvye+PWrG8KcKmecGpaNIloAvggbRVtQCu0AnHXioYwGwUyfUVbVVIHPXnFZs0TGiJerLg44pxi24HPT1qRQXXgAEHn3FTL8zKAMj2qGXchAjeMAoBj0PWkEUDLyvPY8VcWMttVVOc9l70j2pAG4HPcEYoNYyRnyW4DsvBUDgMKSS0G0MyHbjsc4/Gr7wKEBfg/7J/nUG1VQ/vCEPYH+lF2XfQznjXbgr35GKhaMnao+VfrkVo7MkkOucdjn9KUw4jIaTcTzgAc1VxXSMxokbaFBA7/AFpjKclXJK9Bn1q7Lb8Hac45wcg1E+QgyGIHbqKCmUpHw37wYIP4U0/eOwZGeM9Kmdd6YZGz69arPGyE+XnGM80EizIQmQRz05qDbuzzgin+Yccxvx360sSlwdpB+tMV2tysAwLdye1JLE0gyo5A6kVbePC/eCt71CwOzJbPcYqhc19SkxKDEmfeoLkkbeOuOKtspOGwapTEyS/Lxj5qpEsZNIGUjbyOBVO6H7vBwM8VNO4LcjHvUFywC4JFUjN7CeHji2yvOCeD9a6uwl3o4OQVxkZrkPDzsiuAufnIP5111soaMErhsdVpz3M4bFoHdcLn7vUio58rEWEhVMnG4VYh2uAxUr7ii6UGGRHACLgjHepQSKCLFs8xsFOuT1b6e1ZN9IXEzqvyZ2rx1rWjdFiw65C8AHgVmO/mMNxyQ2cn69AKtGM1ocvq6H7Y2wYOzO0/SnxmTbAwy0IXIPpnrVvXLdn/AHsYCyc49xVOPzI41bh0YbgcfmK16HOtzVgkXYcHjuavwurKOOKyLM7AEOCDWgh/fDbxx0qS4vQujoQzHiqUzgEZIyc1PLyhKk5PFVehJbk5ppDk7lK8PBwDk9qw7+I7MtkkkVt3hLHAHT9az7sDZzWkNDKexgmH/S2xkitS3Q5BxUEK5Zs561dgUnjv3qpMySLlsmfvfnWpFDgEZ59qyocgjnmtS0fJAyC3rWDNoot28fOCp9KlIYEgAgdKamQw5GR6VJKPuqM7j1xUpIptkXBI74qdF+QkioQpUqGUkH0q0UKoNvKnr7UmNO5HIcKDyf6VWmlc42DdzV9lTHy8rjnJpqxKqcjntgdKSdmU46FYccnoRwKlAGAfU9KbKNqjkE+1DEDBAPT8qolInTaODyev0pww3Ix9KrK/HLf/AF6cJeVx9agpInKncD2/rSqAQSeSe9BYEhcYBH51JGy8ZFMaJrZwkfcn0xUgwQGUHA60yHDHofYVZXJ4GKk1SHxOBtfOCOMVfhkQ4C7s449qqwrgHeAV65IqdAXV1gO1scNjoal2NEWY3MbksO/OB3rQjYcuwANU7SMk4lBGMfMP8K0/JQIyuMEAHJ9azkirkQuHzgAkdvWpZZgqFQ6iTqc/40yV4o4+JCzEZ29AKznZ8nK5B+6zDp+NKxUVcnw0ko8tgQ33t3AH41HKkjsdnfjioQX8onyOCcl0Jz+VCAYUq7dSSoPK/h2p2LRK4dSDLDtwME4GTSFzuAZIzj+9x+HFSAtuGJNo64LdfwpuCWLqyeh4BI/Ci1x3GybCr4VFHHAbmoRG3PlhRxuODnge1SOFlUiEbWxgAkGoG8xYwrO5IP8Af/p2oKuMYJvbbuViMnsKqTYLADAB+Wp5NzL825VzkDNMuJBsXeAT7iiw0ypsWNiSrcnHBq5JZRFBgHJ74qBnDAKG2jHBbvUtvO7MYmUN6FTimZzuV5YF8vC4PPBz3qm+8HYcg47Vt3KqI+MAH161lyxqCCcYHQiqRCdzNmBXOQD7jiqRG3JB5PatG5UnJHX0rPdSpOBk+lUkO5TnHAG3Hcmq1wMoCcelXpEJBcFjkc1TnBCYH4VSRDZW8MuEe5VhwJK7S1lYR4xnHeuI0Q7dRuFA/iBrsLNM7S2fftxTluRDY0Fk8wZXnI5wOlR3UwJSMFTuOGb2qZ8IMq2M8YqnNHtJZzhexI71NgeomoiKOIShmYngLjr7VjSu5MRClMH5c+lXJCclCC5OOvYetQ36FY2IwGHPHTg1cdzKZTuEMxUtt2qpHX1rFzttmRWPytnHpWvc3KeUoIwTjGPrWZblpGn+UcvgAH+daHN1JLb95tZSM9wa0I9wY/LmsezkIiBU/lWrDMWIXgjuapqxUGXVUyDGenpUUkQI5yMGpIyUwSc+lDsSDz+FSW0Zs0eASRWffYS1bgZ6CtmZSMkjpzWBqz52KO5LdK0iZT2K8YGAOPfFWkIAwBVSM4IB4FWoznsaUiIosoQDznpV23LZBAGM1UhRmfODjHWp48mTHJ7YrJmqNaG4VOGGfoasRrucHjLd6oRJhgFPHer8bhBtbPPTPSoZpGNy0iASfN0FNZg+8xgAL78UjnYDvOcjjB6VXR1UAcnPODSbLjAfEcj5RkntmkllCBQrdOoNPjKoGIOScnGKhZlRSQAWPbrQlcclYrCVvMJzkfSntlzkH3NRygkAk5x2FJG3zY4JPBqzFky5bPAwOmaR3PAQ4x2BpXfCAALnOKYE4YnHtUlakn2hgAcBT7VMlxk4IPHUVUQAn5RxjrU8K4OCDzyRQxpGraEuvGSO2KvoEVSDkH0NZdsNjDOV9qvGXa/QZxk5qGbRRet1DEZPboatwpg4fj2BrPEoK5UjcR6Vds5FL5ZuMdqlmqWhdEhjViFLKfbmpUmRI2Lk5PA46VWEgWQAqQg7A9aluQHj3IuTj7vI4qTTl0syqJW8yRQAVHUtUqGTywXYbRnaRk4oS2QttXchx1z0/GmgPG7J5hIPBCtwR6fWg0STCCMSSbklXIHEZBw1TtBHsGd24+3T1xQGSBVTLByep6r7VLBCWHLA7m+8R0oJeoiorqojjMjng8dfwFQYEb4bgD+6gyv51O5aIExSSAjn06dzRIpbLyEkv1LHrQJaEMojO2RELJ0K9jUMjzSoFYFVHOCAasTggELGVz90Bs9PWgRqkYkfAPfNK43ZGc+HGXyOONp7+tVjCx4RScdO5rQxljtzwOSRVZkO8EE474GPyqhlOWJ27MSe2OKVN0ZXIGRzj+lWd+9gTkAck05cb23YAIzTM3cY7qxCugVvSqtwpAwwHPQVZnfJ+bk+vrVZ5lCnp9CKaMmmZUylCcE4HTFU5GYsc8jvWvKFkVsFVPt3rLuV5yAeatai5ilIFwx5HP51DIh2kkgD6VNMjDGSPXFMOGXgk5HTHFOwr3MjT1MWtTIASrAN+tdlat5gGCBt7etcpt8rVrd2/iBQkfnXTWqbXGMDIyDTkEeqL8qPghD25pkkRYBmI45wvY0ebIULMAMDgjvUTTbI2ZnIJ6gcipsJsiut0YCqd5PXPaqnlvKoTnLHqO9TzMzvmRQqAcBjyahaZkO4Z+XoSOB+FUjKTuQSRQs0kLgDHUj09KxUZQ/pznI4BPTNabBHkbdIM45B45NZ9+EDYx8wPGf0rSJhLcz7Q8ZAx61rWfMYz931rA0998YzkMK27dsY2nA9MVc0Z0nc1UXkbe/rT1CbiCahiZiMqODxUi5xhhk9eKg6StcdWA6VzmqOHvPlHCjFdM/O7I+WuWbDSv6MxxWkDCroIiZbnpV23XkfkKihUFvY9atxjPsKmQ46GhbqCvoMYoUKGLY9qhj+UgEnH86sIAVUtk4PSspGsYly3jR1GAwIJ4HerqqSygjBx1qtCxDYUDn+VWsopDMDnpz6e9Q2bxQ7YA5LKCSMe1RD5pfnG0dAD61YV4z/ALvvUKlknLcbemR2pFjGSRQ7ZHFUJJHVmJGCeuK0ZF6lucnIx3FUbjq3GD97jtTRnPQrtMAMA9epNOhDFi2QGNVQwByRnnpmr0GTGvds8YFW1oYEhTGRjpyfrUi25IHYe9JDu3AbMtnvVyUnywqnnuMVDLVyqycnA471NGg3gnPHpUiwlVAOD9KNvy7mx1xjFK5pFWJQ5zgDgVYRMqNufz61DEmOOOlWI8k8L8nsKTNki9bxDChRlunXNaNvAGLAhFBGMHvWfbkq6sApx0GcCtWzEjfLt3HruXoKhloljt8nG5geygVaEG1MBguV7noaSCNWfKk+YeOMjFWvKjZtu7DZySOOakdzNkhlicoX3kjO4elJ5EjrvEmOOnrV26ibfuDZRe7NUTNIBlSNvfn+lBd3YhW3VZAsiHB5Hv7UOAIxvGF5I7kfU0QSSST7ySEAwQ3SpPOVg6gDA+Xt370BZj0myqovzDrjJwaERgZAipg++MfTmkumARQ7iSQjbkZ+UelQKriNmDAY7kjH+fegpCJakSMuZFycnHWpCF3FAO/BbsKakpEgJ+Zs5yR938aWW5zNmPjA2nZgn/8AVQJq5XkiwjH+IfeOf5VWKuV2qm48dDk/StC4ZRsADMqg53cEmqqHMvyKqg5J9KY9SrJE6gqq8dSKjCttbPYY6VdZFUFjIM7cnn+VU5DtYMoyfamjKWpUaRmDYIAXioLlgqYIzVpiCxwvHXLVTfPmmTAwPXoatEFZjtG4dD2HpUcxVz8uR6inMwKck/N2qpMzJ0GRnqKuJjJDb2MDBHK1TK7M4+7Vqd94Ude1V3O5mHGe/FWiFoZWpOFmicD7rjNdLZl5IAo4wM5rmdbgLJJtO1tvHPetbw7dNLbwsDjK4bNJ7FRd2bcLIYwZG2g9s96juMM4+XPGRjtUyAod+wMrHDZqrLMhmJVsY4xjFJIb3Ksi7ZPnO45yQD0p0khI3KAdvqe9OaRFJaXkHkADrUErbDuKHkZHzYApkNIEiRUJnwABuLMMn8K5u8ZjLLJnqd2WNba5mV/NLBTxwKx9baNB5Y6HHGeTVwOeoZcytp+p3MDKQVbgVoW0rSkfKV+taPxL059M10SFeGPLCsi2n+YAdSM10TXU48PO6N+1bCkA4A9asNKqAA9T7VkW821ctjHerSXXVnA/+tWFjvUh99OqWkjhcHHcVz1unylm61f1K4WVNqvkk9Paq8PG0D61aVkc9R3kSJhQcipVPyjAyBUWNzAD8anUjcqgEc9cdahm1NXJ4/n2gcnOPpV6KEofmOBUViMPwAcDkmtMIWCsQdw9qxkzpSsRREIisSQ2OuO1XItiopdSVzzz1461GImIGeMtggdKuCLOFYD5R0qDSKREwLFNoBUjB/pUhCsDvAX1BP8AWkuIwka+V8xPt0qSMFUTdEG6EjPSlc05RJlxEwGMgcDPb1rnpmYCQZO7vit2dswnIwxOAD6Vy95PvkYA45wcVcNTmrKxJaJvIzg84JzWnbocHB45ArMttqjvzWnZOFJLcnsa0lsYovpAyYI+YsOB7UFQ20g885xSTSsQuH6/L9KljAdVwBxWTNYobt2kDcMdj1NII+TuPOO1SzRcZwS/TAoCkZUgevWkaxSZJGgVs5GT2q3FuGBjP4ZzVRNqqAQcng+4rQjbCAIFBHcntSNUiaLC4xtLY5x3NWYrhoGCkgMeoOT+lVYm2AZPB+6asFkLDfknHY9KhlpGjDct5iFjgkYz0zmteFVeXfu37RxgEc+tYCkKucfKONxPGfWtKG5Bhy6N1/1intUsfKXztdyrgc8EOOD9KguNPlf945dEGEVQM4Hv7VK774A0YlBToT0H9asWsz7Akhcu3JUjIYfzFFyXdaoyEDIJIwRhckNgcH2qCQtEWVtjswBDEc1du7J3mGyJS7HcqKcCq8tldRoJcfKzYbgn6D6Urmyatq9yMEqzxywsrDqQ4P0p7W7oVGE3qAdpOR+dOhgYgx/cc9iDu/Cr0dggjV5JmjGMDevPFUK6RjsZYkC/Mylsso45FK6CWQMBGpx/n2rQWAGYRqSu7P7w5JA9RVg2P7kiRUwD8jDuKBuSRivE4UqwBY8Ht1q4tmEiB6tt6elTTQiQZiGCDzjnmp0KqgD5zj86DGU+xk3KptEYXkdRjp/jVCSN1UZHyelbzEO21cAqD24rIupNspGcE8EdapAm2UGVPLZQSpHVulZtyCflVsnvjvWpMrcHv6VnTKwc4X6gdqpGbM5o2zjnFVJ9y9vxq+252xj8fSqkgyxAGcfqatMiSKbDDccdMU07icgc96kkV9ynkg8fjUbqSmecZ6irTMmVbwbhk4Oag0J/IvJbZuAx3KBU9xkrjHI9KzWf7PdxTjgq20/Q1dhXsdzbHanXg8EN61DIoV8hflPQEc1FYy+egbO715qy8e0btpPpnmo2NSm6ZXLKu7PGKhkiXdljzncTVhpW5RiVPfaO1VpZSvyCM7uoXqf/AK1BDKV1cFA6oRhhgH0xXOXXBMknG3p+dbV45LlgOUyMZ6Gua1CT7yOTwc49a1hqctVnuXxR8MSanYytCoLqu4189vNLYsVuFYMh25r7OurRZ4mRhkNxXzH8YdE/s7V7hI1AUnzBW9N8yszx6M3HQ41vEioMLGTTtLuNT8RaraaXpoAuLlxGm5sAEnqT2FcxICCRU9tdPbIwiZldv4lOCKtRSO11JWsjvtT8NXnhbWLmw1K9tbq5TAY20u9V4zg+9FsCxUg8VgaFITZSysfmd+STkmtrSZCWw3Q1nMqmn1NBY23tgcVIq5IyCKtR+Wy8HtTYwQ/bH1rnbO6kaVrAAhBwavxxsqgIRwep71WtF8xlC84GOa2LZNuCwGPesmbCRL5qH5MnjAx79aZLE+MKx64Jzwav+WWQZ4U4FPgRFPlkAgkN61maRZSt4gB6cZORmpViVRtkPytzwM8+lX4kXOVTOSDz0FEkeG3KPbBqTaLuYGpbUiZmBAC8epNcS777g9RntXW+J5zFaFioA6ZFcdbklsnnnPNdFNaXOPE6SsaVrlhtPYjitaEAuAAef4R7VnWI2pnAOR1PWtSIAsMr0xz/AEFUzOBOVCsMjDN2HPep1dlZQmBt68ZxTFAcliNoz2z09KtwhWl+UgKPasrm6Vxx/wBWruT2+UDt70sijOeue1TFTyFO4seOOtII2R+7HtUGkFYbFES+8bTx61YjTIJYsxPZadGU/dhO+AT3Pt/9arMuPnLdfXFK5ukV2cllCKVUdOMirEcaGQGRnY44wMc06EosgGeT0OTgfhT4SzTHco5HQH+dSaJWLEDpIyjYSQ2fmIxitC3ZgQzblXsGToO+BVGIMuQGVU7+wqy7M6qYwCnUDmpYmjRgaRkMSsACOD3I/Co7YSQnEKneW4KDGPqarxTELtbcvHODxn6VNJcK0YVd7Mv8XQY9hSJcWaBkuI5N8zRk5xkP/nFSO0jMMsz49iR9Oajt5EazWOWMRY/hUcj65pZzEkSLGxjUkYL5LH3pGdtR0l00YclYyTgZAJJoVC7Ded5PBUdvxp0AKj503oQegIyPeodzxYUMUVgcrmmTYbsVbjCoNynaHGefakmQ7A5DkH14A+gqWUIW4kJUDIKmojP5x2yAEAcBj0FNMLMiyFbhQM89etVppGc5jJwTznqameRVDADIHdTjFViJA4YAYzwAM8VVikRyzYOSWBH4k1lyGQvnygG9CetalzA6ys+NygZ68D2FVmjMhLIMMR1JxVApeRnSLIr7pcHI5x2qjcA5C55xnINbEkfyqCyu3f39jVSRFGcLtOCMn+lO4mzHlUBAhJ+XvVB1+Y7jgn0rYlAY7l+XGQTVCXI3bR1P51RmyhL8xODnB9cVCwOBnk+1XXQhgGwBnvziqzkB2AAYEfSrRk0VGjB55Ge9ZWoQ4VuMZrZlAPsOvArNuzujO7oORWkTFs09AmSSzQEEH2rZeKR1wrhgecelcloErISvOAeCOtdMZTGQ+8lSORjFKSszWEtBJItgXOMnv3rOuGZAcZO49T3NWpJXlBAA+XjHQVWu1cTo0mCqrwKSB3M65xChy3PXJ7muM1J2e7dmb5AccV1ep/vZSy8hQeScVxWqOAflOSc5Oa3po46rsfbqnPGa8i+POkb9Nj1FRuKfK2PQ164PbrWH4zsob/w/dRXABXaTSg+VniRdmfFd1ayLMVjRnGeCBUtrot9cuNsW0Hu3FdmY0EzKAAoOM1bj2Roxyfwq5VdT2YUE1dmFaWptbMQtgsvXHrV3TQEDN360x2+Z+AM1NBCTFkH8qJMVNGzaOHztHPvU9tCTkfxGs2zlaPAAHofWultVUBSBwe/vXPI7KasWLBdiryc+ta0ABKkce5qgnytkkYrQiH7nI47kDmsmbJD3lbzec7c9vSp0xtYnJJPU9+ajSMygbcHHY9+atxQkNs2ls/hg1k2aJDoR+8XPfvS3yfum2jdjvj2qeONkIDAYB+7jv9fSo7oBSTtwScgHtTRrFHD+LMGwO7rlTjHvXPQW7YVUHXk10Xio5WCHHLMTkdwP/r1mQxHzSBx/nNdMFaJw1neoyzaxox5OMcAVoRRkvlx8uc/X8arwAYBA9q04o2lwcAHGFGOAKlsunG5DGxm3JkKoOTitBIw0anOBwBnrUYiRUUcYPvVgAK2COeB7Vlc6FEdhxHlQfqKeS+4FN3I5wPXrSiTKKPlVV6e/4VIvLKucEjknrUM2jEbtU5GwYB+8O1TD5Cp8xyOhLDt60KCu4EEAjg01QpHzKSo70jQlSFeNpdjjrz/KrEO+OJ1LYHXAGc+xpFIQZXcc8ZHFO+byvmHfAPP60gRKil0XZFlv4gBmrquQqpEqqQCMAdqr2kki48qURDgnjrVtYd8e5EJfoM9W9aQm9SJIXJRnDbOSSWxml8wwbDbjMgfJYD1p0MTo7RyOUUIQoYDauaWOMxFJJZISucBfcetId+5ovuldZLgkSNgBUbcTViSNpJt+USTACiRef1qjHdu8bSB2jkTJRUUFT+dRm5eaRGkcu5A59u/0pGXK2aqQzfZ2cSMwUY4OFU1DzsYFVZ+5API/pVZ544SFkkeSMHJAGM1aEsYgT5jCJB8ysvPtg0yHdDpIVhi2I0bZHze30qN4I2hJUqSOCOxqBJFab5ZPlPy/NgE/4UjbFSRUkBQnnHShBqRSp5aBScEcgg44qCVWZlPmFQeBUqH5WXcd3XnsB2qJAXUg5Z14x2qxiFi+2N1+lRzr5cZBJO4fTAp6szMwZQCDkyA8/SlnCyIFBGD39aCWtSgXOwKuMYxuAzmqtwVRQSxB5JP9KvhQcjATjC+1UJYge+TjPHNUBlz9ckA5HQDiqTKVbDDtkVsTDKjIIYZ61m5BbIyMirRDKM+c4IO3tx1qpOpRsY56Y/8Ar1clOHwWIHPWqcmHBO8sAcdO1WjOSK7sdg3EZXrWZcnEbBc5bitWdQFJVeG96x704dgDkZxWkUcsmGkZywPY5roGYSgLvwB0Nc9pJxI44I4zmt6KEEEA8EcH1FE9zSm/dFiby2xjJB64+971HdtuBJ4IWniMqcZwwHr1qjfSsvygjnqDUjkzE1czNatsR1GdpYDPPpXK6zHHBIkQEyyqn75JU2lXz0A9MY61315Ml/o1vafb4bCWF2Z0myFcE8MCB17Vx3jC7hubmzihuDdNBCIpLkggyNknvyQAQMn0rqpo4Ksj7NBOay/FPOhXfXOw1q49+KrajB9o0+aLruUiso7nj3PlGVglw4/2jSyGSWIlCVTpn1p2sQyWeu3lrKMNHISOOozULuzBVJxk9Kqasz3qM04XIZDjcCOp6VpWEeYck8mqEqEDnrWha8QqoPzU5GdMu2sK+YpPI69K3IAPlJOB2xWTb4CoCCCDWrb8sAfu4rCR3U0W48s4AOBWjbEbCoIH8NZ9vkSHoMcZq1EQHweucnBrJnSkbFuojA9xWhA+B8g79frWbb7pF3HHy8YPf0q/C7R8Nwew7A1mxpF1V3opXv09qzbqOWRs5OB15/StKJztYNwMdM1FLEgjMisSD1OO1JFrRHmfiFR/bRRfl2Lnrmo4xtBJ6j+VPv2Emt3YClgrbR7AVMYvkz/TrXW9jzlrNjoA3GD1PXFaMJYphug6GqUA3OF/SrisRnacKD3FYtndCJZiGDxkjHAPepifn3LjOMHg1VjcgljuY4446VbQ5TlsN1xUM1SFjBLgnkt/KrIcFtvDe+M/rUKKEQu2FAHTPOKfGHYssfbnHtUmiJBJuYEde9SokTsQxZh7cClhty8I+U4zz7+9advZrFCSYuh+91pA5Iq2yZKoQwjH8XT9avxIGGZQDF0TI2gn1FNhChHbL45I9PxqddrLvVirAccYGPbNITepAUUuIzKGPYZ4X2qeFfKwXmBOcMpHAH1pjlFdRFtLep559aUSySfK6jbjClv6UmNvQedobYEyAfvAc8+uaZGuxS21cfdGR1NNlAaViPlB5wDgDHWmu5DhwzRjOBg9D9TSDcnFzPGHKKI+AFGzge/PeoGnKu+cFiQS23OWHvUckxw2JHOTjk5zn1quxZ8qAdw6YNOxqolh5fMIeVznGBu64pryNkiNwiqPl59utVS7mXe7EkdB1FRiRnJYdMYIxTsP2ZZjumLZYCM4289Sacl8yJ94gjqCOOtUGDMSSNppoZkYlGOQc5p2HyI1RqCGRmcPI7DOTwB7AUR3KXUpVN49gMDHtWLDKAWUHIznH9aEnlEgKsRtPTNMylSSubdwu1vm2jIwRTFYHjadgPc8Vm+YZWO0FsnJOe39auyK/mLtcbcdB/U07GUlbcW9mMkfkr90H0qsqMFxvzj36VMU2vgn5uu5u9Ojw+W24JOBxQQ9EUZIy+7cdoHU561TmXngYHr6VfuFHmhicbcnB71UuAznnA3ce9WjNmZdRhhgjcc9/wClU5BtYp/D2rRlUKSoJwO59azpnCnG4EsOKuJhIo3ZCg46cjise+BUbjzzzWvcDLdenJrH1RxsxxkHpW0TlmyvpEm24k6YyAR+FdFBKJAVVsY6Z61zGmZVmccqX5reibC4J9CMGlPc6KXwk0hZCfNweOCOMfjVSUFVJdwzfXmrcmVGAcnrms2a5aOUSSwxy7Tkjs3saSJqOxYnkvxotp/ZFzZ277385ZJI1Z+eD83bFcPrKahPq0A1OaGeYpw0TowC5PGV465rZ1vxBbF2P9haazehVuPbrWXprpqeqI8Vjb2iqNpSAEAnPXk9a64bHm1WfZfShRu5OOaQZo5B/rXMeUeFfGbRorTWoryP5HnBzivOJCd8Ybru6ivUPjddGXX7W3H3Y4s/ma8ymXbLH6E1qndo9fDK1K5MB82OtaVmAmSRkVmRnp61pwgotTJm1JF2D5n+bAA9qvW5wM+nes+ItkHjpzWjagleOf0rBndTRpWwyoxjOP51ZjUbk+XheScVXjQ+Wv8Ad27h/wDXqe2B2KOW6E8/lWTOlGtp5EmSDg5xz/npWgoXaC4IGf8AIrMttyMMYbPrxxV+NjuyF3KTkZ61LRVi2FDEdzg9e31qtMT5T8lW3HjPSklnXzQG3biSMDtSXEhaBy4AVscH0FC3G1oecNIz6ldNnLGU4J+takABi4655rBjlP2+ZiQR5jH9a3rds4xj0rqktDzYbk1vbkFm3YHQcc1bjhKud/OB0FPswSvzN0HQjv6VIoUdsMxxj3rBnbFsrrG8jHCDjkg1YjjZhnd7HjnNTW4w6nuDz2q3GgLvxtHPP+FQzaJDFB90EbeeSef8mrqQ7EwRweoIp9sF3Er29TU0hRACBnsCTSKJrcMF/eAKMYCjgfjVoF1BWRwqnsBkkVWjZGwSW28dKt7uMpsYEY6c/nUsHYY6lYnK5OD39KhR2luSN/J6EnNWiIRJ90gt2J6moSSJQE2he/HWgaGNAxkVVId27Dk0q+YkrM7kKo2lmI+Ue1KJSrOPNjG7qFGagl3eaHUAxjqzDAH0pWHZtjlclMRkO3I+YevoKilQkbN67GPzKegNNkJT975zM55Vl7fWonwZdyhv9psYGfpRYvlHsF4xnA4yO5qF1w5A6t2AzSeYFwzDco7H0qvHMkyHCsshOAelFjWJJ91Q3VhxtJxn61FJIRlVBG4545zQpbcGJ6Z5I4NNlwAo52444qrGiSI5D8wbIz7+tRSHHzBhkcYHNOcjJH481E5XaDgDjBxzmgoHk3E/d+U/nSq565wCck1V35YgfjUikFSf4fbmmTKJYjl2lgfnB4AI7+tWorvbtBY7WIAXIzmsnzDuJwRkcZqMErywPzcYPFBjKlc3zId7AMQc5255FTPKSGO358cemawoJWWYGMbjnOcd61LR2mG6QgZPNBzzhyiBy29uS306VTuHXYD82R3rSlxsbIXjqc1mMwKuBwy85NWjnbM2WZySSSWJ79aqygnlxtOenpVi4YCUAAHuc9KoXUm7dsXkccVaMZla7bGSDng9q569JLDGa2LptzAE8dMZrKvSMbcVvE4pi6YSsLdgG9On1rTgwVV34Yc/WsrS2DPMhOMcrWlC+YCP4wCDSkjek9CWeXrhiM89Kx9QO4EKcn69KuPJ5CozAlGPOOdprO1B94OBwe44oitRVJGBqMcspjSGNpCzBF2qSS3oPeun8KWMULpFJaXNveKR5omPVvZcZHGO9FjqMEGnRPF55uLBJmWJIiys78CUsOm0Z610/h5Y5TYxrJJM1vCsbzSKVMhyT0POOcD6V0x2PLrysj6G6jOT703uOKBz04p2MVzHnngHxakaTxUS/wDCgAxXnuosyNFnn5hXoHxX58VsM8hc1wGrvujVu6kVr1PZw/8ABsW4eSNwzjsK2LcKyHee3GO1Y8GXAPAFa9q4IC47c0pmlMsRgrk9s1p2fQEkEA/nVNUUodoGQODmp7Jgqg5OAcYrBnbDc1IkOzGTk/lVmxZeMbdyjGO/4VUhlDLhuo6HsavIhXrgMenbFZ2OguQQsyBlDdTkg9KvxnapGSAx61TtGYgMwIAOWx3+lS7+NoJVQeQev4VDNYliWAONykjDYye9Q3ZVEUPnaR3HAqW3KH5CWUnpgcGq+q5S0cbskAnpUrcclZHmcf8Ax9TbOm8kevWt6zfYEIHXtXPQ/wCsDAgnOOPrW1BKAygntnNdkjzKa1N6KXJIYYA4OKeCGZctwOP/AK1UIZ2ALnBxwferMBLSZHynHHtWDOuKNiONVIKkAn0p5ZIiVfP9aiib5AAeR+lKjtLId2Cnse/vWbNo+ZZXHljZj14p0amQjHzZHI9KS3eMRkyY3EYxTVVsOUxzx16Ui0y7EixkgNxjNTW52sU5OfU81RtpCpETA7+gx0FXi6o4WMkMx3Mzcmkyh8xjiIeQrj1JyfoBTWkQx/IMYGT6iqnnbS4Yb1P0/nU9vDPOFeMCOPBL+ij6nrSsPbcU4C4VMpgAZIFV2Z5SYogSAcHA4H402aONZ1DzllJBOOpHtTpZUjcJCXVAckHgn6imUtSTyQFeJXDNjOQc5+lUZsAEEOzD+IkYA+nrViRzcOdkQUNjBAIC1EyIkQYsrKpOFzg/5/GgafcauHYJtwAOT0/CmKrB2bIweOacu0sN+3aOcg4z/Wkf96wwVAx3OP8A9dA7sJJlO0OoIHUjjNV7mUYIRQMjBIJP61MFVskEjaCSfWqgZtxfAwO2OaC4uxXbG3IBJBz17f41GvPAIwOgp7F3fKZOeDngZpGKhWKDDLwTTNFJkLx8bnG30x3pqnZk+YRjkCpAzBhuOQOM4zSYBUjt3Hegd+40nzME434PfpURaQcN90UrZaNjsx6U1cN8h4HrmgOhMsvUIW3n7pHanxyuD1+YcgZoaNUGV5IxjNIQJDuCncq4wfSkYyt1JGlaQMyOxBODnvUKMxkYkgnPp0ppaVCUAJUj5QO1RglUPUN3HtVo5KiG3TbQcgEk9T2FZc0vytj7tW5myMsOR6n+VZk7HzGAJAPetInHNdylcv8APlTwBis+TJzmrty2Gbup/Wqk/wAoBPpW8TiqMpITDvkC7lDAGtiCUtFlAC4PYdaoaaxM8quu5eprTiTa4MYwvvRPc2or3SCeJjkMMY5xmsu4Pl5BHB54rbuCME5BJ44rE1A/IWP3iKUNWFZWVzX0SVLiyhtoLuGH93cJNDJII/MZh8jc9R29q7nRolJso/NWeWGBY5ZVOQzDPGe+BgZ9q4bRo5X0ywNhplpfOZH8+RrcSNGc8KR15HOa9b0O2U23z2cFu6Qq7CNQuxyfu/iOcV07I8eu7npGOPQUbcJml+gxQclD9K5zjPnf4oEf8JfcENxgAe1cNqwPkNnuK7D4nnZ4vuRnjiuRvW3WzAkHire57eFV6ViTTpN0ETDjKgfWtm34YOeMVz2kMTbICehI/Wt+Il0GRjHBokOmaqHDE5wMZHFPhwshAHvkVFHh0Xt8v5VNHveRW7L2xWTOpOxpo5dQABjPJx0NaKszxxEYORjnsO2D7Vk25OweV1UZxnGf8ir8eVSJs5Qg8Fc81EkdUHdGgFdYMEDcMgsvGR9Kmibad7fMR2PQGoJmYjaDzj+EVXiJdsbiH/Ikiszoga6SFn+6N5Paq2uEfYZpDksqH+LjpRAWD7mTc+Pzqn4juYxpEwHyEA59ef6VMVqOppFnn9quUBPfpWnBGSvJ7cCs+0w6ogIz61sw7sErgjpXVI8yGhbtBxjbkelaFv8AKpYnPvWfEcE7ByPSrsYwgHGSeQP51jI60aMbZQHZgd+aGcgAYA544qCMhmUb8p2wcYqSRyJflUEgYyO1ZmyRdhcBBuX5u3vTwAu7cvBOeexqrA7uG3KeTwfSriyYGWAbBpFpXJEfYBtxx6mht0jDOT04Hf60BBI5Jxg8c8YqU8gKV2ydlz1+tIbIpSoclNq7ei9ev86R7p1iVWbcgGAqnH608224gO+9xzhBwpqUwKI1MoRwCcKDg59TQx6FEYyr7Dv29uM+nNPEZO9m+Zzzn0pGVkwxXDnpu42+lPDN/G5Ix1JwCaRV9BplZAU83I6cHOaZFh2IUE7V6Hkk0NgByib+c+gquZZIgwjbHOSwOBj0zTHuWZMjKsu0Lj0pWijkQlcEjGAKIGhJDBsN1/djOadcSjjYCM8k/wD16LEtkRR+FYkJ2J4xUW5TGwJJ3dF5GPpUzk7QpBKtyyq3Sqm9QsjYAOCAcZwPrTGpDDGQwUj8DzzVZlJcbM49D3qwJG3BvMdsAkBeMVEzMQV4yecg9aZSkRcjcAxzjqOcUwfKVLN06d+asRoAfmAGepx1pu3acjJUdSe1BadyEBwx9D0pyIAnzjAPc1OVVhGcgAHLEdvxqTMZycAR4wNvtSYubSxH5RfllGRyPWoJAypjHPJBHGfapBM4O0HDN0A9KbKBH/rNyj260WJk7IrPu3bsbT069agffvbqw/KnT3KsGMYDDp0qFXkZTycelUc0m2VLpm6HKEnv2qm5AJy2QP0q5dElgCMt03VTdCAQ2CSeK0iclUoXAJc8YNVbhsbgCMDnNW5eGYE1QkAdnB9Rge1bwOCoW9Egeb7RiMMoIye+fatNYvLDKxLexGCKp+GITI9x5N0YZwQVXs3tWpdSujlLqMqT0YdDU1HqdmGjeFyhcR4GDXO6mwRTnp710dyV8sknPeuT8ROGgKDqxGKqktTHFy0Ow+HVhZmGznkhnkurwSvvWZkUbOicdeletaXbRJHbyW8bRRSRh9rMSc8jnPevNvh5ZRW2l2Mk092TJI0ipCRtjYcZOe9es25Eihw0jHaP9ZjP6VvI8OrK51y5NO6AkU3JNGeDk4Nc5ifNfxPGfFl0egJFctPaedbs6ttYDkV2PxXT7P4olLj5Wrj1lXYfKcDI6Zq3ue7g3+6KejH5ZIzyVc9a6OzbaQT+OTXL6TLs1OWNjw65H1FdJbsd/oG4qpIzjpKxrwEgncM7qnj/AHZAYcHnOaihG6MADkDPWrEUTNCrKfmTI/CsmdkdSeI7ZlAb5cde9aYnDj5gqhecnsOuRWPHiIIOcDpV2CYr8iqGAOcY4I9alo1gzTJEnKNjnkZ65qYRgK24jOeT6Y/xqvE6s3lhOAODjp+NPLl4hhiCeG3DI/z71i0dkWXIzxkME2dR/SsnxMI20+VC3O0lSB19quGNmHLMwPDYHftWfrzlbOVGBJ24UnrnFKO46nws5LTcFBg/Sti34jcdeMfU1h2LEKvHA/QVrQOcDjvmuiR5sNjRtWYFfcZORVtCSSQOF71XtGGQ2OBxg1MrZEmzoMcetZSOuJZgw2CBgjk8Y4q7G6mIgrhv4eetUrRjsbd94dsVZjCqFKgHP6ms2bLUcryKjMEbk8+1WUd3HzLgMMdKhckMM8dM80+5beB0UL79TUmiL7FTbKM7WHQEdT60wPsbc5z2JJyapwnzBs5Ix36VP5hRQFGecYAoGkXVLlGKfKMcD0H4U3Hy8lg3XgZJ/wAKYj7vlPBIySetMkAjQ7j8o5yDSGkSuxeFjHxGvVupFZ7uS5yVVOQP4iakWOa6di21YiNxbGMew9TSIY2LbDjAyGPX6UDSsIAZMGNNrLnnPX6UpTKuJGQlTknGTTiyOAixAEck+v8AhULMPMZd2M9eP6UBcfFcGOOQRu0T5+bscfQUsDqEOVDlugbnHtiqciYVmRsAnPvU0cgj3HAbPZjxVEMfMofnYzEdgeBVWdhwQw2nk+9OeUGMFpEIOMACoHkdjjPHQDGM/WiwJjpd5BO7aoGAegpACq5YEHPBA70iRFIXXd2IPf3p3lgRR7gxB+96UWC4qvlM5y2cruGKjyXblSAfbtT5J9hEYxu6jHpSLK7mMSkDbzhR196Y1InWMRoS7fNkjbxwajcmPBXkk46fypWfYrEjeAcr3JphdHXjejYydxpWKUmU9rC5IZtwBwD6fjQ43OQ7n1ODUkqEx4QpnPrUESsjFG2sRyTnk07Gbnd2GGJEUDAQfqahlkG3ao59R6VYuINyh+eP4c8VWkKMgIbdgc54FBMuxRuG3MOfxxVe4J2cd+hq06/LtCjHbFUJiWzzgCtYo4qpQnbcCScCq7KB0Iq3PtVAMc45NU8/wnkDnIroiefUJtHt/PnuJBKYwmBx3rdE8oURXKCaPs/cfWsXRmIluOuODxWiZHL524z2rKpuenhV+5RBfRoMmJ9qnop5rm5bU3F4kf3snNb16spLHge1UdJURazZu4EgMoBVuhHpWlI4MWnZnsHgPT5IdFtVgmhgIZjIrYyxzwea7CVWUqHkV2A6rjFUNCMKW6lbKBPYE1oTMrMCsapx0Bq2zw5SudGBmnD1I+lBIApQwxgHFYkngvxrjB1+Hdjla85urVJ0AjXDAdRXpvxwhxqcEoPynjNeYremGEqELE961a2Z7OBl+7sc5IXstQjkJJCtz9K7C1bK8HjqBXIas/mknB55rptObfaxg/e2jH5VT1QpWUzprMeYiOpxgYrQgwkygHBPTnr7Vj6PKI22ORh+n1rVA4CsOCcg+lYs6oO5anjd1PljJzg88Ae1LbsAAG4l5+8eM+lSQkhN+Cdhwwz94HvS3NuC4uFwBxlfepv0NfMtWUheUkExkD7p6DNSj5GbccHnheeKzI533ZPyHpnnGPrWhBMBJyyqWwAxHNZyRvTqMtwSK0Ow8Ac57ZqprFvH9ldlG2XBIwetTxTxhMOQFRvvAdajvj9ojEafcxw/U4qFubSldWPOrJiEBLYOSDj1rYtpOc8YrJuo/s17cQL8wDkg/WrUEhjABrpltc8+G9jfimIx2NWIMuo9+eKzUfcCT26e1aFidrqCeMVizrTuW4VIJIzj8qmSUsxVTjHOajUnb854HBp0eFlIx07VmzWOhdZ9yLnn045pk4Vsjuf0qZGYtwQDxkGmyR759rL845IHepNISGwNuUDIDY61djZ2wS31qnGhEvzfKB6/yqaKUxlsDryB7e9IpyuTTQlHjKmQluhPUn6elJMoMaIGYgnjimtOxJ5ZgVx7/wD6qsQyLEAwOWbjOcFfp6UDUupEqSKAEYfewu44GfeoI4cHETGSUcSbBkD8asTb+SEO5uTuPf2pkbyGNYgyxop6L3J7k96Y+YeIEjwoyzHliTyKjl+4z/IvVV28k+1SwRYQNvTB4YscD8O9RyvEwCEEIMjjjcf6CkiXIqIzeYRvO1SRngcVE+xujALjG3uPf2qSRCVB4VN38PSpIbRyNqooHqfb3qthXuVlTncihgTxnvUjrJwCikjoB/KrkkICgMhJyAe351YtIF3tvOEBxtA+Y1LkNIy2tLiSPdKcDpgDj6UwwurBHyAOOmM1tBBuKOAFGSeScDtk9qjCI0W9exOR1yPahMrQzZoEBXYQHxywP8qa6BeSPmUnJHG6rigbwNiBM8KBkD8adPC8yghDgE7eOPzp3FaxnsCQWIPPT/DigqgXABU+pqzHDgqHIAxkEdqbIo27gp2n+fvRcsomPkhcn03AisxkdL5mDZG3BX1rdUks2V5A64qiLZBK0rffbg+1VF9zCp0K7kmNjtYbutUzHtDEDAPrWo8fljYWJwORnNU2DbWZyAW6KOwpoictdCgzBeOcEdaoyqH3lc7RV6ZCSVyecGqMgAYnkfStYo4qsijd5Xpwe3FU3GDj2GfrV6c5PBz1qnL9w4OSTit4nDIl0RgHmLc5I+X1rTdyZehIHpWRpG4SS7ehwDiuijAbaGOMj8zWNTc9jDJexRn3hZ1Y7PlNY8M/kahbuy5RJVYrnGQCK37soqsrDOOlcxeZGSOvUVdM8/FLofT2lRRy2aSRWvynkEyU65jCOAUCHHTdmqXhi5E2iafIwb5YwDjoQR/Or11wyp83yLglhgmrZ4Etjf4NAGTQvTmnL0zxWZB5b8btNL6OLpBkxHNeERSCUKycoa+sPFulLrGjXNsV+8pFfJ2qWM/h/V57G6BUbiUJPvW0fej5ndg6qi3Ei1W2VoCQuB1q1pzkQW5xgbRz6Vn3LmUFWPAHTNXrIg2cXoBjFNbHXU30NqIgEc98g1vWsgcDOeOOa5q0l8xSrEZUcE1rWcpZRzllrOSNKcjdgYMAm7AJyD/SrayiSB4pR8wORg8H39qx4HGVJH8VXnLbuG5PPrWZ0xfQWTInUjcImxRHKVfAOE54601plVGWYnBXhs8qf8Khd12jZhuPmXPI/wDrUrGhqxzLJgEAYOM45pZH2EsQUA9P8O1Y8Uhyqk4PoDk4q4jRSOuVAfHJ5NQ0aRlc5DXVMGqByMeb3pkUoBCMeeeeua0fFcAMBmTAdDle+faudhuwxU4xjkVvFXRxzXLJnS20hZG6bMdK2rZ1IGCCMYzXN2Mmfvcr7DrWzbyrvCjAGOBWUkdFORtQKpVn/vYAHrQMIwGec55qASH5QT05Aq0pBQ5xkDrisWjpT0J45slezk5q3HIAW3sN47is23U7zzkZ6kVaRgsh4BPTHak0PoTNJu+XjPvSSQHAXB8xh2PNNgjJmLtgA9x2q2AQcOMe4FSaJpFdYXiX5uy4x6UrEY+VRjsCckGpiMv+9OBjOB1qrdIWfeqj2Hc+1A0upZldSY+ueO+agcyvNsjOQSNqhKWGAkBmKj0Re341YS3XI8tizdSAaBjYtkip8rGQHH40+W03MocgmTjCtz/9apIyQX2LtA44Peoiz5AdV3hicdvz9aBWbFRUikIjXhepJqRUzHhTuG7r6fSkgUu7OFVgowff6Vcji/uDeRyeeBQNNIgiUkpk7nI4Gf1xU0eckDG0fLlRj9amSJREJJXC56Yxk/SmMqxclAuTkYzUg5dCORYlbynA2jggc7vr60jRF4k3YGznaDggegFJLArqJVXaw5+bim28atMTDlixAy5ySfTFMFJFqGOEoN6ruXkRoOB9SajkcSTqJA7Rk4ADAU0rIpRZnAOM7l4wcnipI4SrL8qtnnIGcfSgNNypPAFBU4Gegxzz3qGRFChAFKrwxPar8iL5xKRsrjgsx4/CqElxCJ2DZD7tuFGMmmJz0ImhIjbpxyMnrVKRDgu6kE+taIjEaZZt5PI53Y9KrXBBUtL19On44poyc9DMkQsGwGYdj0IFVJkIBHbuR39q1ZE2tlGJXHAPGDVCdhyewzj3NaxRhKRSkjCIxO5c9x6Vk3GDkscDOBV+8dmUbT8h+7nv71mTAcAEkgdq2ijlmyiW257jp+FVZPlUk4xjtVx1GMH8BVS5JzgD5eg/CtEcsh+iSYEhbs2eOtbauZAOFTj15Ncxo1wmWXqdxrdWf5wCoLduKxluexh3amkSzAMhXHPaubvjmUBeeNp+tdFc/cOThiKwZGeK7SSFirodykdQR3rSBw4jWR738PJ1u/CWmq0hRo48HIOCfX610N0wJRQSwVcbj3rk/hTcs3hCyklupVZ2f5AucnccmuyniDpv81nbbuG5ccZq2eBUXvNGwD704H15pijoKXPH9KyMh7crjt3rxf44+EDfW32+yizKnJwK9iPTtUF1bpNAUkTKMMYNVGXK7lRlyu58Uw3DRHypwQQcZ7itixAFug7EnrXoXxP+HnkySahp67cn5kFefxxNHEiuPmXg10PVXR6NOpzk8TeTKCOcHjPete2nWRN64BH3h3FZG3OMdhikic28wByFPes2dC0OrsJhJGoY4YHkf1rQDElVVVypPPauat7lZB8rbTjGQM1ej1BwojcM2D1U4Kis5RNoTNCeQNkEgPnAHrSuGAyQo/3RjH0qCYwSRho1k2dC2c1CLqRCo83eCMYOM4qLGykSjBkJLsrAdD61aic53h8E9+xrNNwgxuLDngtzT477ykGwNj3XI/8ArUWZXNYu3AW4gdJTktkdM8Vw08TWN00LcpnIJrq/7QSSNuQSOMdDWF4jV5oBIsTHachu/wCNXDTQzqPmJNOnXdtGcCtq1mXzRnAI4rhYbjDK8bEOOvNdFYzluS2c9cUTiRTlY6/zQEyDnipoJ/PQuvRe3rWNFMqRj5wQB25NTae8jOxK/KT92udxOyMjas5TJlXHWr8TqzBQQQPSsuFi2VAAGMFjVpJBEny8r3qGaxZfBYDnhV6VN57lwM/KfyxVGN9wXJHI79KVMkklsYPBqWjRIvkAKrqQUHOAaaXRnOQfMHRQarSTpFEN0gBfgZ6fWmQTxk5RhuI+pJFItdi00ZEYHmZI/hBxTkl8oLuJCkYz6+1QZzKCPpkdc+lOZ0R2WVCx6ey0kUy5vJUcEE87f5fWnRKpViRhD0yeh71n72KkoFXrn5ulSpL8oQszEcZPX6UxWNIzwrEvP7sHPyirNvKFhY5wj/dxjJrJkB2kI53bTnHOB6YqK3nkZvmOc8AemKBNG9GQR8ykgnsev0qa5k8233EAKeCRWfFcRu2Fbc44bPAxUsaRhTIjkjr171NiGyYxiOBWV/mKknd0xVTTyZoBLKUCfc+Tp9T61cZQDuumYlkyU64Hrj0qKwlYWSomFibGQOx/+vTSJ5hACsYDNv2ucufbpU+1IVwvzluQQeajl8u1JTIdpCAQeaqrIxcrlkP3SSP5UxczLM5HnIAzKoGCT29Kyrgj7SXkx9PU9quF0MTHDFTwWJ6Ed6pMpabOCdwIJPPPrTsSpXHiQkAR8pnn61UnUks3JB7kVchISBY5OD2YdCapXMTLhWJOegzjimkS9ytO/J2nAY8kdzWTcqMt1GD3PU1fd2DNtIJXv6Vl3MjNwAdi9/f1rWJlIr3K7iQvAzjr2rPljXkA9Rx64q9cFUi2ZIbvWc/z7gCce30rVHPIqzYDnbwB1rOumIUsDzjvWlPgAdMjPNZd1gKcZPPOR3rWJzyMzQpk3uT/AHj/ADrp4ZgAPlPPp1rgrSR7acnrGxznHTmussLoSqO5x2NRUjrc78LUvGxrPnco6LjgZyazbqMCf27n0q6CqICM7245OcVDOqgnPUioi7CrRe56v8ImdfDEQuAnkedJ5e8ZPXnGO1d7O7rkfIVdQFKj+H2rz34VTp/wj1pBcRk7GcoynBwWPFd/OcrGQu1NvygHPGa2Z87VfvM2z6UqjB55oHJxTsVkYiY/KkZQQKfjtSMffpQM5XxbDv02ZT2GRXzhqJU3k2AB8xr6M8WxStYysrkDsPWvnO/GL2dW4y5raOx1YbcgKg9DtPapRnymilTdkY+tQ5YDcF5Bxj1qeALMS4kO8dvapeh6UVcqxJLbyZTlGGQe/wCNaNtP5kZ8z74BG4df/r1EkjRPgqTGDnOKmuYEmZTGSjuckj+dHMupXs30JrW7CMjRksMcitCO6tphhAquex61iRWtwS6qplzhgYzz+VRzsRiQqQwPptINJpPYabjub0hcdEDp3BPIqt5wQrvV/mJ7c/8A16z4NQUgLLuPGMk8VZ82GVMMSCDwQaTTL5ky4ZYMbzHiQjBzxmnNHb3VsfmGHHRf61QHmYxHL05w3P5UiylZCWX72CT3PvQkwbOW1e0ayvGYcxZ4PQ1d02627WOWAPNTarsm+67FjnquKwlma2cB12r0J9a03Rhs7nfQ3CeUSGABHTNXLS4J3c4HYjrXM2l2phUA/TFaVrO2cmUCspROiEzoY5hu6n0wavQsdp3kAkcc8Vz8EgKqS+M+nr61oIdzqgOcdWPrWMo2OqMrmtDKq7QSdh4FTSyiGF9ufm+7xWYWCqhP3Se1Et55a7AQxzjPXArOxumX4NpdzICxC4GP4fpVkECJCoOfUjmqUU0e0dvf1qxE4Ee7bkY+6OOalmkSxvB2hzsbJOTzmpAucfwEn161VL/deQHdjoD0NSKMFgZMs3UgYNIrUlESPIjMxUKORnNIzIh3sxBBOKapbLowVuBjPamyxIBhwd2R1HakNMnF2rICww3Gee34VbjYDmHldpLEfxemKzEl8y4ZV3lFAU7e1X7S2kikIV1WI5I39FqiJMsWqPOpJ4BGSq9atCYQx7VjPoG6/wCTUDRSGUEO0cgHO3oV9j2p1tNEzgSeYjndhWPegzbuWYy7SM7MS4GFduy/5NJa7rYNFDyDwSD90+v0qOGd55ZhHEAgPIB+n+cVPDmFyE+YS5L+p+lIQ+WOIBiGDlsY6ZqO5hiuYwoO0DPK9fxp8tvI0iIQIpADgqc54zz/AIU5W8tOR8zD8jTE3fYy4o9jNHJlo0G4Ag81eUKkZC4G4/LxQ4/dFgAvlDkHvUzEsrcAjHFBm0Z8xG8RlQQOhA796zpg7hiTuxwM8Vo3CFRvckj1rMu5wx2YPHAHrVolvsZ7hoy5Cjk/hmqFyAu4nJB4yOMVoXEgYhuAq9fes663EfMTjPTrWsTGUzOKncV4IAxnrmoWCqxBOOeauvGQ2APUnNUpwUDNx9MVaMZMpT8lgB8o6H1FZV422B3PYE/pWrIMyNznisbXZRHYvtGMjArWK1MJHP25/wBGjYjIYitmwthhWicox7dqx4/lszGeqNzW5pLBgFbPPcCpqHZh7XNVIxGu6Ry0nIC9qrEqHU3RfYD8wT72O+KtCBT92UgZ7iql5EZZVt7YFndgignqSaiOrNsQ7RPYvAK6bFp9usDXhXGR5gXPP0ruJ5EZUEedqrj5uvWuG8FWdtDBEhvQ8i8NsjJUEdQD3rtZIzHtGQwIyCO9bSWp8tNu7OhPtSjpSDgjnIoXPNYkD+1NfOw980oJxwc0m8dDkUDMHxVgWDjHY9a+Z9VBXU7gkYHmNn86+nPFYzpcmMHivmTVSDqNzn/noRj8a2jsdWG+IZHxjpg0kigZeLIcVAWbyflBwpwW9K0YyAqKFJJHU1EtD1IakNpIxYBwMMM496n8gkLsyB1GKkeHadw2mNu/oatxWjlP3ZG736VDkdEF3GWnlR4Yk5Hv+lTxIxkO4MiN1DjcM+tJbxNbkidN+TkFehPtVyGVWGJAd2eMHFQzZRVtTMvbC0UgNsB+lInh+3kXzIZyQ2OCa17URuXUqCAcc1oxWQktgq7SwBA/2fpS52g9kn0OWuPDt1bYIeTaehBDfpWRdW88OcMwZT0KEGvRLczSxgA42/KexBHeh7Iyq8lw65XhSRgGmqjQSoRex5c4ucEyR7g3oeKyLxWZiPLcL6npXp93p9psJjVTKBk46CsddIhkikcKQ56E5OffFaqqjnlQZwljdfZ32EnaTj6VvWl0dp+YMvrVbVNBfznEX3l5xiseOS4s5drgj2YVorSRztODszt7e5UbiuM/w9sVpWswwrAnPJOea4i11GNgAWw3oa2bK8ZmCL8oHO73qJQNY1Dpxdo0fJwemB/Sk3CWRSv3hxjpmsRHSWQlWy/r6e9XoZ1dwj53qc5UVg4nTGZ00SowUzqBnoG9PWi1uVE0sfK7Dld1Z32gRlC0hfpx1NNgeWVtzI+MkZzz1rJxOhT2NOeeF7lJQQwz9OatpcjpH8zDnGcgE1lQoXnJ+XaO+OSenSrCx/ZgxAO/PQetS1Y3UrmnA5mGQMZPrzkd6azHByC68jcW6fX/AOtTLQS+XtVvm5A7ZFTJFJtXzCpHIw3GKRTG2cJVgzYjkxnJ5zWtZOJ7bZPyBlcACqtrFu3/ALw/L0PNTsqqVIRQxX5lJ59qZG5cYAkRtnZgAqzdKfdW8Uoh82MIueCGIP51TiSVlDRkKgbLbjzgf0q/PcRSwP8AMobHzE96BSXYhhxGQqEyKo+Uqf0qwbuJGUxjhjtUFfuH/Gs4SOkAEJCjGFOOv1q1+8kgVNqqqkFtxyWPfjtQS0auT5e92BfHJI61G8iuMIvIPBPQ1BGrMquCGVhhQexpYmZIysYxMB35GaVjN9kL8yuXlQkdAAOgqpbSGMyBgSM8c08zM0mHY8tj0AFPv1iVyI/mUj8DTRMnbQp3dwPmIU8r17VkTcBMcMQcsev1xV29nCYyqoQQT3wPQe9Zt2WlIwuC3OR2HpWsTKT0K868KDzkcjsPSqcgMr7V7Hg1PcMFTYPvevtVSVyigLyPrVowkNn++RngDHXqPWs256hR+NXnBIKnKjjtVSYIuTkkDOAatGckUJOC+cDjmua8RuBCidN7CujuT3YHLZPNcxqaxT3AWU/JGC2K2iYPV2Mi5JSbIPDjBq1pt5MkwQLuxzyamgtFlt8uQR2zTNL2xzEk5+bGTQ9Ubxi1JM6GxW5umJYlFHXnGaS5Z7Z1khDrOrBk7nINbVmUXTQ2MsWzWFqbyGTfGxVw2VKnBB7EVlH4jrqtezPbvBc4ntYZZdPCSuoZiu5QT347V1szsxG5doAwFA6CsTwmupS6dbNOs4k8tQ5JI3H1xW1M0m/97u3Dj5u1avc+XluzoQeOtKeuetN6H+VO696xEJQQT/hQRnpSZx17UAYvik7NLl44xXzNqoB1C4K9TIf519N+K2B0pwD1GK+aL9SupXAb++TWsfhOrC/Eysqtsl28knOO1WbQ7hGBjIP3TUsEeF3dR6U2KMKx4O4HIOOlRJ3PUgrF5QpUpwN3btUtrHJGArIHB4yDVZJhEAZOQTycZrQtpFdR5B3gdvasWdULXJbdmU7URWx0U9qslWZG+VGHTHXFVRIXmVFAQtkFicYqy8RjKshHBG4L/OoZ0RswihMB3gBccFRnmtCEwxRh0Klm4AHBzUYljDHcQT0+Y0gMKDLNlycEkZ2+mKVy2rE9jExu5iWYlSDjHy1fneVlZCpRARliucD2qlDcP5ihNyoB1C/e96sXEnmvtecop6nHX8KVyoxXUpSWYluELb2t925v9s/4VNPalZZHaMqmNpCnGB2qwJ41xEC5U9G24qvd36uRCokwOGz0AoTYcqM++sIoJRsWMuV7DJHtXHeJdLj8ouSol6nH+etd2QjuXkdWI6BRnFcx4jUm2kRVGeue9bQlZnPWgraHmM6nd15HStPSLhtnlu3SnLp0krMSOAeuO9QQRC2ugG6HjPauq9zzORxdzqbRQql/vDHStC1lXfINh5A46c1k2LjABOCOozV61CM/msTkDgZ61hJHTCXQ0pN/y8AKRxg1ciBMC7QQ+cc9BWftZ1DkjaORuPb0qa0nYjbHgrnJ5rFnVCSRb+0uHKuMN93n+dWY7rIRdu1M/MxOBWaFNxcPJKjLgZVRycVqJCJUHloDjrnrjvxUs1jIvLepE3kwIXlPAYHpV+zgfzA0rbnbPJOcfhVC3RQqqilCRksRjd9a1bKeSHd8gYkcnofoBUMu0mtyZY8ShZctt4yvHWmxrMkhCYZWzjHUVa087pwrEDIztp8gWKUIzHn7gHJpgpWIdgETBpM4Xk7e9LF57xynCFeM5HGQOppZJ8yRr1kHIjYYDGkS6AEiygbzgBT60FLXUd9oWCIo5OW/uDIPHTFWIlVnRQpVcD5V6fjUGxSf3W0hRkeg+tXYYUyG8zDYGRnFITaRJCvkxOUZRn5cenuKaI3ddsOFbJwcc1NEItrgNnGCPYe1QoqksqO5AOPTH40GLREvko5E64mAw31pk8kTKSGBIPJ/pTrlDIF2quB/GT0H1qi7JKsqHJPfHSmjNla+kjEbuzbsnkgfoKozyDywF4JGSx/lTpxgiMkjBy/P6VBd4ADJnPoO5rVIzloVZm+UFcZ9aqnBOSTx2/WpS3O1jkZyKYgywOMDngetWYPUhJC4wOSeeOfyqlddDjpzV9sBGkOSQOKoTHcCTnjlvcmqW5MjJvn6gctjgVymoSgzSYOQAMkfXrXU3v3ZD3A5PrXGSSM9zcKowhO0k+1bx2Of7Rp2zIQC7YUDk1UMStdyPbhvKY5XJqOFczJAzHGMnPeuu0Kyg3b3XKeuKT0OuCc/kVdP+2Jb4IPknueKSzmxrliSnmKkyuUPcA5NaesXI8vaOI0GBWT4RuIpddieYZiEihv93PNTTXM7hi6ipw5ep9CeHzHPumS83hzu+dSGHtW5cuHK7SWCrjcR1rF0G5cytDdNG0Z5Ro8YUdiMdvatu7UL5K7g2E6g8dTVS3PnmbnelB4zTRzzk5pc/NjvjNYkjgcgcUDrzSClwQM96BmJ4s2jTpM8cda+bdRGb+c4x8xr6P8AF4DaW+QelfO2oL/p82OPmPFar4Tpw3xBa5I7AYpXVk7gjrmo7dljjG7IOcVeHzjgg8Y7VjI9imVGVdpJf3J7UkAZow1vMEyenr+FPktWI3cgr2J4P4U+KSO3YFosZ5FSbpajt8pA3243fxEHNXrWOYDKzADH3H5zWadREkqqsJbHPy9atbvNcElzkZC4wBUvzNoq5c+2OiIJHXaTjaBmrluqryxZcdAvP61VtmSPpE4x3K8VZjeNvvtyT91Rx+NQaaLcuxyvhmiQHHG7PFVjczvLsRFJQ9FP8yamY+dxFlY14Iz3p0EYjQvtKt33d/fFBa1Ip/PnG0qobqHLZqaOREi5wxP3iB0pY5ZfmVQASOWIwfw9Kj+1Kny26lghGSeRn0HrQF7Erq6xAIigjkdefrWNqdtLIGWRY14+8D96tpshim5gzDOAOnvUUtmohO5C2TnBPJpp2ZM4to4i5tligbAZ9p+gB9a4+/VxIQSSAcgjmvT9Ss0SLYhCj+Jc9K871WHybhsNuB6YrppyPPrRsiaC68uEAg5I/OrysP8AWOCrDBwemKzrNQ8YD5rThjDW+7fu7YNVIyiatuS6B0bKf3RWlDPEiImOgwBiucSSSN1WEEK2QeK1IUZGjVmykvJPpWMkjqhLoasd0iAoGR1JweK01kOMrGMevasOAJu+TITdg7RyPetuydPKBVTheD/TIrFnRFss2sz4Af7pHBzwP8+9aMQg3HaXyFwHHJPNVrVWK7ike0jbjNWxKAzCLdHKVxtUdeakvmJrZI7hN6EnBIxnGcCrMazAjndEO/8AFUdjCxhCMMODjg45+lXoI3XKshYKeBnqaV7FXuVWOJEdsk578/nUDKJJQmFZCchfxrR8tSJBtKqOQNvzZpIbRn/e4bBwCuCR/wDWpoTlYW1EgUKERlB4yePx9TUhhCTg5xzk5qyiw26uGG4ZyPlx+VOljG6N8YYDKjHQ0rkS7jHCgtIjqB0AHOPeqM8qxsyj7oPLE9ac2EjdQWAY5b1GapTEKoVOQRnLDkU7CTvuNeQzbg2enyr3qC1jLny93JPJz+dIgYqrtkqW4BPU+v0o8vaU5CKeT3P0+tNEysiGeNmkfaG2dMnpj+pNUZEBkCsxJ5wMVo3M258qcAnj0ArNZ8SbR1xkk9fpWsTnkVHj2xAL13YyfT2qJEIhIzghT36VYdT5iE5xnpUDu5LADBYd/SrM0RyZCqM8H161nXR2xgHqOSKuyMdn14yKzbtsuwUc+vrVRRlNmTqLARu3OOoFcpaLLMnyjarEsT3NdLqzYt3XtjFO0fS1kZN+fLA5PStW7KyHh6XtJNsoWOjyTPkozcda10kNhA0QcEE5xnpVnUL2C3LRRN93gt0/KuM1XVvnZYm3Mf0qFFzOupUhQ2Jtf1MsvlqRubjjsK0fA9sXlU8nJrjYw80g6sxNes/DewMN3aySKSquGPHvW6jyqx4uIquerPYPDWn+RAFlkVZAOVwTj2JFbMiFGwRz7Gk02AwxQ5YgqMcLnd7j1zU10RvVcYIGCPTnOKze5wtG7n5iPegE7iPaiisSRR1FDZ3R8nByCPWiigDI8Uc6U+fSvnPVf+QpOO26iitl8J04X4hFA2q2PmqeBF3Yx3zRRWEj2I9C7Io8gHHJOKp3CCQgPzg4FFFZnVEntI1i8wRjGKlVvmzgZAODiiihnTTLO4mYKSduM49a0IY0liyyjJODjiiioLkRXIFqAYMqO4zkGq1reTTSbpCCQcDjpRRQTEsOxExXJwevNSxKFdkX7oOAPrRRQadB8DMH+8eAT9cVaUswRixyc0UUmD2MbUsyNJvZsDtxXnGsRqJ5QBjDdqKK3pHBiCrAx3Yzwa1o5WACrgKcDAooraRyI1mwIYyoC4zgDtRbFjltxzu6dqKKxZvA1IF8uMSISGAyK0rZ90DkqvbjFFFYy3OlFlZXAwDwWAx7VdH7pS6k7lY4JooqTQ3tOA+0YIByR1+laflKrK4LA46Z4ooqWA4QIpkYZzkHOaimleF28s4BbpRRQV0HM58tmwCwBwTSiZ3WQZACrngdT60UUEzM+ZjJJtfng896q7RJvDjIA6etFFWZ9SNjiAt1IOBntShcQx9TliDmiimjNmbdMZZyHPAOQKqA5uGB5yCTRRWkTKRD5rbyOMHn9aZcqBbuwzu3gZ9qKKszKM6/MoyQBkVkXBIkfHckUUVcTOZjamTtH1FWru5khtUWIhVbGQKKKqXQ1wnwyOJ1G+nlldWfC9MCs8c5oorojscFV3k7m/4Xt45bpS4yc1714Ms4VjQheaKKmRxVzvkdkj2qxC46A0wcmiisupgf/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple erythematous patches are present on the trunk and proximal extremities.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mycosis fungoides - plaque stage",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 311px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAE3AbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDF+2yQMNjlRjIcAZI9DUkt/NfxpvZZW6YxjNYtndy3EBQplSep4wamiJETnABx1HIGD1rjep2xZJLJiYyYBJbDqB0P1qVDhjC+cMNyjdkGqa7HLsz4uMlemRjPBpouY1cQyqMFfKYM3T3FSzRGjA7rKhmLYBMQx6kcH9a0biJre5VLeXFycDKHBb/HrWPNIpQzOrCeDAYt/ER/FSybru3iMRLvHgvJnBX0BP8AI1DNFsbCzTWUxMTgwFdyhWyBnt9M9qtR3BjjxcIDAo83GS3yn+n9aydOLXWJJHdGB2zx4yJB3OPX3Fab+RFNHGkm6N0IBccqP7vHrxVJkyRS1Eys0YmjYwPgpJjO30UmpyUklcwEEFeIv4lYdQOx+npRPutf3SfKhXcvmngH0B71mQXcrytDjzCxLbBx9Cnr9KpEtF65v4mEZVjG4bIbgmI46emDmsszsryQMNrurPkZw4yMj8efzqrfq6SGYoVAXaWwMHPUYPYg96qRuZ4zB5n76Ib43ZsErzjnv6VcXZGMtWbseopas0DMJosFMhc5HYmpZmxA5UL5rMCVPX0ArEt5oX2yOdp3YZR6Ywa0maLZhA0cinC5O7PFS5GkYaEMsD2sskckTMOjIDjI7Ee9TRx3F5EXjaO6iBwyyrtZPqRUbXiyS7nUliMH5eenNR2V28TRmF/JbBAcHqCehz2pxkDhclkgmSEPAnlbDkoy8H15qC8lurtIo7l8NHnYQeMdh9K201JLqMrco2WyrPCPb0rFmZjFiBlMYwWUnGD/AEq2+xlyrsZ/DQv5kcQUA5KnH41HE/lMstv8jdiKmeEmNySUVX6M3XNUVMrTjy9rIfqP8mpFsX5yLiFmJG7DA5HB54xWO8pJCK+cckn1rRWZGUxksp3DGO1Vp41EqRJkvjk4xmnLYiO5HcQPCWLg4z+uKrozFHyzY/rWjdSiS1SLPKk4I+lUHI83Yg6cfWsNzpehXuEf5CzcFcgZqndsfKUE8+laUMRuWb0XIHtWZeKFYgZZs9aqO5nLYrW9sbzUrOALkNJuNetQqERUHRRiuR8H6cBKbx1OQNq5rr1ORmvosFDkhfueFip80zL8V6UusaHcW7AeYBujPowrwiItFMVYYKnBHvX0bXiPjzS/7L8SSlB+5nPmp+PWoxsLpSReDnZ8rH6YQSCRnuea6GFyQAo5A4965jTWwM5HPpW1DK7EYHzHhQDjNeQ1qekaxkZSqooDeuORT1k2IrFicZBO3n3qujbFYBdxJ4JHJPtV+1064lIeVJMj+HGMUCuDsGI8rIyNvJ65/lVmNAAEkJITqAOn1q4NMkkT90gyB82R1+tTLYSiPGQGI5UUmUkVI4zOCIlC45yO4qwWKts+YsEC4XnOfWporNFmVXkkTcO/f8KmhiaGWKSORXXB2nGOagtKxHCkezaXKl+rDKgAHoadPE8YVnbB352tz9KETzHd55iquG2qRwPb86mcH7CqNuzgl8LkZHrViuVGwkeVYB2PIJ/lTJkIVsOcg/Lg8A0+dJDa4RTjoc8/lUbfOVXjKAnAGAfakMYSRFhwA7c59f8ACpF2SyrucKvQZH6U2MDADxggjkHNOdkUxpFjzCcsew9hUsCGTEezcQQOME9Ka6bmYgjGOAo6GpXRGUng4OMZ6UwgRJvR1LHPGM0FEDYICn5geD7VG8e0gb8Ejr2Jqde5IJP06VDcqXHykn/CkIrBV8gkgkk/l71VdcsAOferdwqZCRk8Cq8mQwHOPU0EstaJlbyMbwuc5zXSniua06dYLmFyAw38g9DXTTH94cDg817OXzvFxPLxkLNSInORUTjjHpUx6UxxgHFeicaKS3Mf2ZQmcnpuAP69arPM8cgyxA6Bc9jVfSpFnjLPkH2NWZ4doYxkDeOQf518lz62PqVC6ugUvM46tjCcYyAT0qwYzER56hsN+7YkDg9mrO3MpwVyByGDbcfT1qSe/kuSqTbcg/fI6D0+lS2Ui0922+TYdqSkq4H8J/wxSwy3VvJEyHa3fBxvGf1qmFQwP+8KDPzA8jHbHtT4SRGiF+Mkr379fpSSKTOl0+U3TPKVA4DDnBHY/jVq8dLWNmYZBHOMbgen51gW93lw3mKpXCtg8+34VoNcs5dXUEDIIbofQcd6dmhpplgLBdWYZ5iXxkAn+Wf5Vj3crwqoVxviOUZeCD7iry26/YzsBJLZZQenuO/FZdzCFQiSRQC3AbhjQmOQ64vnlDea6sWAyc42n0rDuZXR8OSs0edrf3lNaLQwtHveULxgDGSaolA7BWAcDJHv7VSMWiG2nYv5jFgRxIAeRnv9K1LK7XJR1bryV657HPvWJJmP/V/62POAw++v90im284ZgUYrkYHP/jtJq44SsdRvJkO+QHuSDVa6uGWRo1J7bCvTFZEd0wLBmOehAPX3FTtdbygz8yjt6Uti20zYt5HZNyybsHPpTpphIv8AzzKt95T37ZHesSe7ZE25yD2PJqFrtiPmUE+1O4SsaM9wFJSRlbAPK/1qEyFziM7QT+VVhcqVbcoX1wBS2cz7ssoMZ6gjlvp6Va1OeRfQLHLJuONuCB2NUL6Ytch1GM9AO3tUtzN5oDJyiD+Id/8A61UQ/nOkeQo3cmnOWliIxbZag3lhISPlPOe3ao42V97ktv5Oaa5yHCHOMjcP51FvYqQDtBAzWSNnsWtOcIpD8Ag/iaz/AC99z5YPBbH1qWWVowgU9Kr3bm3tBL/GTx9a6KMLvU5609LHoljCILaNAAAAOlWRWfod0t5pcMgOTtANaAr6OFrKx4MtG7jx0rh/itp5n0eG7VctA+GP+ya7ccHpVHXrP+0NGu7bGTJGQPrRUjzwaHTlyyTPEdOYEhfTmt+xPmyA4PPAwK5q3JheRCPnB2n2rsPCKxtmSZCQCAjkcD3rwJqx7Ufe0R2mh6XapB5s7CWQ/dA6n2FdKiyN57BcB8EqOQPb6VQs3WUq7KvynaMDqPbtmt2BlMaMZApA2jJAA+tYuV9j0aVCKV2Bz5Ks8cIRsAjvuHSqs9nMSWkjcrz+FXkkhdjH8rlgSCck/hTGvYGO0tGAPlwxP48Clc2cIPYx/sylg4kjV+MKwPfv9KiSC358yORhk5bPAPtWlORAy+Vl3OcFCMY9MVXvnTylEbMXfr5h4H4CmctWCjsZtxEhtpDCh4wSxbORQ6iG1EzsZeMct79OKkLAhW3SHnBVU7j07U93iNuzyKFY8ICnf34ppnO46lQSmOFWRDkN1c9feoGlX947HcxGFJXkHP6VOZ18oFI4yqHBbgEg+1RzrMxJLAgdTxzmmKxVkLBtoHAA7nC+9PiZUkHmKGbqw7GpJWTYAGC9N3oQaII4VDAjCqcA+vFLcBjQld+4BDL8wUHrSRgiJeAeu3PIxT8IZN8ieYwJyaeZE8hV4XnIGOBUlWIJP9WBgBiOnNVJOFcAfNnHHerPDEuhJCHHPpRMjMWcqPm+YeuKYGc2QQGXG3iq8jMMgYqy8RZyB83GcVFKA+5tpU+g7UiGQQFSwXPDfzrqbSTzbSNj1HHFchk5yOorodDuDIGTAxjdkGu3A1OWovM5cVDmg2aR/WmU9utRnlua908pHC2d0VckHaccGt6C/SaPZINpIxurh4bt7aUJcIQR0bFa8N0s3Vhj2PWvkpR6o+mpzcdDo2m3RBByvbjFQoIoypbdn36is6C5K4RTkdelWAzMSRIMj17VlbU250y8nktCSCEfJGAOv0qNZ2I3hlJY4IyAQfp/UVTuZiE4AwBjaP54qlDLiUFCVOeOwq9jNyuzYjZXG5iDIrHch6EVOkzQmNwDFEx4z8y8f1qpBcqx3TR5kXkNjr9akmEgjEhjbY3zqCOCOmR+tLqVpY34ruZWBE6lgc5XkA+vtVW7zO7PMqjB5kU4/HFUbJS0waJioI5C0++dnby94yegxj+dPqVfQiuYZN4ZSu0Hgrkjiqzx+UpfnzCaC8zOqkNx2GeRVq5W5jjgi8py8ieYquu47fX9KdjO6Mu8CFFZPmfPPrWaZl8xzt2j+Je+f7w963oLDUb9gnkCJMEiSX5F+n1q5YeE4riJrm+kkcJIFdbcj5Rznnv26VSiyb3ehyKTF2XaWYjncg5Hvj0qxD9puVxbQzSnOAyISK9U8OaGlnZ3smk2626oA80rn95LGSBhc/icVZeKKK38y3SKS3WTIU8Z9ML0xV8qKhTlJ6HmMei6zKFLWpXeOAzAVq/8IjqRtoBA6Ndv9+3YEbOeMHvxzXcRv5siPcMwIKhdw4Udjx0x6VcuSrPG0kwYAnLoCrH/AGc9/rStE29g+55/H4SuDZZadP7R3Z8rHyBfUn146VMnhG+ESbrmNSewB3Z713EUgjmARolP3wmBxn1qeGbasnyMzngseKNEWsMmtTiW8KXENunlS+Y+CHHBz9BVNfCUkanzZWjbOPmXpXpsclr5nm3EDM5GcAAj6e1SR+VKWEhEIJ2rGo6g/X60aMpYdLoedWvhQrE2ydmZhg8dT7VND4RiGP3knmdTn+HHWu4n0/yuInjG7gM52lcfQYpOYGwYSykZAU7sEdj7U1FA6dN6WPPpvCEXmq0l46bRk7lBFUtS8IPMgLX8QiSMlCEPL+h/xr1+5Wy1C1tpFhS3fayuQBgnqBj17VSXTUhkkicHIQrjG4ZqlJx2MZYaE1dHnGhafdaTa+Q6+arAMGXgH2+tbvlSLCkhRsHPA5I+uK3/ALA9t5YiQrFjODwD7/jVqzgTaykphxlVHBX2rphjakVZGMsqpS1dzn0iiAHnyyIWA2YjOCe4zUKbDHuKysc4woFdtLorLp9tdQRF4pco3y4XIOf8mqM2iwCR/O3IOFUMOpP+1TljqrRlHK6F9WeGeIPAmrvqdzd2Vsv2Z33YLAFSeoxWjomg39hbg3EWY+BhDur2uCwAiEYcYZvur1/LvULWgt7kpI+Y3AVUIwUPuO2a5ZVebc6oYWEdEzhrdJo7UKkRcrwVzge1Y08moXUziVtsanBjUkc+9euvoCLpzXbTSRL90BMY/EVl634ZjPl3lkyMNoDBhgk+hrOUrbFcl+pw+kzi2eOcvcRzqSNzksAMVvWUkF6CILcmReWKLkE+vtVn+wXRibiLCkZGxv8A69NS0SwuBLYmdGz99iAKj2r6mnI+m5bfRbu5U77dVGPkZQFIP0qN/CN9JgiZFbtleK6zSvELAot3amUDq0PNb9zr2lADZZ3m/HRkAArTmi1oc3LUvaSPJrvwrqMPEcsZ5z1IP09Kzzp95a7vtdt58eMBdxxu9a9Xu9Rs7oDZYSbiOdz4A+grNmj2KxaGPLdCxzj/AOvU8z6FukrX6nkomgWZhOPLdPcn2xxTzfRys0SKiLjcCDjPbNQ+JVVNZvFDjYpG0M2OtULWVQikYBLHOO4+taqxxybTszTV/PO5wMEY2oOlSBcSeYhGMYHGece9V4S21gEyCAVJYg4z7dasx/vHUKFDA/cXgYHt60wGxMHTbHgkngMcYpoDORnAHOSTmpRG0tw5t8FAS27HT1FAXBkZQBnoOalorcqsPLYLuBwMdKjd2C7mbke/GKtspDApgqeSR39arzIjZ2jpxg1I7FRvlIAHJOS2e1Vpwu8BcgE4Bq6V2s25twI6elV7hQ4yCOmcHtQS0ZlwD5uOdvSr2lzeTMpUYHfFQSRggFT83WrVoinAwMgjitKcuWVzOUeZWOhJ+XI70w989qkKGNVD4BAFMYc8ivpU7pM8Nqzscxrui2+5khZS68YHNc9b+Gb4TExOqR56Oeo+ld5a2/ytlQDwME4z9auIsaDEakkjBZR1/E/0r5WMuVWPpHFyd7HIwaFOApll+Un+FSK0oNKICeazBRwQa6TyxlS/J67eDTFiAky24KeC3fjqBU3uWqfmYraTbFTujEmeBkHNSR6LbRnBgBBxkls8e1byTFgCsajB43Dk/wD16nm81jtywkX5zu6c0HRTjFP3jKtdOjjS5tbREcTr5bK4+bHXK+lXtWig1OO3324idFCRqvPygHOT6Z5qReWE+4DavLIc/pU0sy3aAQqWIwp4wD3zTux+zpt3sY08Een2iSCCBVlJUFVyeD19qngFlIsdy0R8qNeY8Yyc+vp9a1IbCG4BW5HyEnJ5IU+vFM/sW3MTRqJI1AztB6GpfN0No06exV2q5aaziSFWbBCrnA9Can2GK+IkHmRohG7sVwRx34quIpbOeOLcME5BI+8B6itISI8QHywqsYUHk7h2pKbNVQg1ojNiaZxJ5jjy5O+M5x/WtNCtuYdiRtGm0DK4Hv27+tI1m0gaLJ65AHUfSnyRLHII3JIIB54GcU+dl/V4kvlpLdvG/wAqysWdgeE79PSqBeEJI0Y3RjhWPGOnOKj1ESrMJklPzH58nOf8at6evmA5QlPT0NLmdyuSy8io9zumPmEhT0AO4CpoZFcbQokQen880X9oJtptFKEYBPqe59sVGLRYZ2WNssAN5Hr1zSuxKKJCWMhE4aV2xk52nH1/CtdE3eXjzAmADjBwf51Xgt3IUnEqq2fkUgirEgICDJUqecjGPbNUn3E7dC00pM5Z4Y5F4UIVI49ahmkLEqY5o1DBflbd/wDqqrDMHLr5pEi9d2cn0q3a3hEscEjqCxCxsxHBPcincfKOLWyzMpDBQPvCTGD7ikkv8rtigSZEOdxJ3YqPXbd3IVAs0oyGCMMnk84/Liixkazjg82BnJYbty44z0oUuhm4Jq5Yt0F4CEtwkjghGbJ2n/Z9TViK/ureJra9haVioTzUXBGDySO/XtVK+1sM7qgKASYUq2Gz9fb0qt/aTSxgzzzNJHwrP82Px+lXzJmLpytc3I7y28hoZZMw5DRnON/OD78VFdsiSeUA4Yn/AFikDAB+lc4ro8+2SIMoGS8Z2n1yc1otdr8rxtlFxk5ySeeM1ErrVbEK6dup1AlkS3kFozFIU3m2U7t4xyw7fWrDXr3FoVmjaOAKGXyiMAE/+PfnWT4O1S1uILq2kOJllBhcfeT/ABp17diJktWYiOJssR90jtj8TUuTauLlvKzRctIFj86GeJCdoIkXkZ6ir0mn2+p6cI7dXju1+4TyD7DPStPQ4rZrUS+cYv3Zyxw2fbmqdkjzXkrWh8tAc7gOD6nFCTSIc+ZvyMvTPOmSTTbxQs0bZYsSCSO+O9X40ktrCezuIg9vJyjNzgg9ePajXoZBKJm8oXWQqmM5LE+lW8KYkjvnaKbPBU8YA5NNJlcyepA9nbCBTJEu4j7q8ufw7VljT4pJGAs3c4yOMAexz1/Cte6v4bZD9ljAC9Cx5Y+v86fPrcKQCR/mIHC54P8A9ahQQlKT2My00i4mcLEiRAkgKox+APerMlmljKqzzLKHGfQqay73XprxNiOUjUcBfb+tYl/qbRgtI5JxkZNO6Roqc+uhtXt/FExGQecbqwdY1qOCFpC/A561zGseIY9p3SAY61x+oapNfkYO2LPA3YP1oTcialSNJd2JeyPd3010V3bm3ZPGPY1aTBK7ZIxkDA2kc02IJIkaKJBKPvMF5bP6VcWGJ0UtvWRch8gY9ulapWPM1k7iwRgBWBZWxyVOB+GasxpIEUsoAyOvUjvyKEiSELIpYnAUDJ6+tJK8oY7gG78HkZ65p+oyyAqM4QBRJ95c5ApJF8olSxYYwxHeopii/cIPAAJByfoasCRMKFZt5+9ngD/Gh6lLQqNG6keUPvcjI7Uk6bAFJBz1A5IqWQFrkhGVkHBI4/AUxtxkBjyRz8xx09Khoq5VkTGxSoI6ZB/lVaWNWDtnBx0zVwsWfcSEI6VWYBpDICAMYwBxSFuU40Z2AGCo9eorVSydIEkABeTlQGHIFU4lBlbg9O3rWtHh8HYqp2Ycgf4VSBLqiy6MqqH25wM4Oc1GRnrVndFsdFIY4DZI6fSoD05r6DCT56SPExUOSqyNUbcXZcDHr/OpvkzzheOGHQe1PZeGJVWP8RyPTFTxWxnjC7hkAYA6Yr5o+kRDDDg5iOFzkipjGXGWznHOeuaurbqMIoZCo4J6Y9TTWBwcIWdTy/oPWkaKJTjVodxdt2AA2V/Hg1PanzW37hkrnGQc/n7VMI2eMszhVJJO4DFMgjzEvlg+Zt4CKPoCPeldjSLDROURp2QoygIBwMDP61NEIY2RkUbWzndyQSOnoKjNvK6OknmMEUE/NyPfFKsQ3nDE85LZHT2GKpSGKkEpJALqmOVPAI7VNC06KHZFeIfwE5J9TTR8xh8mQyc7fx605WZpdp4UuS2fT3Ip3HzdBt7Zy3I85olV1AKAkZANQ29hDHarDLIHBGRuwT17mrpYyp5bN2LZjblRxnHfp2phsy8iSAbVZuSWHP1x0qWy4za6kkNuq5VJN8asDu6hfbP50w6eJHlkhnDAcHccAfnV+NF+eM4BA3YAJ/HtkVFFDNIXBj+R8gMF6nHY0aFqct0zIu9IjnIjlLkJyuw1o29iYGDCAlV4DAlcDjHFPU3C/IhbKL8oaPPsfrUtg00jxG5AEp+T5V3H8jRGwnVkS3NrGzFmtWbd1/eZG6oLbQftlzvt0nRkwpGAQp7DnHFXi7kBJFiLDO1mwNv4H+VQ+S0kjCS4LFzuDLIYxz2x0qhKc2tB02lNA7gSLtAwZFJ2n14GTVX7PJE3lI8N0jEH5SwHX3FX4S9kjTSNGIQmNoyCCe5B4P4VVZ0SISxBdj8Bmz69KVkQpy6jru2jin2xJHHKnUB96k/WuZvLKVb1SY8M7EKDnr169K67TzbXFr5klzCqRnbs2/MD7AnpV9JBGZVREEZXhgmR06g9j9KXKmaqtymXb6dIqmUPChIUsPOAcenGcmj7ErnfK8jbkzgEndirlu87GaYIiRNnJ2Lzj6rmooXlnOXhCogzvVSAB6571TMnOb6mVqGmLJA67niSQffwDj6jOfxrn30uWGQia4EkI5Jh6/j6V2stt8/mrtYLgZfOPwouPLkUjKSPjLNwD/LNJpFRrW0OAurt5ZPLhVFjReBt6/X3qbTryAQsssTb34BDY/MV0t9oUF1HHmYRSDugzmo/+Efjs5yjwyBsDJmOPxwKaui5ODVkZOiyx2+rNLE21JG3AHoPUZ7V0N9fW0sDScbi+Nq9gP5jNZ+oaHJ9m8u0SMMTkkPn/gIrCl06/tY3TPzdChOR/wDWosktDO9zobXW5AjhJWCg7RzwRWhZ6/hOXOSOgPQZ6VwirJHsQQGEqNp5JD++T0NVJNRksZGE6Mp9W5qNUOTi90dzPrTPd70lIEWSCD3NQ3OuM0sEktyXKH5uema8y1PxPFZwtI7Hd12jkk1yVv4pmknld3ZPMbJU9hVKEmrmTrwi7H0gNSjeEHeOeay7jVYgq+Y4Ck7QD3ryBfGcgTbGpY9sZqnLqmqXsy7YX25yNzYp8suoPEwjseuat4hgtItlqQ7+g7fWuH1HX5pCyuTI/ZV7VkKmoShfPkEUecHyxk/nVi2so4pVADMzHB5GWPv3qlHuc9TEyfwkENu964klyxY5CjjbV+2t2UqrjJUnqOOfSrkVukbAguA2AcL/ACq5Fgr+6DAE8t935R+matHNruxIIZBMdoVfLAJU4HI7VLKjRSAlGOfm+XGPzp5BDO8cXzHj5uh989D+NOgOEK4cnGQMggHPX1pgKgYmRBJkIdxXPAHrmo5sRpIMfKR8qqckH3PpVlonjWMxO5CjLbxyBnHQduagwXlVpMyRoSinZjOOoIp3GRkR7lAY8DBDDJUgc5xUpdjbIhRSmcqwAy1RRrOLhj9mAUk4IB9Mnilk2CVWGWjH3eCD9T1qZBFARF5Tsi4w3Knmm+UzEmMZJG0AfxU90lNuT5foMn1pPlWQea2445wMfpUGhVCsIWU7cdieue9QZPTnYP0q/borgjsAQBng1CYg6FcNuH3iO1ILFeEK2ckde/Ga0rZw9vvVCjIcBh0OapwBJvNUEAgZ96mtcpMyxgyBh90nj61XQ0pLW5rRMMb0wN4KNVUrz0yKsSnYIZNqhAcsAc98VFIVy23OO1ezl8rxaZ4+Zw99NE8tqC/lliyx9dvI/wDrVbil2sREvKjaR0x/9frT4ocquB87HnA5B96exWJVRDycF8/pzXhHurQkBDrlXHX5g35gUqxhpQsYZio6Z/OmpA65e2ijJ2gNuP3fWrkKYjSRgQexVuf8mhmiZBPbxfZyUDAkAmMHJ5OAaRoiSpjYrh8ZBzx/h7VoTxomzMoYyjDbRjGOin8cU60tl82FZ2EWd3z4HXp+Aotcm/UigtWWaSOQyRBcZVDxx70gikkYmEozYIwXIBA/n2rRmICQghlPOXCnqcfhVdpIhAsqRIQikYkztP8A9fpTUbCcrlIxsECwqp5xkqAfTv15qxshQxicqodTkqwwSD39KdI0beTsjC/MSfm5J9AfT6UjRQyRqcvKA2Np5CnPP4YoDUkxC1vEFj8twmx+RgH/AOvTI7eIyt+9yQSM7cED2HrUtxLFaxEw5CqADESBgZHfvT5Cs7urlcqSMqfbI/wqXuVEbDb/AGnaFlVZdg5J5Hbn8KjnkkkZRJDtVThXBIHXkkUiZCkXAzKF++eMeg9DSLMHGANnyjO/OQPp0oGOlmkRgqFXBXluy8/p9ahMk+8JMG+T5sqT8wxxkDoakznflQ8jFlT+EH6A1E6vK8nmk4IGGUFeR2x6/SjYLj/PMcORIJPM4x269c/4060uVcqi3CAnhlKM2PY9veql0hjl3DAUc5GcFcdD/hUQhMQJLcM3AQMdvtmlcabWxsqxYGJjGEJ4ZDncPyqFokheRIRtQL/E2QffFZkzrIioqABRuIDYJoDOsaPHH5mGw65bdx69qHIZemig8sBJlC9yMYU46n8akikSzhjja6DMxzkKQPwOetVLW4Z/O37tpAG3AOB+XNRDG0varIqKQQw459znijmQNyfumompHzWG6Rjndhvp3qa2v4XSYDyZByBzgJ+FZcEqxZLtvZhg7jlvf+feqz+bEwZdyxrwMpyP0ouyXE3lZpWYKyKmN4I74+g5q2tss4M0Uz70AO3BxyenesJbuORSPORXxng4/PvVy01WeJFVWXdjqm44+uaUmCVzUkiYfvDLhgMH0Jx0/wD11VRPtDJLh/tPICk4Ax0zzViLU2OPNj3gjkOhBP8An2qZh9oRhbxoXBxsbC/zP86FLuNNpmRcrsuVjeMnHVt4wG446+9aEyuiZuCUVSM4Oc56dRj1708zGNYSyQxTRfKRLEzE+mAeDWfcXTbyskhYsxyQobj09qu/YqUnU0SGXkauhMcEbqTn5XD4H0rntQ09LmIo8atGSfkIGR+B5reMkwiaJCoXOcFSo+vvWXdxqieduDPyAxHUUGbV9Gee6n4QgWUvHGMOc7c7h+B/pWOukQo5UwJhexHNekgq67gUOB86gnr+P/6qo3NrHPuljQ7QQAw6ZoU2c8qKexyEOnIYsx7FwPSra2ZChkU8jLY5wK1Utmhmz5aHc2SdvK/0qRYkO47GwDjIPy9+oq07mbhbcoxQ4JD79jD5VXqTU/2EKSDnBHRutWLS3C3G11wy53ZyQD7Yqdo7hFkmjLKy4JB9D0JNOxJXeFo4hGd3zHK5II4+lWRGTGYVMa8bsMcAfhS20G8M3lCV84Kt/EfbtjrUsFt5tvJKqoADtKsOmPX8qCkkVCBGrDYokjOCDznj3/lSgZVFD5cYDKBjJ+hqxsliZzcBVHG1WXGeeT9KJogJJDIY0GARhiu4/WmLl7EhtrjauGLRsCHGdoYA9h6+1RTlXnYW5ZpcZ/hGOORk9RSNJbeXhZiZN+DuByoPX2NKVhRiYw0kb9Sw+ZT7UXBRIIEBDYaRIw+XC/N9PqKacySKdyg94z8pPoadalFil+dCnbzASc+lP2ebGXcZOdpLcY/DsKG7oaRWdZcZVSdh/i6VVnlj+0RrPIgLHAAHX6CpmiKSSKJgBjqoLZ71FMkYALqBKvQ9T/8Aq+lSAnmDfJvcjb6VGxZk8uNymDu3gdaWMoyF94wT8pIxmpJcsqFOQQMknjNS9yt0Ns2RJJPMwAwwH7mtuxtPs8ZncLJG44UDJUH1rnbdWdmgn6Z4I7CumuJooYVitdzRhQBIc7j7fSqW1y6bu+UiRPtcZjc7IkGWZRUUsXlMF3ZXsR3FSorLbSFQQpI69xUTZLEMwYg4yK9TLpe80efmkVZM6BseWz4YCMAdOv0/GonEYhWXkbRhGHUH0IqWUxqg79R1OD0FSGDc+ASwOMccAdeK8lHqvULWRpZ0MiYj65HGPerj2wa5DpgBMYXPU9v1qDbIjoPLVkJBOev+e9TRQJbSHfG80fPQ4PP9KW472H+XI8IlaFQdp3Ecbst1H5VMi4dTuB3KGRs4yM88dzQm17RG81opFkUGPAOfX8OoqSS1RikhMZnVyDjnaPQ9s01chsklkfzZmuE2xJgYC8g9sDtmqjPeRwJFIB5aZKKeMbv84zVq5kWCK7Eu6Z84eQc7ueKgZ3lwrQAxkAggZ2gH09adwirleU27ImxWWRFKhYyTg56/h600RCCXgsqKxR1GQT3zn8avSQu8YZf4Bk98An8qbGqNs8yMK7AqWB4PNK5XkZ8akyFg6spAHXhMHpx24p9vdM0aypsB3ncVXg9/8Ks2ttmOZ4ZljkhXcVxjd1qCO0227lXWOQKMAn1PcfUVJSZGZ5PKBBDA/KxxnjOanhglZAqgln/hHH5H/wCvUtj/AKsiPkA85YAL1GT+lWH8iK48qKNWjjA5HP459KViuYqJGI/mZZPNjYuMAZPHT6U65tyNp+XDNtw4xyAOTjirEkcM8ERdS7BQFkXG0Z9aT7O6zOUjUk/K5Xpz3Hr0NVYm/UgksFaIrvPVyMcBQOOtQyWnkRhfMabK7yhUr1xx9a0FQmJnh8oq2QqscFT6gelNnibyIhKDGsgUbjnleckD1pBcoDTUZFdwgB4B3dO+T3x26Uw2oZpEZ3KE9Y246ce5rUUHEsnkt5eSF6g46cGpreOKaQtOSiM+NzDgkfy+tJopSMmO2ZScOWwuArKDj1z3/OmrGHVlkLlmPK9vwq60RS4ZFCSE5+fcM45/wqCGNyokB8sgEEKqkMuPc5FTYdxiBTIz+VLtzwuDlce3WpfsZkk8xgXj+/kOxHoc9SKesbxGNomQfMSQee33T78j86ltZI4kba0rvJhQqNwgByc/5FNEyZk3+jyGXzLW3SPaucMDk9OcmktLtwDHIFU4IxgDBH0rbN0s+6GQ/u9w2yY+bv0XPT9ar6jHbxTPFFJKGII2yDa34jpinyrcjmtoyKB2ZY95Cb+E3P1PoeKrzpcWxI2o0b87hgksPbFXRbj7JE29HAJ/hOOB9abCZSjFJCzHG/neB+PWlbQu/Ur3bXMixySxs4yF3tjjPYH+tPjSSLdCZF5+7uO5gR6Eira/6vC587dhgefwx6cVZRIUi81sqqr90glXORnBxxVJA52MlEu4yTG0jHBALy/cH9Krrb3QR5ZP3hZcbCc4x/KupsL+R0lSJInhj2rLIDt/ddCvt1POM1m6uzxvE1jFIgaQ+XuYkHBwOD0AB9qOUlTb6HK3EDJbxGaIlACMLkMPX61Utxs+aNtoK8Z5BB9a6G5u0jmSOZyPs/zyKAU+oAPOSfwqilmbhZDBbyBwpclhgYJOMD86aVhO+5QNuZGcE/P2Xhsr6iqU8ckUYZGJVDjae30/wrYNtIqo4diNvysOMHGdvsaikdplJnjCt/EVGN/v7H3otbYh67lOyjnbDQsxUZLMcfoO9OG53dPlVcEY3Yz161HLaOiqyEMufuk4z9cVcs3WRMThYZkG0DBBYeucH1q07mTjYpRSvZwmSMM/z8Y5zx6e1X1kaTYMJGrclNgPHUj2qs6zRO7Wqtu5LBeVUZznJ7/SpGlaRVMqufLUvvz1zxk/57U9gWoluGx5lyQ0a7m2McHbjjj0qK6eXz5GLj7OyhdgXnJ7AHrinRK5tneJFaMg7PlygI7L3/PvUSNGrhlaQuo3eWCRt/HvikBHbSwbdhgZpi2BuUnJHt71Kxxbs22LznIVEzuOD3x6/wBaU3Lt8qSF0U7juHzH05qp5ygs0sJQFd3DDAPrxQNiTXBOYDCgbjeCpBU+vtQMYYXLsUY/KAct+VPSSV1ZhvMbHcR94N+PrzTElYOEJjV1+bLAAe3SgQrEFd4j2KvAGDzVOVY3ffKWUlSWRQOfT8KtXKyuihJi5PJ2/KR68VTVYxKGWUsSuWJ6ikNlPy0Zx1C9s8jPripIw4LYVSM1LKQFIVcbF4J64qB5dvH8TfMRSYJJEtuNrlj1HHFT2V21yybWKbAQRniqcbgsArdR0qxZCGGdgJFVgeF9KpbWHFpO5pPKs8SRuzIzHGBwPY0CORFUujKH+ZSe49a0HsYDpltOsZnEhYtJnATBxs+tGr2cVs8TQgxpJGG8pmyU5PHrivQwN41UcOYSUqbLtuMOZEkCggMNy4IPP+FW44wZVG9ww6OD1x/+umGCSSMMJUWEnHLfMBVlY2VkkSTKxoVCkdVrzj1EKytGvlzfvvM+ReMY+p/rVmdE2G3DMWJC8ZJyO2ahOC7NcKDGVygHTofyqZNsUbRwtuOCyAng+nPpSBi28oeOcTIzRjqoABXjGf8A69NZNum42u5DE4HT0B9fXNMF3/pEm6OP5Cd+MhW4+760mnTeUhzLuAVgAvJ29MYpitoEciSiG3uIBFI/3g43AKeQQO5wKme4Edvtkj8tVyVwe+cAn1GKQKpuJmaNmWKMBR/db19S3NRi3UQzG9clwcfNzjjP86QWNC2WFLHfkurFdhOCCe4Ht+FQCUSSK0kZWGFzls/eHsO9RabcRWhElicxjDFX9ce9Tx3r+dmGEBxk7mbIAI6/nSRTRFHZedAZVPk78ZGBnPXH5Yp1qn7xBOQzb9xcj5T7en4UscQ3OoeOORBv2nBDcA/nSyxzxyMHKGFDliMjLY7etFguOu4XEcb4VQw+6BzjJ6+lMVX8t5mGWUhPmPXj+eannHlFlaR13bVY4I3YG7oamVD1Ajb5d7c5PzAkEemP60WJbK6Xsn2oxPGohYFQMfKGC9j+NRJIs/8AqlYkElgV+YKo4/mabGrSHa4jGCo7gKScD8a0Wso1aVvNDSorKDuyCD2FA3oVYJceTIkbOjodwZcYc/5FTRSyQhMxgSsjZBU4AyOR68g1EkSIolnCrnLptyBjJH5cU+1+0bEmh2sFPyA/NjA5+nWiwmLKVW2ZSh3lRtw/3ieSce/arUcaXESW8gdUwMAKeuCSMD3qkmXjmYAReQQrFVwxPA5Oa0I0ZJY48NMD8uQBuX5fTvxRYluxmmFZSfs7OF4wvUufw9qtRWCq6IsQRmJ2Hbjv3PTiuh0m1WaNWCNISgO2KMgjHTnpz357VZfw9I0B3KPMlLOYDIFPXPyn+Ec8gVXLdDlUW1zipbN4y0QmDpIPlkBwASMnqMZqCG2NspSRi0YyCc8kDtx3963tWtG066AIIhlXKqo+6Tx3449azLlvOYgyKxUFQ4XCs+elTyopSdrla4VGUyQqwg/2uc9x/WprK9WNXt7lFG45JYbi3pnvik2ss/lfL5yEAKAcHHfpilaO3uHjIyhxtfAyxHQnOaa0JlqSW7xzyqLpC8WSCy5Ix3544qG5gkKpPDsKk7VG3ORnHP8AdqV1jUyrlVUtuQsBkA8A4B44H50+5t1k/efPGAgcgnhj0yMepoDRPQpynyyjMoZFT5ih5645/wDrVekm3spwscYXLBJEw3uAOP61XiVZIoTMkqxqxHzhse5Hb8qhukLkeUSRjAO0bT+XGfekhvUfLawKrTMYZJmLgqW49jgHj/69W7dUura7e0tIhICqiMyncTkYAz1HBqpFHOHitliYysSm1sAP7A+v+RQGMd6AUkwDho2GGU+lUtzSEbl3URaXV01zHKFnb94UdevHTPt6VSurJ4V8pJBIHZ0VRwQxPDAde9SamqIILmBsQyhozhgwUjqvqOven2WtpLe226MvKNshYIOdo4Gfrim0h8ml4me6xBPKMUkTQuqSZyeMY3Z+tUCkLFtzqVD7ASfuEjt7f4UkF1KmoT27eYryFwzMeVOc1pXEMlvb+c0LKs5EoV4zxjABz789KLIidPlMSKykWYqSC6tsJwQelWZbUS26rtAfB64+b2+tXDamS9uVR2Kicc5K8hffn04p1sy2t1nGWSMjDjpk+nf1qb2Ekcpq1neQEbE/dKSQpHUHv/8AWqkLyG4YLMJtyMoBB6gDoc/0r0R1jNuodYm2jHIwW+g655rAvtLtg58sfLzwTjkdqq45QjLbRmHEYREdkkofBGcYA469uaayRGNZZZ22L8quW4ZffvUt+kqRh7YptGcoRnPGDWdbj90GaFHZfly68Aen9KLnPKDiyeFlctGsY2A79zNwAexFVQiQy+Zt3YbkFeMe/P6VPND58HmYkKrn7oAJ+uBzUloyiKQRCaNgo5x19eKBeoxGSWFlgd4yCT1G0D/GmtCZNnzDKr1VMfUn3qTZ8hWARmEnLyFc59OPWoDcCKJY4ypRgQeuX9yM0CeupEqBkARZNzcHC/kc0xyqq3lAIo9sn8a0rFH8ppizwoo3BU/i/wD1VTeAXDM7sVAONp5z70rDd7FGQo77skdgTTW8tIyF+Yg4BAzmp/J89ioCllHGfT39ak0+NJEfPKg4yOKdhRTZRRcDc3ysemaeM7w0abn6NgdqvXvkLgOSXxgcY4plmu+4jQyqis2N2Og9aaQbG9oNymm6bHPPd3UYuWOI4QCAF4JOe9RXssM7edA0sm8ZLTYLZ/Dt0q5JNBY2yW8Wp2CIGJw9uX5PfkVmT3S3FwBHNbTKiDLQReWOp6j1rtwztViceIf7uTOohaJcmJdqE7QpHPQfzqy0P2iMIu5ZscgfdA7VCJZGlEzQjGMAdcAVKJWkkdonCMBhg45z9K889RXFLCEbArqudrMTlSx6A+lB8xGUvtZVOANwxjqePSnyKiJGXQv5pAJ3YXd6mhPKZo1nQZEmN2R82P5DFIY6L7O6yLdhjn5VVO7Z4Le1RrEVjkkUqF8whnY4wfQVfh3OxRoI2WZ2+dR/dHGOwHP6VXiZIUnjmjVgYR5Y5++eKG+g0NSORvLNpuRGDM5bopzn6n/69JHb+ZMplEjlIyXRFLYPPNXbZXkm2RuT8hVlxtww6A/lUjQyBEaI7VmBPXkYosx6mP5EPnbIo8qylsOSSBVo25hESGcxqEIKLnaMnB9alkLMjrGPLkVChwciQE9KaC8sRjlZiU5CgfLx61aVjVUnJ6k1vaM8qxs0RyQwJHytnjBPvUMUTfaJGuS8iA7TGVyyjvg1LAYprDddXI81HAWLHzMv19P5VJcq8sG+EONrYwWI2L2WplpqiJR5XZiHDxNGzFQrEqpOScngn6AUkJhuCu/K73JYoMYHuPw/KmwLi7aYBxcKhRAGxj1DH0waiVImYMcqyjJ3ErgHt7jipVybIZLGDaROwZfnLk9FYjHGO1WZBLNaEBsoGGMEBunf2pYpHZfIKIZWK/ME+6c56/1qJg8ag71QDIyo5I/2j9c0XESQ3sexI5bfO079zOTu4OAO2Oc4qaOSMogh3LkhXJIHXg7Tj61kzo0bqYcElvTPPsKlikVbMpKNhjLMGYcden50waW5o3DCGPakqbW2yeUoJ4zwPcgVt+GrZLrUmkuySyDzZADt2qcAA/56GsAqZDFHcZBVfMR48gjAOCfatXw5PPa3SZ/eu2Q8UmF3KR6n29apE7xaR2cryLfb94W0XPyRjPOMYH51eltyxt2RQXwVaTPQVl2qRXCRXFk2Uzt8ojlOxyPWtr7YI5DHNGUQ/Ipx14rZHJNKNuU5jxdbLNZsUHmTLJuyTztAP+HauN1G3jiuHdmKbgrMAmBu6sM/lXReIL5bq2l8ryzOZCd7kZVF/qewrmbm4Z4Wkd1LyZ2s3Uk9T7AetYy30Ommmo2YxtrvG0QUKBznd6ZzRN+/jR2ZX2AN8gJCDof/ANVCoPssUkMhabLJIBnJ9xzQsYXmGOQRYC7guO/61NylqSLMjyT+YjsgZgAQyYH489KWNozE2zEKlcOhctkDtkdc0l2xmCCMSOScNljlgT39Ka1vcOTJHIEYDLGQZAz2BpFWLdvOZgFjaIx7seWXYhuOnHI+vFVpYJXRU2ToY2+7MSF+goNwUQBoEXoxU5TdycgEdvrU/mPJJtEAkZ2L5jZvk6Z2Ae1NitYrT29y4yIVdgclGXn19cj6mq+oahJO4lvm3HoVZgG444PetOCa2e4DSxQtCq4ZDu3EDnJxyOeKqarbQvaOZLWaOQ/vIjjIAx69ccd6EEXZlG2uFt0mhZVlimAbD/wkdDnrSQ3kMW9woVnVlXHBQn+lVJ4pVtY3QBgpyccEg1VnO2R0clkYblJ9D0q07G+jG3Y83ffLnzFfEmRkNuP6Vqx3n23S9ipKzCUEtn/V9OPp7VjTyMLKVYuGUbtpP3vf61XtNTuMI0DLhwMgkH8vShsv2bkjprGRx5+Np81iA23B2j0HrxikeMEO0alijKBg/Mdv3t3ryev4U/T2WO3RB++cDB4zubHSi3O35OJQEK8koS/pn2NQ2YuNmS2p+aQRr5jSjaHc45/vA0y5sXncBjGXgGSoxxxySx96t21s7TRqkj7kwS0ZPBI6nrgCtyze3njNvDaRSSIjRvI2SZGP8QJHt3PemjKbcdUeb3MMY3nJDk5K4x29axbiFhuliyOOe/412Q09TM6ShNhOSSfTNZqRKkcs25cRykeXt+/6/hVuJ0SjGS1OXt5l3KjM5ff/AAtg9O1TTQMc7g0cRO7LuSfpx61b1u1RLsyW6/upD8uBjnGcY9qhtZn3LCrbVfBVDgZHqSalPocclYpCCEYcyyyIvcKFAJq2PLWERROjYJJcgjqPSnyuvnfI23OcksCufbjmqxdrcbSX2KSJMAHg96pEMlhmlZpVUfIPlDkZHtTZFYxq+5SzHLcYAqykwFp5xie5DEFY4iFGBxk/nUms2W77P9nWQMQSyAfdJ9cdKb0KhFyauYV3NHKreUrBR8rECr2hwR+XcPcAJGyYUEfN1qzHpFysLvIpRQMBCAePU1ds7SGzt2e7bzGkBY4PRQOP1pWvudCSUWkc1qkAe4kc8ouVQCqdpbypCCjjaCeD1+orXFhJJG8ociEEDODgE9smmo6JI07KQkK+WvQ5NNLuYzSexXu3jZIt5PmInzd9x7UulWksKNK/llHUEbXBPJ7jORWrY6LBJaWlxMrtGwlmncNhQq9E+pNQPZxW3lzRwm3a4jEjQFidhyR355AzXdg4t1UzzcbNKm4o37e7YbXWXB5+X+ED+tWlvPlflfMU5LOccViyGJYIZN+bcHb1GT9PSrEbQviXdw7csXzj3+vr615rPXjF9jTmuYzEGAJjxn1IOOlT20u/yiZFWPbsyoHBFY00+Rs4whz8x4Y9wPelguv3UDxTsrqd+I+AV6HIPVqi5bRvxXciwEyqYgrkqC3DD29qisLuOWaKRdyyyMZMnouOBWH9vDpskG9nYk5JJwD0xTLe5NveFzwgBbb3Geg9qSlYqCV9TsIp/MDGSR0852JPXJJx1/CpZJhcNGm4BVcqFYY69ay4buF1OVfcAPlXuatQzMynfACMcIo54HBJrRNHXJQew3yZ4Lja/wC7dj8ofOOD1pYYpWM8kTN9nRtrMf4ieoHrVaW9mvt7zTP50CbUHUKD1xTBIbfS0USM0juWkIP3BnAX9Kd7Gii7a7j5L+OzmjSKFJGJ5LjcSvStYXDyt+7n5G18sB/D05rnQQ4aYAB+iHHzEVcIW3sIgluwuFfDjGc5AwP50tyK1FS23LN9d7J0WP51ZjIwYZ69RnvUN4fMDCN/mddwGMjA6CppVZoUDuPOVvmUr0GPWopZFjg3qpO7BDKeSB3NS3Y4uWxLNPuhQwBoptv389OxyKmE4mKs+7btCk8fMQOOlRyFDJCSpIkxnuCO+Pc1Vkcq0bwbWBO0ANznOKRNrl2XfFZQhk4RgdoHzNuNOubUTTbJDsw3Ik4KN1J/GoY5DKw3M3ncbSe2KsybZbkO2fNcbs/3jjn8aLiehBHuEixyABjw3+7jAXnjH/16s2qtbSebJb+bCByM8D8RSOreXckgLEgG7IBzxn5aYx2YclmcEbl3ZXt6U1IVk9jTtL24MiXMKvJcuu0JIhBkGMHAHpjrSvq7ahIFiWVWKhCzSFiW6Z/zxWOJbmWFAJv3jE7eo4JPQ9h/jTQZhIcoFVXXhTjA9B69+arnBQL8wkdZIrt0eV3J46IAefzxVaXb5rlIopNxydo24HsD2wKYuI38xdxXIOCQ2fQkd+tLLCwtwwAG44O0HAGOf0oTJempPJNGbxNsJjixmMMcDGOvH4Vek00PbRSQ3oMhT5yoxl/7vPX07VRk8qd/K0+CWIyEAkSAnaOo59SBz2qeTzXghJdSsZYgMSuD256E89qZNn6BNLJazw70hUMgyEGUUE9cdSe9OSRvOfymM9uoLMFwAOeC3pg9qrrcPGjeZ5VwgYKXDAMOMEKD1xnk+1S6g1u93GqQsESMps2lJH6Yz2JNTYpPoRmOO4lZ5lZcszOSCQ2cjIX04/WlsVSOVwjsG8rISID5MdmB7euKqW/luIstMSqklQG3RDvz168/hUUDuAJQI5VckHzjnpzweuTSK5WzfVLeXTLma/upXDEsrxxq0YYjI6DI/TFYdz58YucPHPHLFxNhlHGOh9e1QLqSxXiuspmfHmKxjwIyOny4w31qG61JbpossksRU/vjE0e31Hvz0ov2EoNMrPduqlJ0MbYAx2Hv7CqkphdiVLNjoxGAKu6jEB8iy+Yu0Etu6n+tVoYCIBPnay5K99/PH0p2aNFsNMe2TLKSqkHd1Fc7qBuNJ1Pyjt+zyfNEVHAB7fUV1kqeZtmhBA2B3Ur93/GqF6llfQyQXLGNQp2nuD1BptXR00ptblzTr97lEUSKXcYJIwB9PetNFZAqb/LAH+syCWrzmzu5tMv/ALPM+yT7ysOA4/vCuqt7/wA2MyCRnUdt3NQ0XKmpaxOqjmityuUIdvvBSQT/ALQx6dOa0o/Ia6A2s0QjAaNmJI9x9OK4k6qSjBCuw4BHU/n/AFrW064aaZTHKA646/dYf571PM0c06HVlnVbgfZWk8vDlsfKCAprAtYXnspPOQiNWMgx1Y46/T/GujuWhvCIFKwEMfMJyV2jFXNUhgg0hhs8yd41ZpmIConYAfpitIy5jOUnFcpwD7XkyFAwnyjBAUnjn35qlqlmts+yQYCzFCQOfrXTjTxNpJve91d7NvQBF5IrnruUyXCytGArS5RG/iyf5dqHoZtdCpExkYqEGcH5icL06/XFUriZJEezihDDaWdt3Y9s5qW73iNHgG2UZ4PTrVKztJLzzCvyxStjJ7Y5OfatFLSxi43Zp+HldUeWR+AgREHXr1rcF0kEqDDFCdgReSzev51m2tuYbELGpkLqTI+cewAFA3wxm4muFtvL+UbuuPb3qkdKSS1N6a8jjlFtCcyMp3yuA2D2/rWS0iwkMI8Krcu/Jbv0pgnXKyQyMY0HdNoGe31qCcPcch94JGecKtJ6lRUYxEu7wyeYzSjYeSOAN309qy4kA3OTuH3mTH3jU7syyAgp5a56Dk/Sqhut3ETEZPJHequcyVm7HR2Nn5+kOfLmYTRyMqK5CJsHAx/Ee9Z93CqRWsytL/pEQkIlbLA5IOT6cZFXrG8OmaXEw1JbeOcnbC0Hm5PTcOaXU7FpYzc/bxdS+UspHllMx5xle3B7V6WCXvXPFxsnscrbX20SBirKg784x6VoaNLburyvI67jsVF4z3yTXPyA7mUEcMcZHX3NIl3JAfLG3aO6n9K8XY+jp4hJWZvXtyzXPmwNtj6cfp+NJbX7rIGkO7af4h146n1xWZBcbxLng9lHQ8dalhnUswGBxkcZB9vaokyea7ua8cu2PdBhgxIJHUZphl/ctLvILMEKnoOf/wBdZMExQKpbGDkYHTvUqy+bDKsjErzt56E9M0rFc52GlSrcI0kpPJJjGfvEe3pV+GO6laVzKqRxjcqFsA/41zugkSRRCNR5quQoBwMZ5z+tasl2LhfItnwIjukZzxx/npWkVodlK1iW8WeAlYpVcO2d6HIyewNSRajDauq3LBmYYLIobB/Gse3uS9z/AKPkuD1c8Ak4q3c2dnE226kllug2GWI7VHtzzmq80aqfRm1CLZHRiWSaVMqG5BH97HYVesZikrmJ2G1cbgfvGufldIbZYEVAhYbSnO0n1bvUxmAhQwyHaByCp6+ppvRGcpWVmWjcNtUyHJJ2sxHbvU8kkUjqvB2jjaOuOlZRuQq/vMGRzkEt93HPIpEuUklUEZ3MxV+gX/61YtnNN3dzUV2uHRpFYqoO1c8Lnqf0pyRov7raDnn7p+UehNGlFBLI78hhxvYDj2qzJMkbyGOXaCMls8Ci5EkQSLuNvllUyE7QBz7j2NMaV7acF1+RtoAI+6T3oc5kQg4DKWLf3Tjr7U+ZM3DMskmMZG5uMD0NNu4ldblqS8dY4ofNQANkkYOPrSMwM42Bpd3GOMtxzWK0UynEkoVRnkc9+OtTWbmYqrkYXPQ4J+goTGol+MBXJjEkaAH3J56kVNLJMWSORW27MgKRnn1/rWesnmMQ7tEqnI2t94+lWjKAwKqknOWbuxPeqTIkuhNLdCSKL9wVdfvpx93gDH4Vaj8rc6sYizg5DDAQn/61VBMTJLFKQifeIXkE/WpJLREYuxSRnXIDtnjvR1FohbgA48thIw53DAUAkcAdv/rVKJ43kYTh5G+7lZMk9OenGAOKiiMC2o58wou1EUkbOckD8TUyQMXUAM7E7yhQjGBycnrV2IbvoPWOOaLZGhackj5gML6AfhkmltYY98bCURI5HzRuoy6/3gQeCcVMQkCCAIjGX5FYpkKCeobgD8adPDbwwIwhtW2SA8pvKoegPPJPX8KVyN0QSRTwTm2aaKVS5fYpKEsRxyOuR2qFoAxtpNKE326UlGi3kBCTgEH160TRSR2s0rGJXWTiPcVYY9FbrjpT7YztJHKZmTbGTFgKGb1wenr9O1JaloxtQS4gkxc3WZY22rG2SfQgFTj61jl7fzZWaWUTbshocnHHuf8AIq9ql1CJpYUV3KgKrqwGPbOOc881nXMNvu3QRbHK/Nk5wfSm0jrjTSSuV3lEjqfKERRdoZBgMfU571dtdRXyY1hUqyjB5zWYYJjvYK7oSAW7VPHGVDrPsU4+RIeOf9pun4VKdmEuWL0NzTnR5AhVmUD5gOgP9eDVTWdKjN9v8x1UcbVAOfl6GiygaGOMkjzZCOv90DGev8quTFpSEXgLghUT7o9Saad9zOMmndGBqmjQX1vHBOCskeRHL3Q9vw7VwOo6lqHhq8EV0m6I8JIv3X+nofavZJrYSKIQpRgOVfGQOv4n+tc74i062mg8m/hWW0mOwh+qccEHsfenZbsv3p/C9Tg4fE6PCXjlXk5KHqK63SNfjmtlkhPzdD7V5T4t8NzaEwuLKc3Vg/8Ay0CkGM/3WH9elZOn6xc2jExOcHqvY1UqSkrox+tyi+Woj6Ks9eVbt4mbcrqGYKfvD0qW5vJtTuxFGQIlTcxY4Uf/AF68X0PX2N8jOe2ACc49q9A05m1bd5bGPC7WIJ57/QVnFOLsy41Iv3jrb3XbBLaxsIX8xbZt21yMOxPPArMtohe6hcTSKwjiG5AwK4J6fTvUY0y3SJIrCAvIOc8Fy3c5POKs3MC6VZyWS3C3M0pBkMWcBj/Dk9fTNbebJcLsy4rMPbNIxwVHPpyeKrQwxpNJFtOdzKWVjg+tavzLKoIXczbmUH5RjhV/qayepAhO6TcTkfXrWd9dDNuzTNXEaxRySvGka8RqzYyfaqkluZbnfcjCREsc9Cc9vWqGoRz3EsJHz7sjOOc+9WJp54LRIklV/KH3x15P6VadzTqF3dCViFiAUngv29cD1qnf3ohwqHzJGOOegHpiq8LnzGLZc8knqB71ZuYtOjullijdt3GM7gD600mZ1Z30RDc3+y4hgRInkCAFgvJJqGZIUu2dXJQEAhfu57mnzLEXeQsIg2dzlec47elRpArKjq+6Fl+Yk1ZzxdnY6DSdPa9tbeSaG1ltk3vH9olKOMH5sEfw1NrFxPatJA62v72FVUwkkRxZyFH165o0KK4+xWbxWLukDyIHMgUOjZyOe/NV9fTypLa3WF4o4ogqeYyszDJOTjivZwkOWGvU8PFT5qj8jhtzNCyB8lhlRntnnNQltxfJGOm4jH41RiuI2uduSvbrzTLu7AE0agHK5GTjmvn7HtXNaE/uVKrznA9/anmffGSu3YV5IPIPYVz9vq4VXkz91RlegqWO9M0ZjV1Y43hRjgH6UuTqUqhqSzjejBjuBwR37VKLoq7DK/eBNc+9y5UMwCSICGyevvSG62qJiRh8Agn7vpT5A9oztbHVxp1pK8gIwBwCMe9aFjO1/Z+cFSKM4cs3AA7kn8uK8w17VS0flxSqwfBwDnp/kVtQ6lc32lJGr7VA27c/Ln6VXI0rmtPEtOx6BDewtYwR2pV8ybvNxgnsOvbPpWdNfzid1kY53HJJ5FUbXUJItNVFjt90YAG5R8wHOMfhWZFc/wBpXBaaXarHczjqfYCplFs7oYmMTpLW4meVposyCMgjg4J9fwroWvJpAfNRWmkAPmHj8M1ztjfxG1ktrdlAWQEK3Qp3+tbF7PbTStKmY1kAKxKQAvrSastCp1FJXFkuInuWE6AHZlVJ561LbONixGLKSLlzkjb7fWsyV3d3ugxjIXEZ27jx9eakgmmkQiVwGBGM9W/Cs2zFWNpQkbBW4wMfMT1q9A22Bbdj855DgcDv+NYscsswP3kIPU4z9cdquxEoqNIxOX5cgHPtjtSLNBjKrSMQGBYDK8A49qvJKBKWdVEax/cUnPXrVISANIqNwOd2QASe34VJa4+zhnJ8tG+VgpJxTRMkBjEZl2ttL5YZ6/TPaoVhwryR7mCgHB4H1HcVYjIklaJQMON+70PvSbYpkcgyHnkY+Xr2quhGxDcmMoAzKT3XI5PXmrSfZ2Vldmk6LtVuAPSqLwJN5shjJ5PII4IqpE7qjFZQVfuyjBXPvQTuasksVuXCFCTzl3Hrjmmx37urHYjZOA3p1HX6VWh2g+YH24G08jp0yc8VHKCIvLZQYg3BUgE+x56UXHY0NNPmI0lwzJGMbSo4yOnT1rUMnnt5lxIpTgYdWJ47ZzkVz9j12R5wCOUPK+mRirkCg3BQFQ454zyB6E+tMqyNmO7ilt1hEW8q2FDMxVVJ4H5c1aZBA08cccMs+4Kk6McA/wCyOness3AaVWiiYqUA+ReB+NacMjJbq7SrH5cn7tXG3GcfMD35Az7UJkONtS1d6Ytxa+dE8tzcdZA/VlxyR7ZzWDbRySQ/ZY4TvY7VBboR/k10Uep/IYmnbylBDRwJ8zMeuWPbPpXM3Q8thh2iJO7nt9Kp2auioXMk2S28sguVY3JlOR1CjHY1dijBjJXy4FjBJKkMzMegHvSyyZy69ScfNUcqKQxXCpDHuaQ9c9/yNCVzobvuNv7ZFgEs8OCnyhN/zA49/escCKGUBTAAvJ6ls8+nBpb427LGiNcSXRDs8p6RqDkfXvk1WtHy7Pt3NnCrk8/1pNGUoNK6NEybVEmz5uArBeRk5BPqTWhbB0mWRmS4d8k7SOD9enH86xY5BHIwZl3Lj5g+fmrV+2oHECbwVAO48MvuT6UkQbFhMhZYWjeODcp9ZOM8E+v1qv4ght/KunvI32mIMMtyr7vlLD3Hb8aisZGhkDYUxdWdm5Pse2feoPEN2s0MR3M5kcs6SEsXx3J/z0qlsVSTc0cbJGkRlE5DQyjBBwQQfavNPGng+bTna90pTJYv821edn09q9TnVrr5EUCMMe3vWmI0msLi3dArR7cjHBB9KmlJxeh14vDRqxu9z5qguJEYHdyDwa6jRfFl7ZOuJXYDjAPUelanjjwiFZ7zTkw4PzxAfe9x71wEcmxysnBHBBrqXLUV0eC+elKzPX9J8byvCyqY4XJ+aX/lpj+6D2FbkGtsdzxqxf8AvkcA+34V4taXjwsHRxxXSaZr0ykZkJ9hjis5xa2OiFd9T1GOSSRFMkiq0ny7P7vv9TTrO3aSUvGpCLGdpHoOB+ZrmNM1GS6kUAbpWHG5/ujuTXZ6bcwwwyySzKz8MqocA4+6MemefwFZR8y3K+xTuXa3hKksGVSGAOD7iuba5WZRNApCnghznbXQLHJqF5FCTuedwoPuTzXP+MtFn0TVZIefsjfMjduvSrp6k1Z8r0Jmd445AR+9POO2MdqYtyyNH57pFGxypxzWNdaoPJTaSsioQPmBA9DVMX2EVjI5mIwVHPFbcpzuroaf2u7u28tQBDuI8wjC4rYtYAEWNC3kqc4PesfTbW5vZUeRTFaqRjcMZ/Cult4lVo494RScFm7e5rtw2Fc3zT2OKvi1FWjubGLT+xrH7e07cuIxCB8gyMg5755rKvfsvmD7F52zHPm4zn8K3rZ2tbcQQa3ZrGDnaYyefxFZOtSO9yjPdxXRC43xrtA5PHQV6seyPKZ4p9smk3BLceisxORTxJdBU3xAyY5Y5w1dd/Y8Bk4Uxr3DZzVldIjBGIzk9cKT+Y7V805I+h5WeetYvNI24kL6YIFWIdMeBxLAzowHVTg/SvQk0SMKFYgHIG7jA61PHohSaNHUlR0LjI+uaOdh7M8/msZrhmmuGeRiMuxHU02XSnCDc2QOATXpI0c5KGIgbs+YORn6/SnXGhjMSgnzsbguR8wo52PkZ5WdPKjKYweCTx+FS2LS2Lbo+AeoI4P4V6JJowcOUh2sq7tjL196wdS0efcodNoIyOefrT5rkuNhmk6jbXLFbtBu6BGb5S3qK6e2msbe2TzbYbiCfufLn+teeSW4t5MSxkkHORV+w1l4cQ3OZISe55FS0+hcJWO1eaC55sbICXbzgBgPf2pljbXMhEk42qDwuGOR3qOx1K3uYl+zGEoOWVeDx7Vft9S86UrL5kWTgFOh+vpWTbOiDu73Lc9wCqSSbZWQgfeI6cAfyq3LIyx7ljEAYgiMcE574/xqhGoEzLJK7RA5HThjzVm3vIbZsxox+XBm+9/9as29TeJeiEccbRlimMYCjg+5JqVUcNGu0Ou75FBztHrUUM63TYVHOMEAjg/QCkldoJtgd3CgnYo5H1qTVEhneISGXgo+Nu3J/wD108XSBiYZnMhPzLjoMYxUEzPCwxF5zt8wGc5570yTyvtAKq0eFI24zjP1o2Hc1rO7xPGFYGMggdzu7dP5VZuJpFWLcu1T1ZiOT71g291H8rltsSZVlUYO7I7irTSIZFj8yJQckAHp9TVJktI11cYUFwEKYGACM/41XCAY81S2M4dlwQPp/hVaGcRCRMHaD1Jzn8uKszq7PGUBZWBBBPYd+en1pohxH2TR+Uill3A525yc/wBfpThGkskx2LJMFBPOM+pH6VCI9ssbKSSpGCvBI6YGaPuzqrPhiflJG0j0z2zTEkNjnW3nYx3JRm5UL8zE989sVGJljkjGA6BskdQox61M6zYw8aNIOARjzAM9sdveo5IA0hd1ZFA3M8a7jjtntRqx3sWLTVIssr3Oxjnhvuj3zV1tahhQmB1klB5DfvF+o7ViwWD3UjCRvJJBYb3EZc+o4O76VBcaCQu6VjkPtGFxgf73SjlfQG7uxtx6oruFdps7ei4YD3xVmWdp/wDURFV24MkxAIA9B61zcltDC4AgmkYDhonG4fXFQLdFDHHJBJHI3QOpO/np7VaVjWmluzf27iBwXZgQCeB/k1JJt8u78x1EbkRsD1bjOffGKr2cpeN3UeWyjAAwApJ70y5zHGh2pIApco3RjyD+QqkVKN2ZNm006y28MjNxliDjj39qqWt/5l1J5OUIJTLDBU9zWjp8inKsqLb8D5V4B/rXJ+LtNu9Gvv7VsQ0lhNzKoPKf7WPSpS0uaT01Z1odZSHT5n7KRhs92/8A11P/AMe7LnbvVsbVwWrlNG1VZoiUZQGHJJyTW1byxyRYUluxwOnsDUM55QSZda4d3DqSGCkAdvy/pQ9wyspnjUOjZVVPGe/rUaF94ZtqsFAJPUD+tVLmQecNpYoDwoIyx9/alzMcZcpaVovMdolCKecL2qa4uPLLBmTM2BgnJAHSqdw8lpy4/euMKEYdO+P5U2yiTY0lxGzoCHZicAnso9f/ANdHM2OdVtEtxal4t7xKUOcHvnrj8K8q8b+F5Li6a702HnH7xOhb3HvXrZS4lUWsP7yaQM5CjhF75+mKxrsrE6HBaNRhnC9ferg3F3RyVYqaseBwOYnKsOAccjpWjGRwQD7EVs+ONBFnfpcwACK5+bYvY9/wrPsdLvnXMVtKVAz07V2Jc6ujz0+R2kb+gXcKsEleSPPAfrxXSiWSE7C5UY+VwM5FcFBMY8qAR2aNuoNaltqNw6xxNJ8ucCuacNTpjOx7F8MLVr3VHvpc+XaD5M8guf8A61aHxN0yPVtNlAfa8UgZWH6isrwjqIsNMhtoWAC8luAWJ9a09dvkfTHG7lzitqEUpJMzqpuLkebJ4XshkO0rZ960LLSrOyOYIV34+8eTV0nmm55r340oR2R8+6k3uxxJoRTJIqblXccbmOAPrUeaCa1INQ6Q3e/0/wD7/wD/ANaqV7b/AGaQRmaGXIzuifcB7fWtzR/JWzswttbSmcyq8kihiJACUX9PxrP8QbhLaPJAlu7wAtCq7dhye3v15qU3ewySDTE2Is6+Y2OWxjA6ZFPFmYVMfkCQKSAwzjH4GtNI0ni+VWiIxvYMCSc8CnxwNDMxCybHYdMbc44r5Wx9VoZn2aN5fLWDywSGJwAG+lTJagSJumLsAfunaOfUf1rTmaVoGjtstIMEEjAPPv8A0qrJGElMkJ8o9fmUDOByPegdiJrdQyhYmfcw+WM8KD+OKGtIApZyu4k7mUZGRxjHUYq4JUgs45H272PCYxu+nao5jHNGzyrslHyrC5wNv971zQJmbcWxubeUZjRI25bpn0APX86xL+wlVTLtJh/UCuzu0XdIGZGfbt4GM8frVG/iUpb7kItSCuSPmH41SdiZRTR5xq+kwuS0TZZuF4/rXK3tq0I+XkHnGK9PvrYKWCNKkLkruAHX/CsPUdNLq25UynH1GOtUmYuNtEcHFNJbMjI7RuCS2K1rDVxuxKPmz1J602+s8s21OT0I7ispoNhyfUUNJ7ii2jtkvhHHztIOG5NatveQrFHFGPkdi23liPXrxXnMd88DbMl1I6E9K17DUkkARTyByDwaycDeNXueiQ6gLeFYhKRzt+QDcfbPpV+0u7VkaOIkN/EvALepz3rhYrlLto28zy2Q84PStGJiTFMjseQWwcEe4pM9Ck4SR1FxGiwxrHI2WP3Y+AMGq98qlRITIvGQoGCMdQfrTftCtIo+ZVIOMY5NRX26MM4H7wD7xIOFxUyjYU7IrG5JVhx5UhOMjI9afblfNiLxs6MS3yrjj60TlWClWcKUyrbgPmHtTbaWQwAP0zlcHtx7VJnc1o5IyBuA2DK7Bnj3HvVy2ufOkEe4lCuOfwwKwo58zOUGG3dm7delSTSbX3u4DEc57HrxTT1Hc6N7cPvJQjDbi28kJn2oRRb7lnIwpAGeQ3vis/TrkyRZYo+5iTzjIx3+taSXEU0UUcciZPt9w9yKvcVyWKBGlMhgRQWKks20gkeneporRbZlkj2qEbOfMx+OKekBDsUDlwA5B4xjuPTisjVrmW6maztVcxDl2IGSfT6U7cqNqdNTZYu9Y0oxvbpPdkgYzuDRhj3AxWdc3dpsf7NBIT03yN149B/Wpjb3MfyC0jI2ggNGuee+aS/iCWSRiOCKXq2G5x6fWqV2bKnGKsjA8ycOBFL5Sj+I8mr9ndRR3A80faGAwh9G9RVCcMkfz8gDOAKr6OBNfSSKJGEeOg/Ks07OzLnFNXRtptMqzu5Yjh89WOepAqzqFwkkSrI2HmAPkxHcyovb2BPNNSRhJII8xxyqFY4y2fr+FE5heFdjeUCoVmJxwB04/lV37EQSb1K32lmkjjVAkYXIGOFA9+9X7W4R7cx3SqquSq//AFvaqltH9qlMUMgKRD947EAAe1XbwJeTq6IBFENkeOCwHpST6lzkouzOC8U6HJo0zX+mKTaE7pIgPue49vbtUel+JGkiBWVUYe/avQdTEiMkTICiRDr3PevJPGWgz6LcyXunr/oZbMkaj/V+49jTcVI463u+9HY7iO8Wdd0e4g+nIz61LHzIMEGX+I5wq/j61wGh+IA0Sxux54GPT+lddHds8LbWAXhuO1YtNbmSmpG/b2omuIWlcG3TrheX9j7e9bOoXNvYJH5KlnGZFBH3nPAP0HpWBZXW0RqhZm/9BGKfpwa81JZ5ctDG+MnoT2FaU1fQrlT3NKVRpmm/vWL6ndnMxYbSoz90H+dQ2caR6ZLeXgcGZ/KtsHAf+8cdx2q9qOzUtXLTybEJVWZ852Dk8n19faq/iXV4zPJf2UPl2Nqogsk4Kg45Pvjr9atxsYPTQ57VrW3gvlj2qyIPlJGQpwM4z2yaQDb049Kz4rmTUZ97bueM+oHU1og5X3r18uqqzh8zxcwp+97RbGJrXh+01JvMH7m5/wCeijr9RXMX2i6lbRKiwebsORJHzn8OtegkdxTa66uFp1NXuctPEzp6LY4rTNQ1G3KRzW04I6fIea663ubm6RJLoGNV+6h6/jU+aaV9azpYKFOXNe5pVxk6keXYczAGmlqQ9qYenFdhx2HE4pM5X3pDzSxFBInmhjHkbgpwcexpgaMlsF0e1mhhkkkkkYvIuSEI4C4Hr1zTdeRY54JRG8Uk8QkeJmLFDkjvzyBnmrukI6W5ktbbVyHY/PbyAKRnjt1rP1u2mSXzja30KMMM918xLfX8qSeoHXKzGJmlQbs8DbwBnsP8akiEvly70d0YkqFccn2pHac7GTc6p8jMZOuB/EO/4UkdxFdIzBnWbptIwSRycetfKH1NiOJ5FsFTOB2VsZx7fjmnmQyHa75wA4Ugso+nvUD3CzRljujXbliRkBvXB7H0/Wq9u8jypLLsjSNf4XIVmxwcdAaB6lt0ijjSRmLZBZCew7gD0pt3dQyYaRIwAwAeMd+316dKrzXEcW92kVo920rFjn8PT3FQx3CFB5bKq8gRuMnHtzxQwSNC4uLWeBFXZu4YEEqW9ifUc02QwzWzB4nZABs2OcYzjFZJuYZJI51XcdwVkPBcn+YqxPPJHdOI4jGR8vkk4XHse5+tArDUSJWKwEZZWHmEZI9itU5kQWk0SvHMEADfJnaT1GR0FOurmWWUi6YhTnvhl7jkDGKgBNtcyKBGplyq7WA3Drww/rxQDSepz19aRsWYDeD0L4G3jpXM3lmFI+Xk8Yrt754Tahpd7THj5QCoHoMfyrnL6QOoJDr1Pyr0GaaZlKNjkJrYoGJHOcE+lVGRlY7chs8HpXS3MIKlztYDptPP4j/Csu4iXaHJ4PQkcVakQVrbUJYX5O71B61rafraKcA4ZTkK3QVgyxBBlSNvsarsOevBpuKY1NxPRxrgmjgUtvfdkY6AVfa9+0K+Sf4QcHJb/CvLYrmWBl8tsEdM9K2rTxGYYXSSM7j/AHehrOUGbKu3oz0CaUpZj7w+X5W4BJFFhcR/ZAkyKzo52lnIGPTArktM1pNQleLcdgQFVY981py3BKbUCjecZ9/b3rPla3NI1E3c0DcDfIqjaBkrtGMVL5yCBVkZmKn5euB6jFUQoju4ix3Ky4JA/Wp4yoh3BweerLnHOKmxSlcls9RMUjI/EeMDpj8q07O+Ak2I4AIzuLAHOeKyfsyODgqij5GJXJ9eKit4ZvMWNGYhWLDcvbsatWJc2tDuobguVYzFVK/eCnJ9jnFTzNZHekkl2rcExwxgBvQk89q5/THmJCSK7ZGcrHk9OxrSubu7QRF1lOUCFz0yB19vpVSvbQ7sPK/xEjGBVZoLa7G0fM0koGT+VZV1M0Uu6Q5yQD3HNW7uK9ukQht7Ou7cB8pGfp1rNbTbl1ZnWYsjcIPl3Y9zxUpSOqU4paFC/vmaSfsDyB7Z6VU0C48u8kU52Se+PxqbUmfTNPlubzSZmweN75A/AdabCbfVoEurOeOF1XcAq5DYHPHY+1Np2ucvPeVjpFmiMQmcvz8vUAZ7H2p+5JcMBsJ5K4Ln6/nWSssckEe3MhK4YMOn+6KetwUVDHuyvAX+76iobszHmcXobVoUQtGwhi3cbiOn1/8Ar1oQXIeHMQb5SNzEY/L61zIaVm5mxEORtPOa04Loy7GZ34+4qn7mOuaOYpyctzaeNpWd3A2SZ2n0APv61m6nZrJA5kRX3qQc8jB9RVm4v977pXABHyIBxx2AqrLcpJAuThTyyj9OarYprlR59c+EtNXzo4VaCV2LRyqxIU56Y6Y9qxjPf6LM1vqG7yz9yUAlWHsa9EuAkhI2FwRwFXhQPWsbUYRe2FxZypuLoQm44yexz6iuujKFdezno1szya8Z0H7SGq6oZpOqxTWqOhCpjkDk10WnyqlioCAEszheyk+teNW9xdaPfNY329TGwJGeCex+lda2uagRCluFaEHkZxn8axdNwdmdNOvGSTO2+1TXEvmXTDyGO30JA7D27VX8Q3P2uNYljVnY7Io04WNR7dvrWUJ9W1OOMu0Nrbgn96wAJH4elShF2BYGLI3yNMeC/rjND0Q5ybXKkPhJitcoR5cYESsP4u7H8TUySbmIzkHpVe+nto4VtrfnC/O2e/oPoOKSzDMFbBwBx9K3wtTlqqRx4qCdJwLeeaQmg9c0V9CeAIaDQe1JQDYhpuaVutNoC4hIApueKGPHFN7UCubdrtvtNgtYrp7aSBmLrsZlfJ4b5e/bmn3moQG3u4/tMkxFulsAykGVw2d5z0x055ptm1zLo8EWl3SQyo7mdPNEbMSeDk9RjiqmvyiS4tw0qT3KRBZ5EOQz5PfucYGanqM6d5WWEFMmCEFgrDqDwPm7/jSGWKWBZ9mx0OCrIcZ7c/lWSlyEhPmmSCUuMgruDe+ent0piyTOsriQFAjHCnbtGcdO/wDSvl7H1Fy8L+O4QuBL5ZGNm5j+h/xpi3apK6ES26AFiuQS69vb8KzvtUhT/Wys6gbuV4HYAdqsTXNvIkccod0OT85Cg/TGc/TipGu4peN7eRmlUK7cIy8Bf7xP4dKZJLbFUjRj8i55BKnPYZ6j2qqsmZoVRYmIJyC20kY/Wlu38mE7SG9CAAB+R60dBskcoLiNcNbkcg4wrjtg+tEk0hcwBjKHXOGb5h6YPrWfK8cdvhmEh65AOM+mP60PPO9q8hKFwRwzYwR0GOtMkvy3INl5RIeP+Iu+SpH0rPu7iHYcR5kccSE9x6EjkUS3YuY3MsAV/wCEqMgfpxVeWXzpFWZxtGTjbtBz+HFFxMYHIlaRoEEe0EquSvTueo/lWVdKXlDhtiKNzfMR7cdauOPKLKm7a3o3I/KqVxG7fNOSB1OAfyIpEyKV6wkkCYB7khRn86o3MO2MfKwQdsitKco7ja6rGxOABwR/u9RVORZATjhR0+n40yLGNcouzvuHUY4qhJEGBNbM0CeYQSzP7DFVZ7YpycKP7pOTWkZEtGPIOQMflUbBiCSa0XhPoeeKpyRFCcZ6d+a0TJaIElZG3ozKy/dINbmi64EnUajl0zjze61z7cMc9KWPDKQSTjnmnKKluJSaZ6mt1HJZL5ZDovzIQeKmglRYmT7u5gcZ6j0ry7TtVudPJ+zudp6o3KmtI+JZnjTfCu5GHIPXFYOjLobxrLqekRSfLcNldrEEEjOPpU0cwW9jZiW2ny+DwRjOK5S21iKWyEkRyO4zyD6EVvW1yht0IAeTgnPr7fnWaTT1NVJM2768MQV4WkWInoDhvz6CrOleJ7q3idUYKM53vhjWLb3KtvSVHZd2RuHBB961tOa2tizxWym5ByjSLwOOmOlVd30Z2U5U5KzR12jajqF3AJdVnS3sA4LPNGGIHYrGOv1pdQ1/T7kqkEbSxrw1zI3zufw4A9q44XGoTEyXkpSD+JnGc47D1resfD5a1F3qzHTdK+8AWxLN6YX0PrQpM2cIRabL0tgmoWARgs1tJlWYDGM9Mj1xXlvirw3c+D521DTWMumu37yLOSnoa9VtL4fZ7W309wIo/mfHGwdFQ+55J5qxew22qabKksRkgdjGoOCDjtVqSIqxclfqeTW2sLfRieIx5YAHaAO3t0NXbe4ZplYks31rlPFei3Hhe+86yy1hI3Ab+Ensf6VJpGrxzogY7ZO496znDqtji9q+a0tzsllAkVX+YZ6g4x+PerdtIVIdzjDcL/8AWrDiuMlAvHGc5q3HINv744yMnHNYmyl1L8jmdxIz7SOEx3NTpIjuNqhYl+SR9/AbH86zIZWWILEo64Rm6D3HpVq1U7I5mjMjp8kEQ6u394+1arUiU2zXKGGFURSJJSVjgUfMqY6n0J689qry2gmuHiHPlqTNjBVDz0P4VaWeK2tZnaTzdTlB8x2JAT1VRWdu/wCJcts8kkW8q+0DhyersfTHAH1p2V9BSfKjmPFnh2PWbcPCQt7EvyP/AHx12mvPY7690+ZreRpY5IztZW6jHava57OS3traebAFyGKf7QBxn9DXLeLNAi1S2eWJdt7GMo6j73sa9ZUvb0lNbnjTqewrOL2exh6b4jZokSRUcg5x93J962/7RmuXEsk0UeQQET+Ee9eX5dJCsowykjnggitbTJVZgG3gDnrXDOB2Kozt7dPtVysVqCQzgbz/ABGt4gy3a2lmDJ5Y4I746muWg1NYoPLQhVAOfT/9deofDzSzb6edRu1AluV2xIw5VO5/Goho15DezXVnN89DSVPqC+XfTquMBz0qvmvpk7q54DVnYDjFNPQU40w80yWIaaadmkNAiNuKI0eaVY4xudyFUZ6mlbH41GetAGlJ4e1U7QLXgHnLr/jS67bvarp8MsYSVbb5wMdd7elVUsL2SMPHa3LIeQwQkGqjhlYq4ZWHUHgikBry3z/ZsSeU8WB945x9B1/Ks4KEdJnWPlSQdzfMD9e/tTkjAjiSZCsjP83QDHY55/UUyRpkiKq7vGhIbIGz8OlfLH01y7I0RhXZKyqxJxKp+X9f1pW+zxw/LOJLgMMHt74qpJJMjgyYd9oKsBkZ9DxSK5d4i/2eYkHKg4P44qWik9LkyvGmSqefJL8qq0YH5HP9KYriVGDfIo+8cA55xz9KilVJPkiChiMcAj8wR1p8eGjczXI3Y2hWB5H1/ChDuKjzSNGsZBQkbUWPALe5xnGKfdNAt2zyHGOPLbkr64PXigQxtueRfL+XKlc5HHHGf1pI4E2kywkBhnfJ82T259aon0IpY4Wnd/KljOBtffnI69On/wCuo7qJ3fhWQY2j5fvD+VWmBiiVTmGcEfdHBHr9alZJWEflozAE8qwHA9fQ0h2MT7NJI4BUqdoz8oANQ7J42bf8ikfK/Ix+Fa9ykAEkgL+ZuHyyHPHuCOaiVdqbuCpBAycc+ppXFymQLcMyyeU0kg+ZsgAZ+tVpIH2/MGVQTtXqM1viJQFjYBFPLIX6f7QquqxqfMDMcNuyVxk9+aVwcTAKqMhEO7PKnjFVZIWyu/aAOMben1Fb9wjTTiUqqsW4XoKq3kRVGZztIIAUEHApkWuc3LbbWZhyO5BxVGaBj/DxW1dYLMSGJzwBxVCYELxleeQTVxkyWjHkhAGAO/T1qCSMbScHPTJrSlUZyDxnPSqU6gEk8DPrWyZDRS6ngVHxknpUr5A49ahbrWiMmPSRkyUcrnjA4rpNF8QCOBILk7Sg2q+OCPeuVLUgJ7dKJQUlZjjNx2PWtGukkgBRlaNwRkcg10+l3TtKqyMHQY2g9QOeBXkvhTVRbSC0uGxE5yjE/cb/AANeh2M5QEuzBxyAAeR/k1yTg4ux3UqnMdJNqNxZ3SFTAZV+75qeYV57DoKLmSS+uFudTv5J5WGB3KegOeB+FZZIcxyoygY45zkVYjSa5UC2ZF2n5ty4JHtWbTbPbp8vKmdLpMaxRGRNrMSQzMePqfpWjHcRJG0KAkDLEng7vTHrWJJOlrEIUwZMAhQwyPr/AIVL5N1CuZWEZH7xdx7euOvfp3pt22OKpNOTE8SaVBqtrcwEKYmRR9M9K8G1axn0jVZ7SRiHicgN03Dsa+iNNtpDbm+mJjtWYmMuuC57nH8q5LxNotrrf2hVQllXKuVyVPrn+lOE2nrsc1an7RXjujzfSNWbzVSbqRwfU109rcrsUtkkdgM159JG8MzJJkSRsVP1Fa+maj5cZWVvmHQ56irqU+qOanVa0Z2sV6I3L3Ue9m4SMcD06VsadczwOZHK/anXYqqceUO4z0rhtNvFu7sNN+8UdAD0PrWvd3zJGFjQAkffJO5vYCs7M1U1udOzxLCRNIki5O5kPLN2UVRvryUyM7P5ly4C46iLPAH1/lXNnUZ4F+dXQ9v/AK1S2V3IZFbHzk/IgOdpPc+9UkROdzrtWvftFzHHGFMUCLGAGzjH/wBcmoG7Ed6zIblYoY4IyC2cvg5/X2/rV+3bdESRnB4+lepl1X3nBnn5jTulU6nG+MfDxYvf2ScnmVAOvuK46JnifAr2ZhkYrmdb8LwXjtLasIZSckfwk/0rfEYVt80Dnw+K5fdmVfAtgt1qMVxeASRxHIQngn3r2GTVFitHdnB49f5V4lZW+r6NcbFiLITwy/MDXVWJu5E33jMP7q1xQoTlLlsdrxFOEeZO7L00hkkdyeWJNMHPekPNJnFe4lZWR4176sdkgHPSkJ4yP1pCcnNNJ4pksVjQTxTaQmgLATUlpIkV3DJKu+NHVmX1ANRZoUqHUyKWTPKg4yPrQI3LwS3NxJPFrsPlsxK75WQqM8Dbjt7Vn67cx3E0ASb7Q8UQjkn248xsnn8Bxn2q1dtosJQw2k80cihgRc4KnuCMcEVlXjWzyg2kLwpjBV33kn1zUIdi9JbsrlERY9iAcAgvk/qfaopFxEQoZFP8JQ8euOf1qUMEbdbtiXrlmwR+B5p9v5ZR5HZvMHAJx+XrXzFz6ewm5Gf7r427QEkOd2OmcUkkHnb4lEeEwVfOMfpk+hNTJHKgaZ5G8uU4zu3AH3GOPrTkuE3uX2bRjdtUBiP5UrhyoIoIwZFlK70GWbOOnp6/jUf2WJdzyxyMmQwKMBn14qGKWBv9c8mAeGPb8qtQ6hJDNK9tJCy4ICMoOcj0pXKtYiVZmgD7YpEVtvD/AD/Q8YPFP8y3Clp3mUE7cOSD16AjjFQR38zSN+78mQtgkJwfz6GnPqjGMQs0jAcoNoyPb0xRdhZCzQhrhgjKQCDlSdwHpnjj8Kr3OdnEok9QGzv9x9PeoF1OWESRxylFZdpGAeO9U2uQJFJ3YTkAd/8ACpuPQvpdRurm7AZgMIVXOfxyKrxTkROQ5RcYJDHr9KqtOD8xAkyOvQiqvnLEjA53ZyOc0Ni0NK4uGI3yOsshGCeeR6VWeWLLMFPPQckCqMt4F+6wJYcmqclw+RknHtQrickWhMkYcEKSepNU7qQLjD4XGQDUEkw+Ygkn6VWmld8qRleoHpVJMybB5dykHGOue9Z87BjnOPx61bW3mkxsQn8KkXRrqQZK7AfWrVkHLIxJpMjBqnOxboM5rpX0UqPnJ3A8ntVSfTCuOOPUVopIlwZy8pbJ+XFQ4Ynk1u3FrtDZFZ8sBBzWqkjKUGilt9qcBzUjJjtTQM1RFhVrqtA8QtEUhu2AwNqSnqPrXLEcCnDHXnNKUVJWZUZOOx7BY6n+5ZN0jADjBGDmtS3mleMbSIsfeDMcn65ryPR9WktHCszGE8DP8PuK6yPULlFXEzMr8qRyDXJKDizsp1m1oehRapHp6EQOzSlvlwoznuQP6nNEKySSfarpjvB3BW557Ejv9K5TRrmd5RiPdK5xgZP411FnEVZZbySOM5wIwdz4/DgGjlNIzTNwX8986RZmuVXgoBwv5dPpU8CRxygsE4YFt4447VjzeKpNOhmsdHgS0hj4l8w7ST9DyT61DpupS3wJcM7ZwqgY3Z7+w56daEkXGrFaHlPjO3MPiK9YRlI5ZC6ehBrIT5V5weOhr1jxZpEV6HiZe/yvjofWvML6ymsrloZlww6H1rSMr6HFUg4u/QhjklhIdGIx+lbdhe3kqNiaHc33mYjdj0BrNtkDfKR161JJbvbAyR/NH16fdptExd9zetrMZD3E6AD0OasdADbR7F6b24OK5yLU9vLAFfQVYF60+BGpIJxyaz5WyrpG7aSFplt7cCQs3UDr/gK6Cz+VirZ6D8656wm/s+JgpVpWAG8fw16F4X0jzfD1xd3Yw86gx5HQDoa2oNwmnHoRVjzU2n1MkgdRUbdakbqfamGvozwRmOvrTSO9PamnpQMYabgdacc9qSgBp6UmM0p64pGoBidDS8etNPYmhuTkdDQSJwT3qS1iSa7gikfYjuqs3oCaiPSpLWE3NzDApAaVwgJ7ZNJgat3ItrcPAmhx7VYqPNV2Zh65z+PFUtdto7ee3aOJoDLEJHgY5MZyRjnnHGefWtbe8gktNK1O/wDtEGQIpWwJcddmOh9jWLqkIjFnKXkeSeHzZDIcnduI/pUrcorq4IdgwUMOmc5+nvR56eXJ8zbsAnPrntWN9tWMZQjJ6g/0qrJfM8x5iIAwMgfzFfL2PpOdHQi8LEsHHr8y5py3mZGaORVIIzls5/MVyUl1hzhhxzjPFKNQAYF8k+5/rSsL2h1DzpljGV65bkEj3xVa4u0aXHmORx945NYEt/kAeZz1Py8f/Xqq98AcZ57c0coOZ0E186SkK+cc8GoEvBuXfkp/stzWJ9oLNkJI30SpVhvXAMdvKQe+O1OwrtmpJeg84O3se4quLvBKtk+9PtNB1W4kVPJ25HB5Oa39N8C3k8xSRmU459jSaRcac5bHOLOCeCWxzimNOzsOAB6E16Pa/D6KNX8zfIw6g1u2PhCxjjVjApB4BAqb22OhYV9WePx21zI2YoZH+iHAq9ZeHdTvM7YHx/tV7na6PDC3lC3UoOenatBbCPA2QonrjjNVqP2EFueK2vgO7dw1w4U/3VHNdBZ+A7WP/XHkDv3/APr16dLZbIR+6GMnDA5JPpTZLaNfvKNx/wBnnt/jTHaK2RwK+G7WFgqxnA78VXu9IVUOYxxnGVxXdzWxQFWBCOMruXrisrUohvZc5fB99x9KCtDzi909RC4JyAemOlc9fWewYVSYzyD616BLbZ3kLgkdwR+lc7dQAu4bjtkjnihaGc4X2OBvYCSwxjj061jTx7Scjmu2vLUAtkdM1zl7bkvlu/erjI55ROdmTH41VKgda2LiE54FU5YQeorZSOeUSnTh1p7x4JqLkZrRMyehIjc9K2NH1F7UlGG+E9BnlfpWKmAanifpUyV9youx2dtqE8ZSe0kLgMG55GR7U+K6uJn3sWLg5HzHr7VzdlcyW7bkOVPVT0NdHY6mGG+NSGAwQowa55RcdDdO5tWljNNcifUJQEZtzb2PPrljya6nTOSu2PyYIyfLKscnjrnj8642LVFVld1Bcc7pX3fp0q3Hq73b/JHLc9yAuFx71F+xpGyOyJWRVLD+LOex/wDrCsDWdIj1S3dwuGZzsIH3au6c8k8gm1GTy0VcrDGcKF9SfSrxkSOI5YZYbuOg7j8aUrrVGytPc8tFtJa3TQSKVdDg5q8iqVwR1rf8RWS3MAvIlxKn38dx61iQD5a2i7nLOHI7GNqenfZSssWTE3Y/w1HbXCQYEY3N7nNdWFWRNjgFDwQe9RXHhO2ucTW07xN1AxkA1tToyq/CY1KsafxCeHbUXVzFLfHbApyVz1r0i712M2wtYDkEYGPSvO7TQr+Jgr3SCMcZXOcV0NlbJbRgAlmxyxrpoYObfvKyMKmLhFNR1ZabjmmnpQTTC351655IufaoyaXPB9aYTQNMUnim7gKRu2Kj3cnkZFAXJM0wtkmkJzSZ7UCFzRn/ACaZu65o3ZoAXOaA5RwyEq6kEEdjTM4P8qnsIluL+3hckJJIqk+xNIB91c3V1P8AaypEi4JeJMcjucd/em6lfz6i8Ulyyl0TZlRjIyTk+/NbE00/26wWJrtIZQD5cB2qmSQFUDjI756nNZmuxqs8Ug2ZlUltgwGIYruA98A1N7jOFt9Lv5iVAjBHXJ71ctvDN/cBl8xFIGeuaKK+X5mfSQimXB4Mu8p/pIwQewrUs/ALyqWknYnqcNRRUqTZpGES9b+BbSNCZQWIPrWpF4R09XP+jocDJzzmiimzSyRbTQ4IgsflJt9uw7VZfTIk8uRQEjBwQBRRSQdzVsrSMTjhTGOAcfriug+ywJsKGTzChLL0DDjvRRWrGiWytC85R1wvUDdVsReVmMrliQAO2aKKhmxZWy3qASFUqdoB75q1NEYoo0mAyh+VgOQeP0oooRlKTJUtmhEaqBufcAW5BrNkHlZRcsu/+IAkE/0ooqjOMm9zP1ZHZiqAFk4IB6H2rBuwJAVIOVbqDiiikb09jKnyTs2qDncD6iue1KLcQVA79aKKlmljm9Rhycjhfc1iXVsXJ9hRRQc80ZU9sFG0DPGcmsye3xyAADRRWkDmkU5IevOapyx4yKKK3iYSImBBpyMM4ooqnsZ9S/A2QKuWzMjhkJDCiioZqjatWjmGVQBx1B5FaUM8gkjTLiLrtBHJ+nAoorme5suhrpKjjdcsVjX5ti9zjvXTeENJbxBc/aZneLSom2OUI3ucdAO31oopQSk9TWUmo6HRazoVpFYtHDGFBU4HU7frXkr25t7h4jzsOKKK2WmxnPVK5OHAkFbWnvmLHpRRXdgP4h5+M+FlotTNw680UV7B5QjNim7sMevFFFAhGbFIWoooAYxzjtSMeKKKAG800k98UUUAAYCmn1oopAIKUMVYMpIIOQR2NFFAGp/bAKsZYZN75LiKdo0c+pUevfGKzLu4e6n818KcBVVBhVUdAB6Ciikhn//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythematous, scaly plaques are visible on this patient with plaque stage mycosis fungoides.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mycosis fungoides - plaque stage",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An erythematous plaque with an annular configuration is present on the chest in this patient with plaque stage mycosis fungoides.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_30_35306=[""].join("\n");
var outline_f34_30_35306=null;
var title_f34_30_35307="Pharmacologic Rx GH excess";
var content_f34_30_35307=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F72801&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F72801&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Pharmacologic treatment of growth hormone excess",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mechanism of action",
"       </td>",
"       <td class=\"subtitle1\">",
"        Route of administration",
"       </td>",
"       <td class=\"subtitle1\">",
"        Side effects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bromocriptine",
"       </td>",
"       <td>",
"        Dopamine agonist",
"       </td>",
"       <td>",
"        Oral",
"       </td>",
"       <td>",
"        Headaches, nausea, dizziness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Octreotide",
"       </td>",
"       <td>",
"        Long-acting somatostatin analog",
"       </td>",
"       <td>",
"        <p>",
"         Multiple daily subcutaneous injections",
"        </p>",
"        <p>",
"         -- or --",
"        </p>",
"        <p>",
"         Continuous subcutaneous infusion",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Mild&nbsp;gastrointestinal complaints",
"        </p>",
"        <p>",
"         Increased risk of gallstones",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lanreotide",
"       </td>",
"       <td>",
"        Sustained-release long- acting somatostatin analog",
"       </td>",
"       <td>",
"        Intramuscular injection&nbsp;every 2 to 4 weeks",
"       </td>",
"       <td>",
"        <p>",
"         Mild&nbsp;gastrointestinal complaints",
"        </p>",
"        <p>",
"         Increased risk of gallstones",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pegvisomant",
"       </td>",
"       <td>",
"        Growth hormone&nbsp;receptor antagonist",
"       </td>",
"       <td>",
"        Daily subcutaneous injection",
"       </td>",
"       <td>",
"        <p>",
"         Injection site reactions",
"        </p>",
"        <p>",
"         Elevated liver enzymes? (one patient)",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_30_35307=[""].join("\n");
var outline_f34_30_35307=null;
var title_f34_30_35308="US imported malaria cases";
var content_f34_30_35308=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F63029&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F63029&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Number of imported malaria cases among US and foreign residents, by region of acquisition - United States, 2010*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Area or region",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        United States",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Foreign",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Total",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Number",
"       </td>",
"       <td class=\"subtitle2\">",
"        (Percent)",
"       </td>",
"       <td class=\"subtitle2\">",
"        Number",
"       </td>",
"       <td class=\"subtitle2\">",
"        (Percent)",
"       </td>",
"       <td class=\"subtitle2\">",
"        Number",
"       </td>",
"       <td class=\"subtitle2\">",
"        (Percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Africa",
"       </td>",
"       <td>",
"        724",
"       </td>",
"       <td>",
"        (64.1)",
"       </td>",
"       <td>",
"        213",
"       </td>",
"       <td>",
"        (58.0)",
"       </td>",
"       <td>",
"        937",
"       </td>",
"       <td>",
"        (62.6)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Asia",
"       </td>",
"       <td>",
"        173",
"       </td>",
"       <td>",
"        (15.3)",
"       </td>",
"       <td>",
"        108",
"       </td>",
"       <td>",
"        (29.4)",
"       </td>",
"       <td>",
"        281",
"       </td>",
"       <td>",
"        (18.8)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Central America/Caribbean",
"       </td>",
"       <td>",
"        154",
"       </td>",
"       <td>",
"        (13.6)",
"       </td>",
"       <td>",
"        41",
"       </td>",
"       <td>",
"        (11.2)",
"       </td>",
"       <td>",
"        195",
"       </td>",
"       <td>",
"        (13.0)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        South America",
"       </td>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        (2.3)",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        (1.1)",
"       </td>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        (1.9)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Oceania",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        (0.4)",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        (0.0)",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        (0.4)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Unknown",
"       </td>",
"       <td>",
"        48",
"       </td>",
"       <td>",
"        (4.3)",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        (0.3)",
"       </td>",
"       <td>",
"        49",
"       </td>",
"       <td>",
"        (3.3)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Total",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         1129",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         (100.0)",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         367",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         (100.0)",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         1496",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         (100.0)",
"        </strong>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Persons for whom United States or foreign status is not known are excluded.",
"     <br/>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Mali S, Kachur SP, Arguin PM. Malaria Surveillance - United States, 2010. MMWR Surveill Summ 2012; 61:1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_30_35308=[""].join("\n");
var outline_f34_30_35308=null;
var title_f34_30_35309="Uterine distension and PTB";
var content_f34_30_35309=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F55323&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F55323&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Uterine distension",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 311px; height: 303px; background-image: url(data:image/gif;base64,R0lGODlhNwEvAcQAAP///4CAgH9/fz8/P7+/vwAAAO/v78/Pzy8vL9/f30BAQMDAwF9fX5+fnx8fH09PT6+vr4+Pj29vbw8PD+Dg4NDQ0GBgYCAgIKCgoDAwMPDw8HBwcLCwsFBQUJCQkBAQECH5BAAAAAAALAAAAAA3AS8BAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkAALAZSVlpeYmZqbnJgLkaA1AQMCpaanqKmqq6ytpwMBobIxAQJbArGzuiy1t7m7wCe9WrjBxiXDWcXHzMlYy8zGziMGByYJCSMHBi/bNNDRwNMiDQ4mpSMDBAAFLRLWM+DhuuMAEgjrJOgi6gQFAg0AHHgwAIIIAQkQNsgmAMIABiIMMCCVQt48WeMMNBAQocQ+AOoSFCBwIAGCBAbU/7EjlUBlgYAPAuKzZ+uExYug6gGoqY+nSxERSAmg2I7fuqKlDjgoNRHFTZyQdPIc8fHnTgYEsmYrCvLoQQEE8GWFd+4X1FBSTRAYEHECtwLcCDjgJpBdOq87BRiYAI+sR7NnI6U9h2AAAoM7EUgA0KDwYbtGIaM74HiqPsCBHw2G8jSzlUmdQoseHUCB5REBowhQQLq169afcJZ+TXu06Vusa+vWzRoqpSk6p3S28ls25ib1DiyupoO5jOFVil+UDqXeWoGLPZ5GcR17vONYqIcT78SZgaEEASQIOJDiAJY7H8aFMHGdgKUE1gM4T2p+fZvgXUFeMwEq4YwEtjTA1v91fBnQEQNYGYAgAA7Fl4BSjOGTwHUM2CIARENdaE5ZXwx4jIlLOOMWANdd54AEBHCzzwSmtLNPO90xOMIEeYnA1WUlFiiOkEg4U1SLbDn4gFs3ZpVVj3blyBZXNtb0I1VEApflLCgaONVMFbYoAj4CZDdAR3XdyCICIlz3gEEEPADllQdtGUWXQwI3FWUPNOUmAoqpV9g2DwAqp5ogDdDAdQe8N4A1iP4VpG92EhGcFNBRgecumx5xqWqVPtEpl6EK8SlnpSKXqmar/nDqE5lqSamevkxqHK3EtGqgroyMWsSrTsQqha9o8crDKK4kq+yyrMBi63TG7gDabtSOFlv/F8TmFK1nMmQr2LbcwuBtVOCG68K4rJpbZLmGoKvuDO42Eu+74rJbyLz0nmsvIfjmy8u+g/TrrwoCI1LwwMIALMjBCCOjcCAMNzxCxPw+PDDFAVvsL8YLa5wvxxB7TC/IgEQ8bbUop5zytUaQ/EfEyDIr88w01yyzs+vO2gOweAi7g8t+wLzdHz7rAHQfQhtSdA5H85F0IUvj0PQeTxMS9Q1T61G1AXRp03U+LoAthTdsrXC1DVnnUfWTJKjkI4tlrxC3FO9ApsLZoojstL3JsH3XCDbiR+EAD1izHgEeqrfRmSK0h5g+8p3HjeQE0PcoiwQx4J/b6FmzEGQOFU5i/8637syT35G93Vh+EDxgQAJzETDBA7bg6ECMDmBzUkpiT1hhUCB1NFQ1PJYEQAQgDiDi8XIeYNBPrb8+l6SkQ+tD32J3BTjcIvRZyu3dRVm2OkGVQtGONYrAAAIQQamOkoXNmWED8Pzk/X3Z401D2nisnb3b4uNHBJxkgPDhaHyIw4pWSDASJ4kAAiP5ilEQEIECsgVRBJDAUrTXjjMRkHqe0hvV+FaTA4ylJw9cEJt2Iqf9bChuBzSKXOjiF8bVBXZyYYgt9sIObihIft6o0E8E0MLXgbBlItQaCRsHIb9IpDCXS1RA7mGYF26vOyppjGEet59CIcB1j2nMeRywRf/GkLEpaoKAY6xhFSqe5Ii/SqLalsiPuVXhI0PQH7zk2D86MiY1V8CjEPTYLT7eoUsnI81toJZE/h2yQLNxzSKt1khD2qFL3uKZEpyTBELSwpJ1wGSpNJkE5UDJCJ6sl85QkMmh1UAiA5BAATO3OWvEST4HeUhJAvIeARyAJ3oBQipf4MhLQnKUrqQBAgICgQMYD3nxIZ5AsgFNCUDEeRyK0EzCEoRh6muVCetWMmVAGRLA74I1eV8ECsWWFbUJneSACAMA6QNvtqCYoTymOHkQPgBQ0ILuC0sFr/Oj63yELzzqZiXBaYJW8mAv2XgdXBgDTx5O9IeKapxBs7OTDSr/NAn4pIMo98kDNb5nPWe8IBnDmFKBOAoC1zHJ5UTStR/Y818MdRhJUTlOFjSgfR+t3jxGSoue8kCQMshdHhdaOlYiU2lMtV4KHMpIkIJSpPosKlStmlMSUJWSXG1qOLVaVaGOJ6viEorN1srWti4LZyHs6sRKlUiV2fWupGFZHOUqgpDS46pzIKrEPslXAPiVVIU9LEYAKwfBDpaYjI2DYx97z8jCYbKUXYFiL4vWzOJUrA21rLYSK9pvkdaz3wStTlH7Wak6lbWtHWpnYTtW19aWtrc9K8FKS67T4va1qvUqb9MV3Ln+Fri2De1xcxsNzC53s29w7nGh6wbp/pa6/22wLm6xywbt0pa7a/AubMGrBvGylrxnuEAB1luAD5hAvex173IBAN/1ypcZFmBvATpggvyyl7/z9e96AcwMDOjXAyYwMHsRPF8Fr5fBzKCAfitgAgmzl8LztfB6MRyNDKz3AijwcAFAPF8RiJjE4djAei2AAhUXgMUlBoCLYRwODqwXAyiwcQFwHGMd83ge66VACoIcYx8VQMgXUUAGVKDkIougybLZAMGk7OQAUPkiFeCACrLsZABwuctgDrOYx0xmpuH1zJy4Q13RzGY26zUJ/3CrnG1GJ8mqdc54zjPN4LqEOn/Bz9E1ah5uCgNAd8HQ2RV0z0CJ6C00OryKvv8DoV/w6CxUOg2krMOkXXDpK3T6DJmmw6Zb8OkqlLoMoZ7DqFngZ2dqwy9BwMYJ6maCU5PhVE7KDwwaQE8d0DqoTPDzAFa0FzviAICo6XXqSmDrMZwqzmA5x9CQeuzs1ZPRKHhIgiZyHqpwbSjBrNxEnPeQiEzEFrDrEGMOMMAnKeh8yN7eJXt6paFoLlEIueW98bieodDvAQ/IRnzuLe5HOaR9pAB4XAjAa31vLh+hgzUc4ZxtufjzOttkk7o/ZKEDTAAmMlkHggxAwXUMAD/oiBEAYqK9Wh+S3g70HVsgFKNngmgqcsGdXqppiwqFyOMgB4kt1rmTCUiAftRM3vL/oge7mk4cCcJGHCmu81MAzBMACcW6/PKiFKawxW2cQ/dQNhjvt82b1abAevr2cc5Tck97DFq7lSTotipFZJ3xU9P9blcRbJ/gfbErG0LNbhdElSIsTmJjPsIOO4Ogo+x2Eym9GZhrKP3ToDhHIPca+CTD26Lulh8oPO3iwaw4HUhNiPoIunOfmrwJc1svxV76AhLEhJ2bVv+8tSOfBA0guWWTTweaIJWdi47+nZG5jg0hNfceqaR1c/Lh6G1URIEDyAmqR756JurS9zDf7JOpDIXiF3arF4Z2LWd2EyZRpOBHxItykukByvGQ479dJdcxAPxj/3koft+M9bd1bmR9/6MTbDFQdVLQbDjAfp4SaXawaivwaUqVgCkSABaQG79nKg6oaX5HBgpYAwuwAB5gASGoAb+ygaLWgWPwgTbAgMC3VanXHBK3At5gAyw4AwqgZBeQgxymgTswN5zUA7IGA7vXd9h3A0VhSizgNr9GAzfoBaQEaD+ihDqwD7xGaukAAxCoAoiWABMhOoPzJv4AEOvRbQehEb2kHg6gbp8TJw+QDw1RbhH4ciYQOhAAU20CU/8QEArCAAJXFBEAAfpRcPngOCXgcLnEAI3CEmORGgnQERLwHnCyhztBDg+RDf1mQ3VyhCpwIQJhDmr0OgsxEibEFg5gDRiicjFBcgPUFf+wgw1K9RIrp2zqd3YkEIrrUSG1JxIk0QCuY3F2cQ8A9XPmYBIogWw2Zw/XRB8RUgoJkFDQZBAGkDu8aA3t4IsFZA45N43Wt4VD5lMT0Q6vJ2/XAU1XlxAnp3tGEQE1wRGSMU5PiC2WMY4iQI0jUhRvyA/WKEbcoyblA27mhHft1DX7gA4sp1QZNGx4YRf5CBKluGzeiAKIZk1bkX6QkX9zMReN53yLhzjtWDsSxIV02DZigzwSgCZFAXZHsYbIpyYf4iQEeHlTgkI9shaNMn6KZzcd1JFYBDYReQKIVhDbdxWN00NvNxEQgXvqJpRdUU4O+Y5zaItU0T7WMI3TY5T/EbAc97hySTl9LHKVfmF8IJEav5Qd+0BGAVEm+zET3NcOWbkf2qh5mxiDKqAUsdQOT0QRAqAY3XEABSBw60M4PUd+9gEozUdtDDSS1BCYNcEAHLWXsrQ+j2EXJIcVXpkhZYQaLbWIBSF/+xABI0JyhDMTkEmZkgkncrkTKigG8cgFpzKBD7iaYdCaW/ApCChpsgkGtKkFqSYHP+lyZbCbWdCbcfCbteiBijkIxpmYwZmcgrCcgKNnqNBL0pk+l3Rn1Wkz1JmdrsBnu8JmOZgJ4YkyatZmnDCemoCe5qkJbxZex4FeFbNbydVXw3UI5lUszIVa9zlaynVds3Ui71mf/+3yn9IQoNNFoMEwIPCZMfIpW8KQG+sZoRI6oZjQG1MloKB2HGtGodRiARfAoSB6Ce1pXA7aBgugAAxaomxwoimqWyaKoh0zn2jAojGqomtAoyEjo2eAoyWDoWawoDLAoy/jo6hGpEEKozlqo2ogpEFjpM7mpDDApEgDpWEApDEgpXujo2aApSOkpWXApUrkpWQApnMkpmNApn1kpmKApo+kpmHApsbkpmAAp/kkp19Ap1hlp16Ap4FFpWBgpVGKpD2qp12ApxUQghnoA4LaAhtAYRVggnlDqFwApr5HAgpgAQGQAT/WAnT6aQrwCY2KNn76LDe6qCXgggDwqQCgAf/tgAEV4AELoAGzYYIV0AG9EQAfugAUcIEdgGEYcKm50A67qgC9CgAUgAGlwWAL0AEdcAGfgAFCFgAccKkiMK0KoGUN6qIraqokgKqqSgHupQC5iqmGxWIf8KgIhgEZoKsU4KggxgEd4HtFIazuKgnOqgEXQAEUkAEUoAHrmqqfsGMA0AGuegG+t6n5maCjygJYSgkXSAlCBqwXgGOqCgD35V4XsAGxKglIigEX2A4dgK3zKgIeqwDtQKOf6gFUpqqqWhQQ+wGwGlsE4gZYGoIjWIKpCquQWrFUsqoe0AEfoAE0ugEWIGTtwLNvQ7RGy7FPBhpNC7CQ8RsUkKncKlz/kroFYOqtLFOxISsJ/BUb67oAS5aqWiZhMhYLrPo212qsJwujnzqtJvYJLUuf+rqqiAaoVbqwK5C1ZlGxT+tlOagAFNYBGZABK6sABasAKraqObi4dlEBO7i4KAuqGWAB/zq3hhUA+6pkCNuf2lqqTwCpFIBiTIC3f6q3KsCnPgC5StaDFXi1WqC6koW6tUm7KCC7nAW7WYC70WW7w+m7JsC71QW8AkK83Vq1XaqkaSC82WW80eG8IsC83QW9svKiLXoM9bVeatAB+lUArpsH2XtfwSBgBYC8YeAB+iW+e0C+BBYMOvZgaqBhL/YHDlYAEBYMrHpha1BfnZsH8vu9/7sgYup7BgKWqHtwYuMxYGygYKTbBzMWDgtwY2yQv1fmBz4GZEfWBh6GrX+QvwYcDM3qBioGqYAAZeEwgjRrvmpTwczwZdk1CC5cZjI8wzRcw7+1oSGqGyNaYTkcGv3LAzjcw6+xw6KCndyZnd6ZAguwFEdcMwygwlJjxE2sZ0k8LCgoHFuyAMYGBQQAxVhzxZhSn8SJKi6gxVbQxUMwxrAixmAMKmW8xU+Axj5YBtDJC21MxpwKx04gx0GgxsHCxmYgLGZcBXwMBH7cBHWsWZahERxBgEFQg9/xxmfsxWhzx2scHlNhEmBRDpwmA0w4gy4gyHr8iABxeiswhCpwhf9qQcmi4EobQhJO0B5OAcgjwHIRsR/gxg2Z2BFjmJYJkQCRyJTtEQHpliDZ4IZweHApxJRzybBwrEaLQkQHSIvacQKF7CquBG7rQ2k9cIqmrJqYzEBOt3FJeTvcWI0rgRDSaI/bUEEl54r2uBUgpxSiiHrOjAITYH2Tc27kwG4QAEwFtA6wJEuISG3XfD3ZXBOk2SbrkIkB0ctsUxP004r25nTIzCKUeH0CMhV0knU80pM6uXqROAEE8JZ/0xXseBAdgRQIMQGtaM97u8W4RwIzMSHpKBeoaA7osEwU4kxJ53arx8r7k9BwWZE16c2nWI2IctMyRwKv+NSkOMvhPAL/p3icMcRB8qZGiodHKlmQINkjCRE/WCLJamFHXfchX5cP5piWvrRCd8dOQN0mQg0v2UxGE4AYLP126JDXkOE2NFIKP5LSO7HSd0PLB+E6QLFycCInIN2WB7EcYjEibGR7JLFCl8PSsmYAPyLKJ/CMhygWsOw20zjaedFPMhnXLDLXOyVtwQN+tsB6X73U+cB5YuPVvPd0d2IZe/ke1+QotqR5pVkUolkohUk445fWiYEAh4kQjkFPnP13NaERs1eUAISUXwFRLiSWBq3aZGUTO8R3K6Ju3YEA1sgNbykSqbN8JOCUl13YU00Gz20Ceck4lGEY6tg4fylBJqU89IdG/9tx0KZTESV0iqApmCwyAfZ9EIoxjXeZOvpnKB5hmISn0cRhyX9M1lQA4MfSxv2kBIlMMBaOyFmsx02g4T/D4SROBB8+VSHOBPE9BSZuNC2+BCvOSjPu4SM+yWl8450kxlI8xXhWxScwyC2gykMQ40zD496h4vUZxEIMGxjOAojZA0guNUre4cJEvWtK4gN9HtakEl5IOIazOGjihgixH/ycAlX+xWphOeRGlQSBGHEYmfin3Bm1E78czHKuzInIDe1xGjX+B0R+AjzdTMSoHjn9lbijOygxEzXtSmteyeegPEA3i8bIO+wAEwGXirkzjdbIEussz7NIE4ODde1cgP/5Mugl4JQhWRQ/NQBXTT5mQhJM3BTcwd3iAujL/Y9E0ep6/dUsMtJ4gQ5/LQDt8CIqh9vhouok0E9qQpEB1BX70A+gDcqpveOs/Y4vuUB8fdV7/UDkjdU9Qtv7sU7uNNYDw+zUkM8upCZCid49qYv4MN11cevYXs3vOENF2e1vF+5IAdnD/nnDxyJjkj9a/qYkvt8JMXd2KQGxLnLsw3f1rdxqjuvEpOuujZmPwe+yk+CQMdxsKUEP/kUrBygche7+ou47QBewyQKR3sqBfPBzmuI3sFLUbO9zDN8yf6c0rwQvP9QxjzAqv8cWfy5KfgSB7gdDX+JFf09Hj0o7v6dXPZ8EP0/XQZ/uTAzkzPLEafzjWu9WQh4uU/vkmvDD0kL21ULENrz2bN/2bv/2cB/3cj/3dF/3dn/3eJ/3er/3fN/3fv/3gB/4gj/4hF/4hn/4iJ/4oRACADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Charles Lockwood, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_30_35309=[""].join("\n");
var outline_f34_30_35309=null;
var title_f34_30_35310="CNS tumor incidence rates";
var content_f34_30_35310=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F75349&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F75349&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Malignant CNS tumor age-specific incidence rates by anatomic site and age all races, both sexes, SEER, 1975-95",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 531px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Ries, LAG, Smith, MA, Gurney, JG (eds). Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. Bethesda, MD, 1999.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_30_35310=[""].join("\n");
var outline_f34_30_35310=null;
var title_f34_30_35311="Livedo reticularis - lower leg";
var content_f34_30_35311=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F61842&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F61842&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Livedo reticularis - lower leg",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A reticulated vascular network is present on the lower leg.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_30_35311=[""].join("\n");
var outline_f34_30_35311=null;
